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Traumatic brain injury (TBI) remains an important cause of morbidity and 
mortality within society. TBI may result in both focal and diffuse brain injury. 
Diffuse traumatic axonal injury (TAI) is an important pathological substrate of TBI, 
and can be associated with a range of clinical states, ranging from concussion 
through to death, the clinical severity being associated with a number of factors 
related to the injury.  
A retrospective study was conducted using 406 cases with TBI, from the 
archive of the Academic Department of Pathology (Neuropathology) University of 
Edinburgh, during the period from1982 and 2005. This cohort was sequential and 
provided a unique description of the range of pathologies associated with fatal TBI 
within the Edinburgh catchment area. All the data was collected on a proforma and 
analysed to provide a description of the incidence in the injury patterns among the 
Edinburgh cohort.  
This cohort was then used to provide cases to try and critically assess the 
mechanisms of axonal injury in TBI. A study was undertaken to investigate TAI in 
an experimental model of non-impact head injury in a gyrencephalic mammalian 
model (piglet model) and in human autopsy materials using immunohistochemical 
analysis of a range of antibodies, and to define the distribution of axonal injury with 
flow and neurofilament markers in TAI. A further objective was to examine the 
expression of β-APP as an indicator of impaired axonal transport, three 
neurofilament markers targeting NF-160, NF-200, and the phosphorylated form of 
the neurofilament heavy chain (NFH), in different anatomical regions of piglet and 
human brains. The double immunofluorescence labelling method was then employed 
to investigate the hypothesis of co-localisation between β-APP and each one of the 
previous neurofilament markers.  
The animal studies showed significant differences in NF-160 between sham 
and injured 3-5 days old piglet cases (6 hour survival) and between 3-5 days sham 
and injured, when stained with SMI-34 antibody. In 4 weeks old piglet cases (6 hour 
survival), immunoreactivity of β-APP was significantly higher in injured than 
control. No other significant differences for any of the antibodies were noted, based 
on age, velocity, and survival time. Human results suggested that the brainstem had a 
higher level of β-APP and NF-160 than the corpus callosum and internal capsule. 
Co-localisation of β-APP with NFs was not a consistent feature of TAI in piglet and 
human brains, suggesting that markers of impaired axonal transport and 
neurofilament accumulation are sensitive to TAI, but may highlight different 




1.1 Traumatic brain injury 
1.1.1 Epidemiology of traumatic brain injury 
The human brain is highly vulnerable to injury which can compromise the 
quality of life through profound cognitive and neurobehavioral dysfunction (Dash et 
al., 2010). Traumatic brain injury (TBI) is an overwhelming and major global health 
problem, and is one of the most important causes of morbidity and mortality in both 
industrialized and developing countries (Park et al., 2008). The death rate related to 
TBI in people less than 35 years of age is 3.5 times more than that of both cancer and 
heart disease (Lewin, 1991). Estimates by the World Health Organization (WHO) 
indicate 57 million people internationally have been hospitalised with one or more 
TBIs (Murray and Lopez, 1996).  
In the United States, recent statistics from the National Center for Injury 
Prevention and Control (NCIPC) reveal that approximately 1.4 million cases of TBI 
were reported each year from 1995 through 2001 (NCIPC, 2006). Of those patients, 
about 1.1 million (80%) were treated and discharged from emergency departments, 
235,000 (17%) were hospitalized, and 50,000 (3.6%) died from their injuries. As part 
of their findings, their analysis showed that the leadings causes of TBI were falls 
(28%), motor vehicle crashes (20%), struck by or against events (19%), and assaults 
(11%) respectively. A different study showed that at the beginning of 2005, 3.17 
million people in the United States were living with permanent disability as a 
consequence of TBI (Zaloshnja et al., 2008).  
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 In the United Kingdom, more than 1 million patients attend hospital each year 
suffering from head injury (Kay and Teasdale, 2001). Based on the Glasgow Coma 
Scale (GCS) (Teasdale and Jennett, 1974), about 90% of this group have a mild head 
injury, 5% have moderate, and 5% severe head injury (mild GCS 15-13, moderate 
12-9, severe 8 or less). Approximately 20% were admitted to hospital for 
observation, while 5% were transferred to specialist neurological care. Most serious 
injuries result from road traffic accidents (collisions) (RTA), but most head injuries 
follow a fall (40%) or an assault (20%). 
 Mild head injury (acute GCS 13-15) is associated with a higher than expected 
incidence of disability (Glasgow Outcome Scale (GOS) moderate or severe 
disability) at one year post injury (Thornhill et al., 2000). Our understandings of the 
chronic effects of repetitive head injury are evolving, and there has been a recently 
described condition known as chronic traumatic encephalopathy (McKee et al., 
2009). The relationship between a single head injury and subsequent 
neurodegeneration is complex, but studies do suggest that neurodegenerative disease 
is more common amongst survivors of a single head injury, particularly males. Meta-
analysis has been used to review case-control studies. Mortimer et al (1991) studied 
7 case-control studies and reported a relative risk of developing Alzheimer‟s disease 
(AD) of 1.82 for head injury with loss of consciousness. The relative risk, however, 
only reached significance for males. Fleminger et al (2003) studied 15 case-control 
studies and showed an odds-ratio (OR) of 1.58. Again, however, this study showed 
that the association between head injury and AD was only significant for males 
(males OR 2.26, females OR 0.92). The reason for this male predominance may 
reflect an inherent predisposition to risk taking in males or may be attributed to 
3 
 
participation in particular occupational and leisure activities which put the individual 
at higher risk for sustaining TBI, or (Yates et al., 2006). 
1.1.2 Classification of injury 
There is no single classification of TBI which completely encompasses all the 
clinical, pathological and cellular/molecular features of this complex process. The 
current status of classification systems for TBI was reviewed in a workshop 
convened by the National Institute of Neurological Disorders and Stroke (NINDS), 
with support from the Brain Injury Association of America, the Defense and 
Veterans Brain Injury Center and the National Institute of Disability and 
Rehabilitation Research (Saatman et al., 2008). Head injuries can be classified 
clinically, physically or pathologically. A number of clinical classifications such as 
the Brussells Coma Grades, Grady Coma Grades, Innsbruck Coma Scale and the 
FOUR score scale have been developed over the years (Brihaye et al., 1978; 
Fleischer et al., 1976; Gerstenbrand and Lucking, 1970; Wijdicks et al., 2005). 
However, the most widely used neurological injury severity scale is the 15-point 
Glasgow Coma Scale (GCS) (Teasdale & Jennett, 1974), although it is recognised 
that this scale is of limited value in paediatric evaluation as well as in cases with mild 
head injury. Generally, brain injury is classified as severe with GCS of ≤ 8, moderate 
with GCS of 9-12, or mild with GCS of 13-15. Physical classification of TBI 
includes impact (contact) and inertial loading (non-contact) injuries. Impact injury 
results from contact between the head and an object whereas the latter arises from the 
movement of the brain within the skull. The type and severity of injury can be 
predicted by the magnitude and direction of each type or combination of loading 
forces (Gennarelli et al., 1985). Penetrating and blast mechanisms of brain injury 
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have also been described (Saatman et al., 2008). These injuries are generally seen in 
firearm injuries and in a military or terrorist situation. There has been a major recent 
shift in TBI research towards blast-related TBI, mostly due to increased military 
funding in this field.  
Pathological classifications can be pathophysiological, describing primary and 
secondary injuries, or anatomical, based on focal or diffuse injuries. In one single 
case it is not uncommon to see both focal and diffuse injuries (Smith et al., 2003). 
The traditional division into primary and secondary brain damage remains usefull 
since time of injury onset has serious consequences for neuroprotection treatment 
approaches (Davis, 2000). Throughout this thesis the anatomical pathological 
classification will be used, describing focal and diffuse injuries.  
The focal lesions can be further subdivided into skull fractures, haematomas 
and contusions, whereas the diffuse injuries can be sub-classified into ischaemic 
brain damage, traumatic axonal injury/ diffuse vascular injury and brain swelling 
(Table 1.1) (Smith, 2005). The differences between traumatic and ichaemic axonal 
injury are illustrated in figure 1.1. 
The descriptor focal brain injury is defined as the damage to a localized region 
of the brain, but the diffuse term refers to widespread injury to either white or grey 
matter, or both (Graham et al., 2000). Focal brain injury occurs due to direct impact, 
while the diffuse type might take place in the absence of direct contact as a 
consequence of rapid acceleration / deceleration of the head leading to shearing 








Table 1.1: Classification of traumatic brain injury. Adapted from (Smith, 
2005).  
Focal Diffuse 
Scalp lacerations Global ischaemic injury 
 









Focal lesions secondary to raised 
intracranial pressure 
 
















Figure 1.1: Microscopic differentiation between traumatic and 
ischaemic axonal injury. H and E staining images demonstrate the axonal 
spheroid and ischaemic cell changes associated with trauma (A) and ischaemia (B) 
consecutively. Different patterns of β-APP accumulation are demonstrated 
immunohistochemically in trauma (C) and ischaemia (D). Images provided by Dr 









1.1.3 Pathology associated with brain injury 
1.1.3.1 Soft tissue injuries 
The initial injuries sustained by the scalp when the head is either struck by an 
object or strikes the ground are lacerations, contusions or abrasions (DiMaio and 
DiMaio, 2001). Lacerations may provide clues to the site of head impact and can be a 
source of blood loss due to the great vascularity of the scalp (Graham and Gennarelli, 
2000). 
1.1.3.2 Skull fractures 
The incidence of skull fracture is associated with the severity of the head injury 
(Graham and Gennarelli, 2000). Skull fractures are found in 25% of fatal head 
injuries at autopsy (Osborn et al., 2002). The direction, location and force of the 
impact producing the injury may be shown by the pattern of a skull fracture. Fracture 
lines usually radiate from the impact point into the base of the skull and connect with 
cranial nerve foramina. The presence of interlacing fracture lines is indicative of 
multiple blows. A range of skull fractures have been described according to the 
patterns they display including linear, depressed, hinge and ring fractures (Hardman 
and Manoukian, 2002). 
1.1.3.3 Contusions 
A cortical contusion is essentially a bruise of the surface of the brain and the 
overlying pia matter remains intact. A cerebral contusion is indicative of a contact 
head injury (Finnie and Blumbergs, 2002). Different types of contusions have been 
identified and associated with different biomechanical forces (Freytag and 
Lindenberg, 1957; Lindenberg and Freytag, 1960). Contusions typically involve the 
crest of gyri, but may extend through the cortex into the subcortical white matter 
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(Davis, 2000). They are typically distributed in the frontal poles; the orbital surfaces 
of the frontal lobes; the temporal poles; the lateral and inferior surfaces of the 
temporal lobes; and the cortex above and below the sylvian fissure (Adams et al., 
1980a). 
Contusions are categorized into different patterns including coup, contre-coup, 
herniation, fracture and gliding contusions. Coup and contre-coup injuries have a 
different pathogenesis, but both may involve the frontal and temporal lobes. Coup 
contusions occur under the impact site following a forward fall striking the forehead. 
Contre-coup contusions are found in brain tissue directly opposite to the impact site, 
being seen in the frontal or temporal lobes following a backwards fall striking the 
occiput (Gennarelli and Meaney, 1996). Coup and contre-coup contusions involve 
frontal and temporal lobes due to the bony anatomy of the anterior and middle 
cranial fossae. Fracture contusions are found in brain tissue lying beneath the fracture 
site. When the parahippocampal gyri and cerebellar tonsils are forced against the 
tentorium and foramen magnum at the time of injury, herniation contusions occur. 
Herniation contusions may also been seen around tissue which herniates through a 
surgical site such as a craniotomy. Gliding contusions have been defined as  
haemorrhagic lesions located in the parasagittal white matter, often associated with 
deep hemispheric traumatic haematoma (Lindenberg and Freytag, 1960; Adams.J. 
1986).  
The depth and extent of contusions in various parts of the brain can be assessed 
by a contusion index (Adams et al., 1985). This is discussed in more detail in the 
Materials and Methods section. A similar index, although more detailed and not 




A laceration can be defined as a mechanical tear of brain parenchyma, with 
disruption of the pia. Such tears are found in the same sites as contusions but they 
need greater force to occur. Lacerations invariably appear around penetrating or 
perforating wounds and are most commonly seen adjacent to fracture lines (Hardman 
and Manoukian, 2002). Although lacerations may be associated with skull fractures 
this is not a requirement (Adams and Graham, 1976). Microscopic or large 
haematomas can be produced by lacerations, and the combination of extensive 
laceration with underlying parenchymal haemorrhage may be associated with 
subdural and subarachnoid haemorrhages, forming a burst lobe. The site of bleeding 
is reported to be from overlying cortical veins and brain parenchyma. A burst lobe 
typically involves the temporal lobe, but it also occurs in the frontal lobes (Smith, 
2005). 
1.1.3.5 Intracranial haemorrhage 
Intracranial haemorrhages have been classified into epidural, also known as 
extradural (EDH), subdural (SDH), subarachnoid (SAH) and intracerebral (ICH). 
They are the most common cause of clinical deterioration in patients who experience 
a lucid interval, “talk and die” or “talk and deteriorate after injury” (Bullock and 
Teasdale, 1990). The clinical signs associated with EDH and SDH are related to the 
size /volume of the lesion, the anatomical location, and the rapidity with which the 
haematoma develops. EDH and SDH may be accompanied with a minor head injury 
wherein concussion can be either present or absent. A “lucid interval” has been 
documented in about 30% of patients (Jamieson and Yelland, 1968; Kvarnes and 
Trumpy, 1978; Reale et al., 1984). Concussion refers to an immediate, usually 
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reversible episode of brain dysfunction after traumatic brain injury (Bazarian et al., 
2006).  
Extradural (epidural) Haematoma: Extradural haematomas are 
accumulations of blood between the calvarium and the dura matter (Figure 1.1). Such 
a haemorrhage is typically due to blunt force trauma causing a torn blood vessel, 
which is usually associated with skull fracture (Smith and Graham, 2005). A number 
of clinical and autopsy studies of head injury have documented the incidence of 
EDH. Clinically, EDH has been reported in 0.2% to 6% in all head injuries 
(Galbraith, 1973; Jamieson and Yelland, 1968; Kvarnes and Trumpy, 1978; 
Weinman and Muttucumaru, 1969) and in 9% among cases with severe TBI (Seelig 
et al., 1984). In fatal blunt force head injury, the incidence has been reported as 
between 5% and 15% (Cordobes et al., 1981; Freytag, 1963). The incidence has been 
revealed to be the highest in fatal cases with a fracture of the skull, being found in 































EDHs are seen in frontal and occipital regions in about 20%-30%, but they are 
most commonly found overlying the convexity in relation to the temporo-parietal 
area (Graham et al., 2002). They have been reported in the posterior fossa in about 
3% of all EDHs found at autopsy (Lindenberg, 1971). Cases with EDH have a 
significant association with fracture of the squamous temporal bone in almost 50%, 
causing the underlying middle meningeal artery or vein to be injured. The bleeding 
will strip the dura forming a circumscribed ovoid blood clot that progressively 
indents and flattens the adjacent brain. Other blood vessels can be damaged including 
the anterior meningeal artery, superior sagittal sinus, occipital meningeal artery and 
transverse or sigmoid sinuses. The involvement of the internal carotid artery has been 
also reported (Cooper, 2000).  
Subdural Haematoma: Subdural haematomas form when bleeding occurs in 
the subdural space (Figure 1.2) and result most commonly after traumatic head 
injury, or occasionally due to non-traumatic causes (Smith and Graham, 2005). SDH 
can be caused traumatically by inertial loading (acceleration/deceleration) and no 
contact is required. The incidence of SDH has been reported in 5% of all head 
injuries (Echlin et al., 1956; Jamieson and Yelland, 1972) and in 9% to 22% of 
severe head injuries (Duhaime et al., 1994; Henderson et al., 2001). There are three 
types of SDH including acute, subacute and chronic; these are classified according to 
the time interval between injury and onset of symptoms.  
SDHs have been described as simple or complicated. This is based on the 
absence or presence of related parenchymal injury. Simple SDH had a mortality of 
20% while complicated SDH was associated with mortality of more than 50% 
(Jamieson and Yelland, 1972). In patients with an enlarged haematoma, nausea, 
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vomiting and headache, followed by a reducing level of consciousness, may develop. 
This can also be associated with other focal neurological signs such as an ipsilateral 
fixed dilated pupil or ipsilateral motor deficit (Bullock and Teasdale, 1990). The 
signs and symptoms of chronic SDH are frequently insidious in onset and the 
diagnosis of this haemorrhage can be difficult to make since a history of head injury 





Figure 1.3: Subdural haematoma identified at autopsy. Image 







Acute SDH typically presents clinically within 72 hours of the head injury 
(Hernesniemi, 1979; Rosenorn and Gjerris, 1978; Talalla and Morin, 1971) although 
most present clinically within hours. Haematomas that become symptomatic between 
3 and 21 days are considered subacute (Jamieson and Yelland, 1972). Autopsy 
studies have reported an incidence of acute SDHs in between 20% and 63% of cases 
(Adams et al., 1980; Freytag, 1963). Acute SDH can result from a ruptured bridging 
vein causing what is called pure SDH. It may also occur due to contusions associated 
with damage to cortical veins or arteries in the overlying leptomeninges (Smith and 
Graham, 2005).  
Chronic SDH is thought to occur after an episode of minor head injury (Svien 
and Gelety, 1964). However, there was no history of trauma in 25% to 50% of cases 
(Marshall et al., 1983). The association of chronic SDH with intra-axial malignancy 
has been reported (Alimehmeti and Locatelli, 2002; Popovic et al., 1994). Alcohol 
abuse is common in chronic SDH cases (Stroobandt et al., 1995). In this situation, 
the SDH might be a result of an increased bleeding diathesis associated with liver 
disease and thrombocytopenia. Imaging studies have demonstrated that most acute 
SDH resolve without the formation of a chronic SDH, although an episode of acute 
haemorrhage is clearly needed to initiate such lesion (Dolinskas et al., 1979). The 
mechanism of enlargement is still uncertain in those cases that progress to a chronic 
SDH, although the evidence suggests that fragile new blood vessels within the 
evolving haematoma are susceptible to bleeding resulting in repeated episodes of 




Subarachnoid Haemorrhage: Subarachnoid Haemorrhage (SAH) is the 
presence of blood in the subarachnoid space. There are several different causes such 
as trauma and rupture of an aneurysm (Herrmann and Zabramski, 2007). In cases 
with head injuries, SAH has been reported to be a common autopsy finding (Freytag, 
1963; Lindenberg and Freytag, 1970; Tatsuno and Lindenberg, 1974) although rarely 
it is clinically significant. There is an association between SAH and contusions, 
although it has no clinical significance (Graham and Smith, 2001).  
Primary traumatic SAH is a rare entity which is the result of a single blow to 
the side of the head resulting in damage to the vertebral arteries. Clinically traumatic 
SAH is often associated with sudden collapse, and alcohol excess is often involved 
(Gray et al 1999).  
Intracerebral Haematoma: Intracerebral haemaorrhages are seen most 
frequently in the frontal and temporal lobes, and were described in 15% of fatal head 
injuries in one series (Freytag, 1963). Autopsy studies have reported an incidence of 
up to 40% (Clifton et al., 1981; Graham, 1996). They were seen less often with EDH 
alone or combined with SDH, but they were concomitant in about 20% of SDH 
cases. Superficial intracerebral haematomas are most likely associate with extensive 
contusional injury. However, impacts of greater force, such as road traffic accidents, 
can cause more deeply seated haematomas which occur in regions of maximal 
acceleration-induced brain injury (Graham and Smith, 2001).  
The mechanism of intracranial haematomas seems to be a complex 
pathophysiologic process, with alcohol intoxication being an important contributing 
factor (Hardman and Manoukian, 2002). Alcohol appears to enhance bleeding by 
altering platelet function, coagulation or membrane-bound enzymes (Cowan, 1975; 
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Flamm et al., 1977). In addition, traumatic coagulaopathy has been known to be 
initiated after mechanical injury in TBI (Stein et al., 2005). Traumatic coagulaopathy 
has been established to be a type of disseminated intravascular coagulation (DIC), 
which can occur through the release of tissue thromboplastin into the circulation 
from injured brain tissue (Gando et al., 1999; Hoots, 1996). It has been confirmed 
that this process leads to the stimulation of intravascular microthrombosis (IMT) in 
the brain (Stein et al., 2004). The incidence of DIC has been reported in several 
studies, being present in up to 76% of cases following head injury (Kumura et al., 
1987; Miner et al., 1982; Olson et al., 1989; Pondaag, 1979). DIC is seen most 
commonly in patients with acute SDH or parenchymal contusions (Kumura et al., 
1987). The ε4 allele of the apolipoprotein E (Apo E) gene has been suggested to have 
a possible a role in traumatic coagulopathy since variations exist amongst patients 
with similar types of injury (Stein et al., 2005).   
1.1.3.6 Brain injury secondary to raised intracranial pressure 
The skull and dura are known to form a relatively fixed space. Intracranial 
pressure (ICP) is defined by the intracranial contents comprising brain, blood and 
cerebrospinal fluid (CSF) (Little, 2008). A principle known as the Monroe-Kellie 
doctrine has stated that an increase in the volume of one of these components must 
result in a decrease in the others (Ropper and Brown, 2005). So, ICP will begin to 
increase if the volume of one of these components continues to increase. 
Normal ICP is dependent on age and body position, and in a supine healthy 
adult, between 7 and 15 mm Hg (Steiner and Andrews, 2006). In the vertical posture, 
it has a negative value with an approximate mean of -10 mm Hg, but not exceeding -
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15 mm Hg (Czosnyka and Pickard, 2004). In term children, 3-7 mm Hg is considered 
normal, whereas in infants values between 1.5 and 6 are quoted (Dunn, 2002). 
A rise in ICP may be precipitated as a result of a number of intracranial 
pathologies including mass lesions, accumulation of CSF, vascular congestion and 
cerebral oedema. The pathology of raised ICP is thought to be a function of the 
causative pathology. Its consequences might include localized deformation of the 
brain, a reduction in CSF volume, shift of the brain and associated herniation. Brain 
herniation may extend under the falx cerebri, damaging the cingulate gyrus 
(subfalcine or supracallosal hernia); under the tentorium cerebelli damaging the 
parahippocampal gyrus /medial temporal lobe (tentorial or uncal hernia); and through 
the foramen magnum, damaging the tonsil of the cerebllum (tonsillar hernia) (Barlow 
and Stewart, 2007). 
A supracallosal hernia may lead to ischaemia of parasagittal cortex in addition 
to pressure necrosis of the cingulate gyrus as a consequence of compressing the 
pericallosal arteries. Tentorial hernia may cause medial occipital cortical infarction 
as a result of compressing the posterior cerebral artery, and caudal displacement and 
elongation of the rostral brainstem. Clinically a tentorial hernia may manifest as 
dilatation of the pupil, due to damage to the ipsilateral third nerve, and hemiparesis 
ipsilateral to the expanding mass lesion due to contralateral cerebral peduncle 
compression (Graham and Smith, 2001). 
 A common terminal event as a consequence of raised ICP is brainstem 
haemorrhage and infarction, due to axial displacement (Figure 1.3), found in up to 
70% of brain injured patients who die. Such pathologies are seen at autopsy as small 
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foci of haemorrhage and /or infarction in the paramedian parenchyma of the pons and 
midbrain towards the ventral aspect (Graham et al., 1987). 
 
 
Figure 1.4: Axial displacement (upper) and haemorrhage (lower) of the 





Ischaemic brain injury is a common pathology in patients dying from TBI 
(Graham et al., 1978; Graham et al., 1989). In one study, it has been documented in 
91% of cases (Graham et al., 1978). Ischaemia is often considered to be similar to 
hypoxia. However, while ischaemia is characterised by reduction or cessation of the 
systemic or regional blood flow, hypoxia is defined as a decrease of oxygen content 
in the blood (Oechmichen and Meissner, 2006). For instance, in cases of carbon 
monoxide (CO) poisoning, there is hypoxia but with no associated ischaemia.  
Cerebral ischaemia can develop as a result of increasing ICP, often due to 
cerebral swelling secondary to cardiac arrest or due to an expanding intracranial 
lesion, or as a result of systemic hypotension (Smith and Whitwell, 2004). This, in 
turn, can cause oxygen and glucose deprivation as well as increased levels of 
potentially toxic substances, particularly lactic acid. These haemodynamic reductions 
can lead to the reduction in metabolites such as ATP, since nerve cells do not store 
alternative energy sources. This reduction may eventually result in metabolic stress, 
energy failure, ionic perturbations and ischaemic injury (Dirnagl et al., 1999; Siesjo 
et al., 1989). In hypoxia, there is only impairment of oxygen delivery. Metabolic 
products such as lactate and H
+
 ions are still removed by the increased blood flow, 
and glucose and other substances continue to be supplied by the blood (Miyamoto 
and Auer, 2000). It has been described that there was no evidence of cellular necrosis 
or energy failure, or any other significant pathological changes in the brain at 
autopsy examination after severe hypoxia (Rie and Bernad, 1980).  
Ischaemic insults can be global or focal and the cells that undergo severe 
ischaemia may die within minutes of the insult or display a delayed vulnerability 
20 
 
(Bramlett and Dietrich, 2004). In the brain, the cells most sensitive to ischaemia are 
neurons followed by other cell types such as oligodendrocytes, astrocytes and cells of 
blood vessels including endothelium and smooth muscle. Neuronal injury occurs 
rapidly after injury but not all neurons in the brain have the same vulnerability to 
ischaemia (Kubo et al., 1998). Neurons in the hippocampal subfield CA1, neocortical 
layers 3, 5, and 6, the outer segments of striatum, and the Purkinje cell layer of 
cerebellar cortex are most vulnerable and are referred to as selectively vulnerable 
(Bouma et al., 1992; Kotapka et al., 1992).  
After the onset of ischaemia, the first sign of cellular injury to occur is 
neuronal swelling or shrinkage. If blood flow is restored prior to mitochondrial 
membranes beginning to rupture, these changes are potentially reversible. One to two 
hours later, neurons undergo irreversible necrotic changes which are recognized as 
ischaemic cell change. This phenomenon is characterised by condensed acidophilic 
cytoplasm, formation of triangular pyknotic nuclei and direct contact with swollen 
astrocytes. After 2-4 hours, ischemic cell change with incrustations becomes visible: 
this being an indication of irreversible neuronal damage. With ongoing ischaemia, 
the nuclei become smaller and the cytoplasm paler, a process described as 
homogenizing cell change (Stewart et al., 2004).  
1.1.3.8 Brain swelling 
Brain swelling is a commonly identified pathology in cases of fatal brain injury 
(Adams et al., 1980a). The swelling may be focal, usually in relation to contusions, 
or diffuse. The swelling may be congestive, secondary to an increase in the cerebral 
blood volume, or due to oedema, an increase in the water content of the brain tissue 
(Unterberg et al., 2004).  Brain oedema is classified into vasogenic and cytotoxic 
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oedema, in relation to either extra- or intra-cellular accumulation of abnormal fluid 
(Klatzo, 1967; Klatzo, 1994). Vasogenic oedema results from functional impairment 
of the blood-brain barrier (BBB) leading to a high level of plasma proteins and water 
in the extracellular space. Abnormal water uptake by injured brain cells may cause 
cytotoxic oedema. Other types of oedema including hydrocephalic (interstitial) 
oedema and osmotic (hypostatic) oedema have also been described (Fishman, 1975; 
Klatzo, 1994). Hydrocephalic oedema is caused by an obstruction of cerebrospinal 
fluid outflow, while osmotic brain oedema is associated with osmotic imbalance 
between blood and tissue (Unterberg et al., 2004). 
 Depending on the time course of disease, different types of oedema can be 
found together in most clinical conditions (Nag et al., 2009). For instance, cellular 
swelling and cytotoxic oedema are associated with early cerebral ischaemia; 
however, when there is BBB breakdown due to the damage of the capillary 
endothelium vasogenic oedema will result. Cytotoxic, vasogenic, and interstitial 
oedema can be seen together in the case of meningitis, and both vasogenic and 
cytotoxic oedema are found in TBI (Marmarou, 2007). The pathogenesis underlying 
brain swelling is incompletely understood, although progress has been made from the 
study of molecules such as aquaporins; the matrix metalloproteinases; growth factors 
such as vascular endothelial growth factors A (VEGF-A) and B (VEGF-B); and 
angiopoietins (Nag et al., 2009). 
   In the setting of TBI, cytotoxic oedema appears to be more common than 
vasogenic oedema (Marmarou et al., 2000; Marmarou et al., 2006). Based on its 
extent and distribution, traumatic brain swelling may be categorised into focal, 
diffuse within one cerebral hemisphere or diffuse involving both cerebral 
22 
 
hemisphere. While focal swelling is related to contusion, global ischaemia is thought 
to be the cause of diffuse swelling of both cerebral hemispheres (Smith, 2005). 
1.1.3.9 Diffuse traumatic axonal injury 
Diffuse traumatic axonal injury (TAI) is an important pathological substrate of 
TBI due to the fact that it contributes to at least 35% of the mortality and morbidity 
of TBI cases without space occupying lesions and it is also related to the mortality 
and morbidity attributable to focal brain injuries (Gennarelli et al., 1982). The 
spectrum of TAI ranges clinically from mild diffuse injury being associated with 
mild concussion, in which consciousness is often preserved, to severe diffuse TAI 
resulting in a vegetative state (Gennarelli et al., 1993). Microscopic pathology of TAI 
in mild head injury has been described in only two published human studies and this 
may outline the basis of concussion (Blumbergs et al., 1994; Gorrie et al., 2002). 
Along with diffuse ischaemic injury, TAI is reported to be a main cause of severe 
disability and vegetative state in survivors of head injury (Graham et al., 2005).  
The term diffuse axonal injury (DAI) is now reserved for the clinical syndrome 
with supporting neuroradiological changes. The term used for the pathological 
demonstration of damaged axons in a pattern supporting a traumatic aetiology is TAI 
(Geddes et al., 2000).  
The typical pattern of TAI includes axonal injury in the corpus callosum, 
dorsolateral segments of the rostral brain stem adjoining the cerebellar peduncles, 
and in the internal capsule (Graham et al., 2002). In some cases, haemorrhagic 
lesions are also seen in the corpus callosum and dorsolateral quadrants. Three grades 
of TAI have been described; mild, moderate and severe (Adams et al., 1977; Adams 
et al., 1989). In mild TAI (Grade 1), there are microscopic changes in the white 
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matter of the cerebral cortex, corpus callosum, brain stem and the cerebellum. The 
moderate form of TAI (Grade 2) is distinguished by grossly obvious focal 
haemorrhagic lesions isolated to the corpus callosum. In severe TAI (Grade 3), 
additional focal haemorrhagic lesions are seen in the dorsolateral quadrants of the 
rostral brain stem. 
In 1956, Strich was the first to describe the diffuse degeneration of white 
matter in patients with dementia after head injury (Strich et al., 1956). She then 
ascertained that the axonal damage can be created by mechanical forces shearing the 
fibres at the time of injury and the pathological correlate of this was retraction balls 
at the points of fibre disruption (Strich, 1961). Since that time research has 
investigated axonal injury pathways particularly through the development of animal 
models, which will be discussed below.    
1.1.4 Animal models of TBI 
Research using animal models of traumatic brain injury usually aims to 
understand the complex structural and functional events after traumatic brain injury 
(Wang and Ma, 2010). These models allow an opportunity to control the 
physiological parameters of the model to be able to replicate the sequence of changes 
occurring in the clinical condition of human brain injuries (Duhaime, 2006). A close 
correlation between the severity of injury and the post injury response and rate of 
recovery of brain-injured animals has been reported in a number of studies 
(Gennarelli, 1994; Povlishock et al., 1994; Mclntosh et al., 1998). Therefore, a 
classification for severity of traumatic brain injury in animal models has been 
developed, and models exist to focus specifically on focal and/or diffuse damage 
(Morales et al., 2005).    
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The most common experimental models for focal TBI are the fluid percussion 
injury and controlled cortical impact injury models (Morganti-Kossmann et al., 
2010).  
Optic nerve stretch injury: Much of the work relating to the basic science of 
axonal injury has been undertaken on the optic nerve stretch model, enabling axonal 
injury to be studied at different stages following injury (Gennarelli, 1994; Maxwell 
and Graham, 1997; Maxwell et al., 1997). This model has been developed in guinea 
pigs and allows a pure white matter injury to be produced. The process of axonal 
degeneration can be studied at different time-points post-stretch, and the process can 
be studied at great detail, down to the ultrastructural level.   
Fluid percussion injury: There are two subsets of the fluid percussion injury 
model namely the midline and lateral models, based on their respective positions of 
craniotomy (Wang and Ma, 2010). The lateral fluid percussion model is the most 
commonly used experimental model for producing both focal and diffuse injury 
(Mclntosh et al., 1989). This method requires the delivery of a pressure pulse of a 
saline solution from a reservoir into a piston using a pendulum falling from different 
heights (Morganti-Kossmann et al., 2010). In this model the craniotomy is moved 
from the sagittal suture to a lateral position, generating a focal contusion lateral to the 
actual trephination and injury site with associated diffuse white matter damage 
remote from the injury site (Thompson et al., 2005).  Focal TBI can be typically 
produced by midline fluid percussion whereby trephination is used to open the skull 
over the sagittal suture. A fluid bolus is accelerated onto the dural surface, the force 
being modified by variation of height from which the pendulum used to accelerate 
the bolus is released.  
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Cortical impact injury: The cortical impact device creates an injury by 
delivering a mechanical energy to the intact dura utilizing a pressurised rigid 
impactor (Cernak, 2005; Dixon et al., 1991; Thompson et al., 2005). Computerised 
software is used to regulate the damage in which varied parameters such as tissue 
depth, velocity, and duration of the impact can be selected.  
Weight drop model: This model of closed head injury was established by Chen 
et al (1996). The weight drop model uses a specific mass falling on the closed skull 
which can lead to a unilateral skull fracture and a cortical cavity surrounded by a 
pericontusional lesion.  
Although some of these rodent models have been modified for larger animals, 
these experiments have only been performed in the acute phase after injury and 
without behavioral testing (Duhaime, 2006).  
Non-impact injuries (rotational injuries): Models to study diffuse traumatic 
axonal injury have been developed for rodents and higher species animals. Initially, a 
non-human primate model was established by Gennarelli et al (1982). This model 
uses a pneumatic shock tester to produce a non-impact injury. There is a controlled 
single rotation through a 60-degree arc in sagittal, oblique or lateral direction. They 
were able to generate prolonged post-injury coma associated with diffuse axonal 
damage, similar to that found in human brains after severe head injury. Marmarou et 
al (1994) subsequently developed a rodent model of diffuse TAI in the rat. Other 
large animal versions of diffuse injury have been developed in the pig using the adult 
and juvenile brain respectively (Smith et al., 2000; Duhaime, 2006). The 
acceleration-deceleration rat model has been shown to generate a widespread axonal 
injury, which extends up to the brainstem (Foda and Marmarou, 1994). Additionally, 
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the central fluid percussion model has been extensively used to characterize diffuse 
traumatic axonal injury (Singleton et al., 2002).  
TAI in white matter tracts and in multiple regions of the brain has been 
demonstrated after inertial rotation of the piglet‟s head in the axial plane. Raghupathi 
and Margulies (2002) were the first to modify the non-impact inertial injury model 
for primates to immature piglets, and a number of reports have been published to 
describe responses at different ages with comparisons between ages. These injuries 
have not been scaled specifically to brain mass or other size parameters, although 
they have been graded as mild or more severe. In individuals subjected to higher 
deceleration forces, neuropathological findings of widespread axonal injury, 
scattered surface haemorrhages and sustained loss of consciousness have been 
demonstrated using this model. These observations were similar to the injuries 
attained when using this model in adult pigs and primates. Additionally, Ramesh et al 
(2004) have investigated the role of repeated mild injuries and found that the 
vulnerability to injury appeared to increase in the immature brain. Another study 
from the same group has developed neurobehavioral outcomes in neonatal piglets 
and suggested the possible application of these tests to other areas of animal 
modelling outcomes which use piglets, including cardiac resuscitation, stroke and 
global ischaemic brain injury (Friess et al., 2007). 
Critical comparisons of the models: The vast majority of the published data 
surrounding animal models of TBI use rodent models, either fluid percussion or 
cortical impact. While these models have some value in assessing the biochemical 
cascades and behavioural outcomes of focal cortical injury, there are very serious 
limitations in the application of this data to the human setting. Rodents have very 
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little white matter and, as such, are unlikely to show a tissue response similar to the 
human. In addition, and of greatest concern, the lissencephalic morphology and small 
mass of the rodent brain poses unique challenges when assessing rotational injury; 
the gyral brain pattern significantly affects the movement of the brain within the 
cranial cavity (Cloots et al., 2008). Brain deformation is significantly greater in 
gyrencephalic animals, and biomechanical studies have demonstrated that axonal 
injury correlates with tissue deformation (strain) rather than the force applied per unit 
area (stress) (Margulies et al., 1990). As such to fully develop a model of TBI in any 
way comparable to the human a gyrencephalic animal with a large brain needs to be 
used. There are major ethical problems around the use of non-human primates, and 
the pig/piglet models are the best models currently available.   
1.2 Mechanisms of axonal injury 
1.2.1 Axonal transport system 
The axon of a neuron is recognized to have two major functions; to electrically 
transmit information from the neuron cell body to the synaptic terminals and to carry 
proteins and organelles in both directions between the cell body and the synaptic 
terminals. This transportation process is called axoplasmic transport (Duncan and 
Goldstein, 2006).   
Axonal transport has been classified into two major components, fast and slow. 
Fast axonal transport is responsible for the movement of membranous organelles, 
mitochondria, neurotransmitters, channel proteins, multivesicular bodies and 
endosomes at a rate of 0.5- 10 µm/ sec in the direction of the synapse (anterograde 
transport) or back to the cell body (retrograde transport). The slow axonal transport is 
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able to move cytoskeletal proteins and soluble enzymes at a rate of 0.1- 0.001 µm/ 
sec in the retrograde route (Miller and Heidemann, 2008). 
The axonal transport system consists of motor proteins to move the cargo; 
cytoskeletal filaments that allow motors to produce force and movement; linker 
proteins to attach motor proteins to cargo; and other molecules which start and 
control transport. Disruptions to any of the mentioned components can lead to 
defective axonal transport and neurodegenerative diseases (Roy et al., 2005). 
1.2.1.1 The cellular cytoskeleton 
The process of axonal transport takes place along the cellular cytoskeleton. 
Although the cytoskeleton is dynamic allowing the cell to grow or change in size and 
shape over time, it also provides the neuron with structural support (Shah and 
Cleveland, 2002). Three main components of the neuronal cytoskeleton have been 
recognized, namely microtubules, actin mircofilaments and intermediate filaments 
(Nixon, 1998).  
Microtubules: Microtubules are long filaments essential to all eukaryotic cells 
and are formed from the polymerization of α- and β-tubulin dimers. The α- and β-
tubulins are proteins which show about 50% identity at the amino acid level, and are 
about 459 amino acids each (Burns et al., 1991). This polymerization is very 
dynamic in non-neuronal cells and in developing neurons. This dynamic process has 
been reported to be necessary for the normal outgrowth of the axon and growth cone. 
However, the microtubules become less dynamic as neurons mature (Valiron et al., 
2001). This is essentially due to the stabilization of the polymer through interactions 
with microtubule-associated proteins (MAPs). In the axons of mature motor neurons, 
the high concentration of MAPs such as tau can significantly increase the stability of 
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theses microtubules (Brown, 2003). These microtubules have been found to be 
organized in a polar array along the axon. The polar structure is characterized by a 
microtubule „minus‟ end, terminating in α-tubulin, directed toward the cell centre, 
and the microtubule „plus‟ end of exposed β-tubulin directed outward (Salinas et al., 
2008). Gamma-tubulin is a third member of the tubulin family, which may be 
involved in nucleation of microtubules and anchoring the minus end, and gamma-
tubulin is found at microtubule organization centres (Joshi, 1993). 
Actin microfilaments: Actin microfilaments are also known to be involved in 
both the dynamic function of the axon and stability. Assembly of actin monomers 
produces a flexible helical polymer with two distinct ends and actin microfilaments 
are frequently bundled into networks within the cell. Interacting proteins are thought 
to stabilize actin microfilaments, and actin microfilaments are most abundant in the 
sub-plasmalemmal area of the cell providing support at the cell periphery (Chevalier-
Larsen and Holzbaur, 2006).  
Intermediate filaments (neurofilaments): Intermediate filaments, primarily 
neurofilaments, are amongst the major components of the cellular cytoskeleton, and 
this will be discussed in detail later in this chapter.   
1.2.1.2 Molecular motors 
1.2.1.2.1 Kinesin and the kinesine superfamily 
The first axonal transport motor to be recognized was kinesin; this was based 
on assays of vesicular motility along microtubules in extruded axoplasm (Vale et al., 
1985). Kinesin, also known as kinesine-1, is a plus-end directed motor protein that 
conveys membranous organelles and synaptic vesicle precursors toward the direction 
of the synapse (Lawrence et al., 2004).   
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The hetero-tetramer structure of kinesin includes two heavy chains and two 
light chains. Each of the heavy chains comprises an an N-terminal motor domain, 
which fold forming a globular head that appears to be essential for motility in vitro. 
The α-helical coiled coil is formed by the central domain of the polypeptide and it 
mediates dimerization. The light chains of kinesin are related to the C-terminal 
domain, which may involve in cargo binding (Verhey et al., 1998; Stock et al., 
1999). It is thought that the two heads of kinesin use the microtubule as a track for 
their movement (Yildiz et al., 2004). This movement appears to be highly processive 
which allows kinesin to transport cargo over the long distances of the axons prior to 
detaching (Vale et al., 1996). An extensive superfamily of kinesin-like proteins has 
been identified, based on homology with the kinesin motor domain. Many of the 45 
members identified in humans also exhibit motor activity (Miki et al., 2005).  
1.2.1.2.2 Cytoplasmic dynein and dynactin 
Cytoplasmic dynein is the major motor driving retrograde transport which is 
involved in moving neurotrophic signals, endosomes and other organelles and 
vesicles toward the cell body (Muresan, 2000). Dynein was initially recognized as 
the motor protein driving ciliary and flagellar motility, but an intracellular dynein, 
which is particularly enriched in brain, was subsequently identified using 
biochemical approaches (Paschal et al., 1987). It has been reported to have important 
functions in both intracellular transport and cell division (Almenar-Queralt and 
Goldstein, 2001). The structure of cytoplasmic dynein includes two homodimerized 
heavy chains and multiple accessory proteins (King, 2000). The force for movement 
of dynein along microtubules is provided by the C-terminal portion, while the N-
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terminal domain is required for binding of accessory proteins as well as 
homodimerization of the heavy chain (Roy et al., 2005). 
Dynactin has been reported to interact with cytoplasmic dynein through dynein 
intermediate chains and controls its function. It may also act as an adaptor for 
binding to some of the membrane bound vesicles and organelles transported by 
dynein (El-Kadi et al., 2007). The dynactin molecule is large and complex and 
includes 11 various subunits. The actin-like filament is the most distinctive aspect of 
dynactin forming the base of the complex, consisting of the actin-related protein 
Arp1 (Schafer et al., 1994). A dimer of an extended coiled-coil protein, p150
Glued
, is 
projected from this filament (Holzbaur et al., 1991), and then binds directly to 
cytoplasmic dynein (Karki and Holzbaur, 1995; Vaughan and Vallee, 1995). The 
efficiency of dynein-mediated motility can be increased by binding p150
Glued 
to 
microtubules forming an additional microtubule-binding site (Waterman-Storer et al., 
1995; King and Schroer, 2000). 
1.2.2 Theory of axonal injury 
Initial observations in human brains suggested that the axons are disconnected 
at the time of the impact (primary axotomy) leading to axonal retraction and 
axoplasmic pooling (Strich et al., 1956). However, it has been shown through many 
studies that this hypothesis is inaccurate. More recent studies have illustrated that the 
forces applied to the axon modify focal axonal sections, causing local axonal 
transport disruption and local axonal swelling, followed by detachment over a period 
of time after injury (Povlishock and Jenkins, 1995; Maxwell et al., 1997). Although a 
small proportion of axons, particularly small unmyelinated axons, do undergo 
primary axotomy, the fact that theses axonal changes have been identified in 
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scattered axons associated with other normal axons and their vascular elements is 
strongly supportive of secondary axotomy. The molecular changes that can 
contribute to the pathogenesis of the axonal injury are being elucidated and are 
discussed below (Farkas and Povlishok, 2007). Many intra-axonal changes evolve 
during TAI, which then progress into axonal transport dysfunction, disconnection, 


























Figure 1.5: Flow chart representing the consequences of TAI. TAI often 
leads to secondary axotomy, which is initiated by calcium influx, calpain activation 
and cytoskeletal damage. Axonal swelling is caused by early cytoskeletal changes, 
while secondary axotomy contributes to axonal bulbs which then lead to Wallerian 





















Axonal transport disruption 
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1.2.2.1 Altered axolemmal permeability  
It has been thought for some time that altered axolemmal permeability is a 
consequence of the shear and tensile forces caused by the mechanical injury (Medana 
and Esiri, 2003). Using the fluid percussion injury model, Pettus et al (1994) have 
employed extracellular horseradish peroxidase (HRP) and the neurofilament 68 kD 
subunit to determine if altered axolemmal permeability occurs after the traumatic 
injury. They have demonstrated alterations in axolemmal permeability associated 
with rapid local compaction of axonal neurofilaments following moderate TBI. 
Similar events in the axolemma and the cytoskeleton have also been observed within 
5 minutes and up to 6 hours post-TBI (Pettus and Povlishock, 1996), suggesting that 
this initial mechanism occurs over a relatively prolonged period of time. 
The importance of mechanoporation is linked to the fact that altered 
axolemmal permeability can allow the entry of normally excluded ions such as 
calcium (Ca
2+
) into the internal environment of the axon (Siesjo et al., 1999). 
Mechanoporation of the axolemma has been demonstrated to involve the mechanical 
formation of transient membrane pores during axonal injury. It acts as a major factor 
in the Ca
2+
 -induced pathophysiology in animal models of brain trauma (Maxwell et 
al., 1993; Buki et al., 2000). The dysregulation of axonal calcium stimulates different 
Ca
2+
-dependent deleterious cascades, including calpain, caspase and calcineurin 
activation, which contribute to the cytoskeletal disruption leading to impaired axonal 
transport (Buki et al., 1999; Hall et al., 2005; Kurz et al., 2005; Okonkwo et al., 
1999; Okonkwo and Povlishok, 1999; Singleton et al., 2001; Stone et al., 2002; 
Sattman et al., 2003).  
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Although it is thought that all injured axons follow the same mechanism of  
Ca
2+ 
mediated damage, a number of studies have suggested that after TBI, the 
response of axons are more complex than previously considered (Buki et al., 1999; 
Maxwell et al., 1997). Stone and colleagues, using rodent models, have demonstrated 
that neurofilament compaction can take place independent of axonal transport 
disruption (Stone et al., 2001). They were able to illustrate two different anatomical 
substrates of TAI by employing different antibodies targeting different functions; -
APP to detect impaired axonal transport and RM014 to identify neurofilament 
compaction. Further studies in 2005, again using rodents, have supported this 
premise by concluding that there is no correlation between neurofilament compaction 
and impaired axonal transport in the majority of damage axons (Marmarou et al., 
2005). However, to date this observation has not been described in any model outside 
of the rodent fluid percussion model. 
In more severe forms of axonal injury, Marmarou et al (2005) have also 
reported that the huge Ca
2+ 
influx alters local transport kinetics by converting 
anterograde to retrograde transport and also to influence the formation of reactive 
axonal swellings. Moreover, the further complexity of the mechanisms of TAI has 
emerged with studies showing no evidence of changed axonal permeability in 
unmyelinated axons subjected to in vitro mechanical loading (Wolf et al., 2001). 




channels can be a source of 
local Ca
2+ 
dysregulation and the activation of the voltage sensitive Ca
2+ 
channel was 
due to the subsequent depolarization. In addition, they discussed other events as well 




exchangers, which resulted in a significant increase 
in intra-axonal calcium. 
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As has been shown, previous studies have demonstrated that there are several 
sources of Ca
2+ 
dysregulation, particularly the direct mechanical membrane poration, 
the activation of Na
+
 channels and / or a direct channelopathy.  Furthermore, 





proteolytic pathways seem to play important roles in the pathogenesis of the axonal 
injury (He et al., 1999; Maxwell et al., 1995; Wolf et al., 2001). 
Maxwell and colleagues have reported that the activation of these proteolytic 
mechanisms can be the reason for instantaneous disruption of the axonal 
cytoskeleton (Maxwell et al., 1993). By contrast, ultrastructural investigations have 
suggested that there is no alteration in the general structural integrity of the local 
axonal cytoskeleton for several hours after injury, although morphological changes 
such as neurofilament compaction and loss of microtubules can be detected rapidly 
(Povlishock and Pettus, 1996). 
1.2.2.2 Induction of calpain-mediated structural proteolysis 
The impact acceleration rat brain injury model was used to investigate the 
subject of Ca
2+
-induced proteolytic alteration (Marmarou et al., 1994). This model is 
uncomplicated and it has the ability to generate focally injured axonal segments that 
can be identified within the brain stem tracts. It has been demonstrated that calpain 
can help to identify Ca
2+
-induced proteolytic activation in injured axonal segments 
and this has been achieved using a set of antibodies (Ab38) against breakdown 
products of the structural protein spectrin (Robert-Lewis et al., 1994; Siman et al., 
1984). Immunohistochemical studies utilizing single and double labelling light and 
electron microscopy have demonstrated the calpain-mediated spectrin proteolysis 





calpain (Buki and Povlishock, 2006). Calpain activation co-localised with markers of 
traumatic axonal injury such as RMO-14 antibody, enabling cytoskeletal alterations 
such as neurofilament compaction associated with traumatic axonal injury to be 
shown (Lee et al., 1987; Maxwell et al., 1993; Okonkwo et al., 1998). 
In experimental animal models of TAI there was a significant increase in the number 
of CMSP-immunorective axonal profiles over time after injury. Buki and colleagues 
have noted that following an injury, the calpain-mediated proteolysis of the 
cytoskeletal structural protein spectrin seemed to have different spatial 
compartmentalization (Buki et al., 1999). Within 15 minutes after injury, 
predominant subaxolemmal and perimitochondrial CMSP-localization was found by 
utilizing ultrastructural analysis of injured axonal segments, which was then followed 
by widespread degradation of the intra-axonal protein 1-2 hours post injury. Buki et 
al (1999) have also described a direct co-localisation of neurofilament compaction 
(RMO-14)-imunoreactive and CMSP (Ab38). When taken together the data supports 
the view that CMSP has an important role in the pathobiology of traumatic axonal 
injury (Buki et al., 1999). 
The early Ca
2+
 influx seems to occur secondary to the mechanoporation of the 
axolemma. This is followed by the initial induction of CMSP in the subaxolemmal 
compartment, changing the subaxolemmal network. With time, this could influence 
the structural integrity of the axolemma causing permanent permeability change 
which can lead to more adverse downstream consequences such as an excessive 
stimulation of calpain and CMSP in injured axons. Proteolytic side-arm modification 
occurs after the calcium entry and results in neurofilament compaction (NFC). 
Calcineurin can be stimulated by Ca
2+ 
and alters the repelling forces of the side-arms 
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by modification of the neurofilament phosphorylation state leading to NFC (Medana 
and Esiri, 2003; Marmarou et al., 2005).  
1.2.2.3 Mitochondrial damage 
It has been noted that local morphological changes of mitochondria, for 
example swelling and degeneration of mitochondrial crisate and membranes can be 
associated with TAI. Such changes are reminiscent of those caused by Ca
2+
 induced 
opening of the mitochondrial membrane permeability transition (MPT)-pore (Lifshitz 
et al., 2004). 
Several studies have reported that the opening of the MPT-pore is linked to the 
pathogenesis of different diseases and is responsible for apoptotic neuronal death 
(Cai et al., 1998; Lee et al., 1997; Nunez et al., 1998; Saikumar et al., 1998). The 
excessive sequestration of Ca
2+ 
post injury has been thought to be a moderator of 
these mitochondrial alterations. Therefore, the calcium overloading would lead to the 
dissipation of the mitochondrial transmembrane potential and opening of the MPT-
pore, which permealizes the mitochondrial membrane for molecules less than 1.5 
kDa (Medana and Esiri, 2003). This course of action leads to the uptake of water, 
mitochondrial swelling, (Hirsch et al., 1998; Lemasters et al., 1998; Trost and 
Lemasters, 1996; Zoratti and Szabo, 1995) and eventually mitochondrial disruption 
(Buki et al., 2000). 
One important consequence of the abnormal mitochondria and MPT is the 
release of pro-apoptotic substances such as cytochrome-c, the apoptosis activating 
factor and various members of the caspase enzyme family (Krajewski et al., 1999; 
Mancini et al., 1998; Susin et al., 1999a). These substances, via the development of 
the apoptosome (caspase-9, apoptosis protease activating factor-1 and cytochrome-
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c), are capable of enhancing the caspase death cascade especially caspase-3 (Cai et 
al., 1998; Montal, 1998; Susin et al., 1999b; Susin et al., 1998). 
1.2.2.4 Activation of the caspase death cascade 
The stimulation of two members of the cystein protease group, the calpains and 
caspases, would initiate the molecular pathways of traumatic axonal injury (Kilinc et 
al., 2009). It has been reported that the calpains are concerned with limited structural 
proteolysis, neural plasticity and synaptic transmission (Bartus, 1997; Pasqualin, 
1998; Wang, 2000). It is acknowledged, however, that the caspases seem to 
implement the end of apoptotic processes through signals from the environment, the 
genome or abnormal mitochondria (Banki et al., 1999; Kruman and Mattsen, 1999; 
Pettus and Povlishock, 1996; Saikumar et al., 1998; Sun et al., 1999; Susin et al., 
1999b; Wolf and Eastman, 1999; Zhao et al., 1999). 
Using a rodent model Buki et al (2000) have established that the injured 
mitochondria are able to release cytochrome-c within traumatically damaged axons. 
Using double labeling immunofluorecent staining methods they described that the 
foci of cytochrome-c release were also labeled with CMSP-immunoreactivity. 
Hence, calpain-mediated protelytic alterations that are induced by Ca
2+ 
play a 
fundamental function in axonal pathology and co-localise with cytochrome-c release 
(Kilinc et al., 2009). It has also been demonstrated, using other approaches, that 
spectrin breakdown protein 120KDa-immunoreactive, a protein indicative of 
caspase-3 activation, has been consistently co-localised with both CMSP- and 
cytochrome-c-immunoreactivity in traumatic axonal injury (Buki et al., 2000). 
It has been suggested that the caspases have no direct apoptotic effect in the 
neuronal soma but produce a localized effect within the injured axon, the final 
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degeneration of the damaged axonal parts, particularly the cytoskeletal network, 
being the result of localized activation of these caspases (Buki and Povlishock, 
2006). 
The alpha chain of the brain-spectrin tetramer is the initial target of CMSP, 
whereas the beta chain, which is essential for the membrane-binding of 
subaxolemmal spectrin, is processed by caspase-3 (Wang et al., 1998). The cleavage 
of the beta chain is thought to result in collapse of the subaxolemmal membrane 
cytoskeleton. This then leads to destructive changes in axonal morphology and 
axolemmal permeability. This is believed to be the most important step in neuronal 
degradation in different CNS diseases (Bartus, 1997; Wang et al., 1998). It has been 
suggested that, as the caspases are able to cleave the primary intracellular inhibitor of 
calpains, namely calpastatin, the caspases are involved in the over stimulation of 
calpains (Wang, 2000; Wood and Newcomb, 1999). On the basis of the above, in 
traumatically damaged axonal segments, the activation of the caspase death cascade 
has been considered to ultimately result in axonal detachment (Raghupathi, 2004). 
1.3 Detection of axonal injury 
1.3.1 Beta-amyloid precursor protein 
Beta-amyloid precursor protein (β -APP) is a member of the homologous type-
І transmembrane proteins (King and Turner, 2004). Aberrant proteolytic processing 
of β –APP produces the amyloid ß-protein (Aß), a 38-43 amino acid residue peptide 
which is the core of the amyloid cascade hypothesis of AD. It has been reported that 
two proteases, ß- and γ-secretase, are necessary to release Aß form the precursor 
molecule (Thinakaran and Koo, 2008). -APP is processed by Golgi apparatus and 
conveyed along the axon by fast anterograde transport (Koo et al., 1990; Sisodia et 
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al., 1993). When there is axonal transport interruption ß-APP has been shown to 
accumulate, indicative of dysfunction or possibly ultimate detachment of axon (Yam 
et al., 1997). 
Structurally β –APP consists of a large extracellular domain, a single 
transmembrane region, and a small cytoplasmic tail (Gralle and Ferreira, 2007). On 
the basis of its structure, β –APP has been hypothesised to function as a receptor in 
intracellular axonal transport. It is thought that β –APP may interact with kinesin and 
the microtubule cytoskeleton enabling the transport of cargo to the synaptic terminal 
(Kamal et al., 2001). Several studies have also shown the role of this protein in 
adhesion to other cellular or to extracellular matrix components (Kibbey et al., 1993; 
Qiu et al., 1995; Sabo et al., 2001; Soba et al., 2005). β –APP has been hypothesised 
to be involved in tissue maintenance (Breen et al., 1991), brain development (Trapp 
and Hauer, 1994) and response to injury (Mattson, 1997).  
Gentleman and colleagues were the first group who used the ß-APP as a 
marker for injured axons (Gentleman et al., 1993).  
1.3.2 Neurofilament subunits  
Neurofilaments (NFs) are the intermediate filaments of neurons that provide 
strength and stability to the axon, and are involved in regulating intracellular 
transport to axons and dendrites (Serbest et al., 2007). They are members of the 
cytoskeleton proteins and are thought to have roles in forming and preserving cell 
shape, as well as facilitating the cytoplasmic transport of particles and organelles 
(Liu et al., 2004). On the basis of the differences in molecular weights, NFs have 
been considered to consist of three subunits, namely the light (NF68), the medium 
(NF160) and the heavy (NF200) neurofilament subunits (Shea and Chan, 2008). 
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Like other members of the intermediate filament family, NFs are composed 
structurally of a central α- helical rod domain (~ 310 amino acids) which is flanked 
by a globular N-terminal region and non- α- helical carboxy-terminal side-arm 
domains (Figure 1.5). The central rod domains including regions 1a, 1b, and 2 are 
characterized by their highly conserved motifs which are essential for their proper 
assembly (Barry et al., 2007). Every seventh residue of the central rod is thought to 
be hydrophobic which helps to form the α- helical coiled-coil parallel homodimers or 
heterodimers containing NFL and either NFM or NFH (Al-Chalabi and Miller, 





Figure 1.6: Structure of the neurofilament subunit proteins. The size of the 
NF fibre is 10 nm and its core made of the head and rod domains. The „side-arms‟ 







The assembly of NF is believed to occur in a multistep process (Petzold, 2005). 
The first step of NF formation is thought to be the dimerization of NFL with either 
NFM or NFH subunits. This is followed by forming a dimer when the highly 
conserved rod domains of the NFs are coiled together in a head- to- tail shape. The 
next stage is the overlapping of two coiled dimers with each other in an anti-parallel, 
half-staggered manner to form the tetramers. Eight of formed tetramers bind to each 
other laterally and longitudinally to form ultimately a rope-like 10 nm filament. 
Phosphorylation has been considered one of the major post-translational 
modifications involved in the formation and functions of NFs (Liu et al., 2004). 
Lasek and colleagues have stated that the vast majority of axonal NFs (80%) are 
highly phosphorylated representing the “static pool” (Lasek et al., 1985). The 
“dynamic pool” constitutes the remaining 20% of less extensively phosphorylated 
NFs (Lasek et al., 1985; Nixon, 1993). It is clear that the most extensively 
phosphorylated protein of the human brain, and possibly the entire human body, is 
NFH (Petzold, 2005). 
 Neurofilament phosphorylation and dephosphorylation are predominately 
regulated within the axonal compartment with the targets being different phosphate 
acceptor sidearms in the NFs (Nguyen et al., 2001; Dewaegh et al., 1992). The 
phosphorylation of NFs in vivo seems to occur in a slow manner and is orchestrated 
by two types of kinase enzymes, cyclin-kinases and mitogen-activated protein 
(MAP) kinases. The region of the phosphorylation of the C-terminal tail domain is 
thought to be the sidearm (Grant and Pant, 2000). In humans, there are 42 KSP (Lys-
Ser-Pro) repeats forming the C-terminal tail domain (Miller et al., 2002; Strong et al., 
2001; Betts et al., 1997). Serine within the KSP repeats couples with high affinity to 
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phosphate (Strong et al., 2001; Betts et al., 1997). Threonine is known to be an 
additional phosphate acceptor site with high binding affinity (Grant and Pant, 2000). 
Phosphorylation of the N-terminal domain is regulated by glycogen synthetase 
kinase-3 (Guan et al., 1991; Guidato et al., 1996), extracellular signal-regulated 
kinases (Roder and Ingram, 1991; Roder et al., 1995) and cyclin-dependent kinase-5 
(Nguyen et al., 2001; Lew et al., 1992; Shetty et al., 1993), while the C-terminal 
domain is phosphorylated by a range of protein kinases (Sihag and Nixon, 1989; 
Sihag and Nixon, 1990; Sihag and Nixon, 1991). 
With regard to axonal transport, it has been demonstrated that there is an 
inverse correlation between the degree of phosphorylation and the velocity of axonal 
transport (Watson et al., 1989; Watson et al., 1991; Nixon et al., 1994). 
Phosphorylation dependent dissociation of NFs from the kinesin motor has been 
suggested by Yabe and co-workers to be the reason for this observation (Yabe et al., 
1999). 
Axonal injury has been reported, through several animal studies, to be 
associated with an increase in the immunoreactivity or an accumulation of NFs at the 
sites of axonal swelling or bulbs (Saatman et al., 1998; Yaghmai and Povlishock, 
1992; Chen et al., 1999). Equally, it has been demonstrated that the accumulation of 
NF protein at the axonal swelling site can be accompanied by a general decrease of 
NF immunostaining or low level of NF protein within white matter post injury 
(Saatman et al., 1998; Saatman et al., 2003; McCracken et al., 1999). Whereas 
axonal NFs showed a decrease after experimental traumatic axonal injury owing to 
sidearm modification, axonal injury can lead to misalignment or compaction of NFs 
(Yaghmai and Povlishock, 1992; Okonkwo et al., 1998; Maxwell et al., 2003). When 
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this data is considered together, it is not obvious then whether trauma primarily 
results in the pathological reorganization of NF proteins, or whether there is a 
secondary decrease in the level of NF protein because of proteolysis (Serbest et al., 
2007).   
1.3.3 Calpain 
Calpains are non-lysosomal, calcium activated neutral cysteine proteases 
(Saatman et al., 2010). The two best characterized isoforms of calpains that are 
expressed in the brain are the ubiquitous calcium-regulated isoforms µ-calpain and 
m-calpain (Bevers and Neumar, 2008). They both exist as heterodimers, each with a 
common small (28 kDa) regulatory subunit and a unique large (80 kDa) catalytic 
subunit, and each of the large and small subunits encloses multiple calcium binding 
sites (Saatman et al., 2010). When intracellular free calcium levels reach a certain 
threshold, this can lead to the pathological activation of calpain (Pineda et al., 2004).  
Physiologically, the function of calpains has been extensively reviewed (Goll 
et al., 2003). It has been shown that calpains are implicated in cell cycle regulation, 
differentiation, cell migration, adhesion, signal transduction, and synaptic plasticity 
(Goll et al., 2003; Wu and Lynch, 2006). Within the brain, the activated calpains 
have been involved in neurodegeneration associated with both Parkinson‟s disease 
and Alzheimer‟s disease, and acute damage due to traumatic brain injury, stroke and 
hypoxia (Vosler et al., 2008; Kampl et al., 1996; Saatman et al., 1996; Bevers and 
Neumar, 2008; Arai et al., 1991; Hiramatsu et al., 1993). 
The major cytoskeletal protein component of the cell membrane is spectrin 
which has a molecular weight of 280 kDa (Czogalla and Sikorski, 2005). Calpain 
cleavage produces 150 and 145 kDa frogments of the sub-membrane cytoskeleton 
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protein in a sequential manner (Saatman et al., 2010). Antibodies specific to calpain-
medaited spectrin breakdown products (SBDPs) can be used to recognize calpain 
activity through immunohistochemistry or western blotting (Bevers and Neumar, 
2008).  
Calpain-mediated SBDPs have been seen in the cortex and hippocampus 
following trauma (Saatman et al., 1996; Newcomb et al., 1997). Three models of 
injury, specifically lateral fluid percussion brain trauma in the rat, optic nerve stretch 
in the mouse, and impact acceleration injury in the rat have been used to assess the 
activity of calpain in injured axons: SBDPs appear within minutes after injury 
(Saatman et al., 1996; Saatman et al., 2003; Buki et al., 1999). The detection of 
calpain-mediated SBDPs in the corpus callosum after human traumatic injury has 
also been reported (McCracken et al., 1999). This suggests the possible role of 
calpain activation in axonal damage after human head trauma (Huh et al., 2006). 
1.3.4 Caspase-3 
Caspase-3 is part of the caspase family of cysteine proteases (Chowdhury et al., 
2008). Caspase-3 activity leads to the appearance of the morphological criteria of 
apoptosis (Lamkanfi et al., 2007). Apoptosis is a well-ordered process that allows 
eukaryotic cells to degrade their DNA and nuclei. The morphological criteria of 
apoptosis are cell shrinkage, chromatin condensation DNA fragmentation and 
membrane blebbing. The final stage of this process is reformation of apoptotic 
bodies, the membrane-enclosed vesicles, which are then engulfed by nearby 
phagocytes (Shi, 2004). Two distinct pathways of caspase activation are recognized, 
an intrinsic, or mitochondrial, pathway and an extrinsic pathway (Gashequ et al., 
2007). Apoptotic caspases are classified into two groups, the initiator caspases such 
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as caspase-8 and -9 and the effector caspases such as caspase-3, -6, and -7 
(Chowdhury et al., 2008). The activation of executioner caspases, mainly caspase-3, 
appears to be involved in both apoptotic pathways (Gashequ et al., 2007).  
In vitro studies using an axonal stretch injury model have shown that caspase-3 
will cleave α-spectrin into the apoptotic-linked 120-kDa fragment 24 hours after 
moderate injury, but not following mild or severe damage (Beer et al., 2000). In vivo 
studies have shown that caspase-3 has been activated after TBI (Pineda et al., 2004). 
The activity of caspase-3 has been reported to increase as a result of TBI, but no 
effect has been observed for caspase-1 activity (Yakovlev et al., 1997). Pike and 
colleagues have reported the absences of caspase-3-mediated BDPs to αII-spectrin in 
cortex, while increasing significantly in hippocampus and striatum immediately after 
TBI (Pike et al., 1998). From 6 to 72 hours after controlled cortical impact injury, 
immunohisotochemical investigations have demonstrated that the active proteolytic 
subunit of caspase-3, p18, has been highly expressed in neurons, astrocytes and 
oligodendrocytes (Pineda et al., 2004). After lateral fluid percussion TBI in rats, 
caspase-3 appeared to be activated in injured cortex and hippocampus (Knoblach et 
al., 2002). The specific formation of caspase-3-cleaved amyloid ß-peptide fragment 
has been observed in injured axons, which suggest the association between the active 
caspase-3 and the pathogenesis of traumatic axonal injury (Stone et al., 2002) and 
may be linked to subsequent neurodegeneration (Johnson et al., 2010).  
1.4 Wallerian degeneration 
Wallerian degeneration is now considered to be a process of axonal self-
destruction, similar to the process of apoptosis involving the cell body, although the 
mechanisms appear very different. It has been proposed that there are at least three 
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distinct phases in axonal degeneration: competence to degenerate; commitment to 
degenerate; and execution phase (Saxena and Caroni, 2007).  Different insults to the 
axon may initiate axonal damage through different mechanisms, such as disruption 
of anterograde axonal flow, energy failure (mitochondrial dysfunction) and calcium 
influx, but it is likely that these initial mechanisms of axonal damage converge on a 
single terminal molecular pathway involving calpain activation with subsequent 
axonal protein degradation (Coleman, 2005).  
Much of the understanding of the molecular mechanisms involved in Wallerian 
degeneration has come from studying the slow Wallerian degeneration mutant 
mouse (Wld
S
) (Lunn et al., 1989). In this mouse model axon stumps distal to a point 
of crush injury survive up to 10 times longer than wild-type mice. The Wld
S
 gene is 
the result of a genomic re-arrangement which includes the complete protein sequence 
of nicotinamide mononucleotide adenyltransferase 1 (Nmnat1), a short fragment of 
the gene for an E4-type ubiquitin ligase, which lacks ligase activity, and a unique 18 
amino acid sequence (Coleman and Freeman, 2010). It is thought this novel gene 
results in a gain of function of Nmnat1, probably by taking over the function of an 
existing protein. Nmnat2 is an endogenous protein which is rapidly down-regulated 
after axonal injury and recent studies suggest the novel protein generated in the Wld
S
 
mutant is not down-regulated after injury and can take over the normal function of 
Nmnat2 (Gilley and Coleman, 2010). In wild-type mice axonal injury results in a 
decrease of nicotinamide deaminase (NAD) by unknown NAD depleting factors, 
which then leads to mitochondrial dysfunction, calcium influx and calpain activation, 
with subsequent degeneration of the axonal cytoskeleton. The Wld
S
 gene product 
may function by greatly reducing the rate of NAD depletion resulting in axonal 
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protection (Yan et al., 2010). This greater understanding of the active mechanisms 
underlying Wallerian degeneration raises the possibility of pharmacological 
intervention to limit the rate of axonal degeneration after trauma, although to date the 
precise point at which trauma activates the axonal degenerative mechanism has not 
been characterised. 
1.5 Immunohistochemistry in forensic neuropathology 
practice 
Several techniques have been used to identify damaged axons with variable 
degrees of sensitivity, dependent on survival time after head trauma (Hortobágyi and 
Al-Sarraj, 2008). Haematoxylin and eosin (H&E) stains can visualize damaged axons 
as eosinphilic swelling 24 hours after injury. They can also be detected using silver 
impregnation in cases with survival times of 15-18 hours (Adams et al., 1989). 
 Immunoreactivity of Glial Fibrillary Acidic Protein (GFAP) and CD68 were 
shown to identify reactive changes days after damage (Hortobágyi et al., 2007). 
Other proteins including ubiquitin, cathepsin D, chromogranin A and synaptosomal 
associated protein have been employed immunohistochemically to highlight axonal 
damage several hours after injury, but they have been shown to be less reliable 
markers (Sherriff et al., 1994a). In early stages of axonal injury, it was thought the 
Neuron-Specific Enolase (NSE) immunostaining could be used to detect damaged 
axons (Ogata.M. and Tsuganezawa.O., 1999), but this limited study looked only at 
sections of the corpus callosum.  
It has been widely recognized that immunostaining for ß-APP is the most 
sensitive method for detecting TAI and most publications in human tissue use this 
marker (Graham et al., 2004; Sherriff et al., 1994a; Sherriff et al., 1994b; Gentleman 
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et al., 1995; Blumbergs et al., 1995; McKenzie et al., 1996; Geddes et al., 2000; 
Oehmichen et al., 1998). In 2007, Hortobagyi and co-workers demonstrated that ß-
APP immunoreactivity could be used to detect TAI in the brain with survival times 
as short as 35 minutes after head injury (Hortobagyi et al., 2007). Previous studies 
have shown that the expression of ß-APP remained detectable as long as 99 days 
after head injury (Blumbergs et al., 1994). A number of studies have also exposed the 
useful application of ß-APP immunoreactivity as a diagnostic tool in medico-legal 
practice (Sherriff et al., 1994b; Geddes et al., 1997; Oehmichen et al., 1998; Geddes 
et al., 2000; Graham et al., 2004; Reichard et al., 2005; Hortobágyi et al., 2007). 
Although this marker appears to be sensitive to traumatic axonal injury it is not 
specific, since other causes such as brain injury such as ischaemia without head 
injury can result in the accumulation of ß-APP, and in the setting of trauma this is 
often seen in cases with raised intracranial pressure (Graham et al., 2004; Geddes et 
al., 2000; Dolinak et al., 2000b). Increased immunoreactivity of ß-APP may also be 
seen in ischaemia (Dolinak et al., 2000a), hypoglycaemia (Dolinak et al., 2000b), 
multiple sclerosis (Ferguson et al., 1997), human immunodeficiency virus (HIV) 
encephalitis (Giometto et al., 1997), infarction (Nukina et al., 1992) and abscess 
formation (Ohgami et al., 1992).  
With regard to the different patterns of ß-APP immunoreactivity, it is 
suggested that mechanical forces create a wave-like shape, but the ischaemic insult 
causes an aggregated pattern (Oehmichen et al., 2003). Graham et al have shown that 
an irregular or „Z‟ shaped pattern can be seen in cases of infarction or haematoma 
(Graham et al., 2004), and ß-APP staining was stated to be linear or geographical not 
outlined to individual white matter bundles in ischaemia (Reichard et al., 2003a; 
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Reichard et al., 2003b; Dolinak et al., 2000b). Nevertheless, it has been difficult to 
differentiate between these types, particularly in cases that mimic the pattern of 
traumatic axonal injury leading to incorrect diagnosis (Reichard et al., 2005). Hence, 
in order to determine the cause of axonal injury in most cases, it is recommended that 
there should be sufficient sampling, adequate time of sample fixation, and 
standardization of ß-APP immunohistochemistry technique (Graham et al., 2002; 
Graham et al., 2004; Geddes et al., 2000; Reichard et al., 2005). However, it must be 
recognised that the patterns of TAI can be subtle and can be obscured by extensive 
ischaemic injury, and in some cases it is not possible to conclusively comment on the 
















The current opinion in relation to TAI is that the forces of injury modify focal 
axonal sections resulting in mechanoporation with calcium influx and microtubule 
disruption causing local axonal transport impairment and axonal swelling, followed 
by detachment over a period of time after injury (secondary axotomy). Factors 
against a significant mechanical effect include the fact that theses axonal changes 
have been identified in scattered axons associated with other normal axons and their 
vascular elements. Hence, it has been suggested that there are more molecular 
changes that can contribute to the pathogenesis of the axonal injury.    
Different pathological mechanisms have been described in association with 
axonal damage, including Wallerian degeneration and complete energy failure. In 
trauma there appears to be transport failure followed by Wallerian degeneration. In 
ischaemia there is complete energy failure with immediate localised axonal 
degeneration. Axonal transport is mediated by microtubules and neurofilaments, and 
traditionally neurofilaments have been used as a marker of axonal swelling in 
experimental animals. 
The first aim of the current study was to document the neuropathological 
features of TBI amongst Edinburgh population, although previous studies have 
described cohorts from the West of Scotland. Based on ethnicity there is an 
expectation that the current studies would be very similar to those seen in the West of 
Scotland, and there is unlikely to be any significant genetic or cultural influence to 
cause significant differences. The second aim was to investigate the presence of the 





This initial hypothesis is that range of neuropathology associated with TBI 
cases in Edinburgh cohort are similar to those seen in the West of Scotland cohort. 
The second hypothesis is that the published descriptions of the different populations 
of damaged axons found in rodent models are detectable in both an animal model of 
TBI and in human autopsy material from the Edinburgh cohort. 
To address these hypotheses, there are a number of components to this study: 
1. Development of a database of autopsy human traumatic brain injury 
cases within the archive of Department of Pathology 
(Neuropathology), University of Edinburgh. 
2. Critically evaluate the published data relating to human traumatic 
axonal injury. 
3. Immunohistochemical analysis of a range of antibodies investigating 
defined injury pathways, in an experimental model of non-impact 
head injury (piglet model). 





2. Materials and Methods     
2.1 Generation of pathological data         
A retrospective cohort study was conducted using cases from the archive of the 
Academic Department of Pathology (Neuropathology), University of Edinburgh. The 
Lothian and Borders data was obtained from 406 consecutive cases between 1982 
and 2005 and logged onto a database, each case being assessed according to a 
standardized study proforma. A proforma was developed which listed 15 sections for 
which entries could be coded (Appendix 1). The current proforma is based on 
previously used proformas and was modified after the discussion with Dr Colin 
Smith. Inclusion data were age, sex and the mechanism of injury. The data also 
included the length of survival time between injury and death, and the description of 
the tissue available for histological study. Pathological data included; focal 
pathologies namely skull fracture, contusions, intracranial haemorrhage and raised 
intracranial pressure: and diffuse pathologies, namely diffuse hypoxic brain damage, 
diffuse traumatic axonal injury (TAI) and brain swelling. Injury severity was not 
coded since it was not available for every case. All data was extracted from the 
neuropath logical reports, police reports and from the autopsy report of cases where 
available. All the details of the documented cases are shown in Appendix 2. 
2.1.1 Skull fractures and contusions 
Skull fractures were documented as being either present or absent, and 
contusions were initially graded using the total contusion index (TCI) developed by 
Adams et al (1980b) and subsequently modified (Adams et al., 1985). The TCI has 
been developed to assess the extent (0-3) and depth (0-4) of contusions in various 
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parts of the brain, producing a numerical score for each hemisphere which is then 
combined and interpreted as absent, mild, moderate or severe. The frontal, temporal, 
parietal and occipital lobes, the cortex above and below the Sylvian fissure and the 
cerebellum are among the different anatomical locators. The maximum score for an 
anatomical locator is 12 (4x3=12), and the TCI has a maximum value of 144 (each 
side 6x12=72, 2x72=144). Contusional injury is considered mild if the TCI is less 
than 20, moderate if the TCI is between 20 and 37 and if the TCI is more than 37 the 
contusional injury is considered to be severe (Graham et al., 1988). However, a 
decision was ultimately made to record the contusions as either present or absent, 
since no information about the extent and depth of contusions was documented in a 
significant number of neuropathological reports used in this study.  
2.1.2 Brain swelling and intracranial haemorrhages  
Brain swelling was recorded as being secondary to contusion, intracranial 
haematoma, ischaemic brain damage or related to a combination of different causes. 
Intracranial haemorrhages were documented in relation to the anatomical 
compartment involved (extradural, subdural or intracerebral). The volume of the 
intracranial haematomas and any history of surgical evacuation of the haematomas 
were recorded after reviewing all reports available.   
2.1.3 Raised intracranial pressure 
Raised intracranial pressure was documented as being either present or absent. 
It was considered to be present if there were tentorial herniae (either macroscopic or 
microscopic). This is often observed with associated vascular complications within 
the distributions of the anterior choroidal artery, the pericallosal artery, the posterior 
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cerebral artery and the arterial supply to the cerebellum and brainstem (Adams and 
Graham, 1976).  
2.1.4 Ischaemic brain injury 
Ischaemic brain injury was documented as being present or absent. Graham et 
al (1989) developed a grading system to assess ischaemic brain damage; severe when 
the lesions are diffuse, multifocal, and large within arterial territories: moderate, in 
which the lesions are limited to the arterial boundary zones, singly or in combination 
with subtotal infarction in the distribution of the cerebral arteries or if there are 6-10 
subcortical lesions: and, mild if there are five or less subcortical lesions in the brain.   
2.1.5 Traumatic axonal injury 
Traumatic axonal injury (TAI) was recorded as being present or absent, and if 
present was assessed as grade 1, 2, or 3 according to the established grading system 
(Adams et al., 1989). In grade 1, there was widespread axonal damage in the corpus 
callosum and the cerebral hemisphere. In grade 2 there was, in addition, focal 
haemorrhagic lesion in the corpus callosum. Grade 3 lesions, in addition, had a 
haemorrhagic lesion in the rostral brain stem.  
Diffuse vascular injury (DVI) was documented as being either present or 
absent. DVI is a diffuse injury in which small multiple haemorrhages are seen 
throughout the brain, although predominantly in the frontal white matter. The 
condition is usually fatal and is the result of shear stress and traction of parenchymal 





2.2 Human study 
2.2.1 Fixation and processing of human brains 
Human tissue was fixed in 10% formalin for approximately 3 weeks and then 
processed using a Leica ASP 300S processor (Leica, UK) with a 41 hour protocol. 
Tissue was embedded into paraffin wax and 5 µm sections were cut to be evaluated 
in the current study. 
2.2.2 Identification of human cases 
Forty seven cases from the completed database for the human study were found 
to have TAI. Haematoxylin and eosin staining and -APP immunostaining were 
carried out on these cases for diagnostic purposes.  Eight cases were then selected 
with a total of 34 sections from different regions including corpus callosum, internal 
capsule and pons (Figure 2.1). 4 cases were identified to have ischaemic damage and 
4 cases were found to have TAI as the predominant injury. One case had an 
associated tentorial hernia and a second had focal cortical ischaemia. None of the 
TAI cases had global ischaemic injury or incidence of ischaemic axonal injury based 
on morphological distribution (Reichard et al., 2005). All pathological findings in 

















Figure 2.1: Representative images showing the examined regions in the 






Table 2.1: Details of human cases used in the immunohistochemistry study. 








Contusions ICH Swelling Ischaemia 
 
 
   No of 
available 
sections 
     
Traumatic cases          
1 40 Male 2 days RTA - - - - -    4      
2 41 Male Instant Assault + + H in Pons - -    4      
3 26 Male 12 days Fall - + ICH + +    5      
4 32 Male 1 day Assault - + - + +    5      
Ischaemic cases          
1 66 Male 1 day Fall + + BSDH,SAH,ICH,IVH + +    4      
2 9 Female 7 days RTA - + SDH,SAH + +    4      
3 4 Male 1 hour RTA + + SAH + +    4      
4 52 Male NA NA - - SDH - -    4      
 
Legend: RTA= Road traffic accident                        SAH= Subarachnoid haemorrhage 
               ICH= Intracranial haemorrhage                  IVH= Intraventricular haemorrhage 
               H= Haemorrhage                                        SDH= Subdural haemorrhage 
                        BSDH= Bilateral subdural haemorrhage    NA= Not available
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2.2.3 Issues related to organ retention 
The retention of organs at post-mortem examination and the use of retained 
tissue in medical research has been the focus of much public and political attention 
over the past ten years. The practise of removing and retaining organs at autopsy 
examination had been widespread and long-standing in the United Kingdom. While 
this was considered to be part of the normal autopsy examination by many health 
care professionals it became clear that many relatives who consented to autopsy 
examination after a death were unaware of the possibility of organ retention for 
diagnostic purposes and, in some cases, use of the retained tissues in research. The 
issue came to light during an inquiry into paediatric heart surgery at Bristol Royal 
Infirmary (Kennedy, 2001). At this inquiry it was disclosed that organs (malformed 
hearts) had been retained as part of the diagnostic process. Subsequent investigations 
focussed on Liverpool (Alder Hey Children‟s Hospital) where the practises of an 
individual paediatric pathologist were scrutinised (Redfern, 2001). It became 
apparent that there was inadequate information being provided to relatives and that 
the whole process of consent for autopsy examination had to be addressed. In 
Scotland Professor Shelia McLean headed an inquiry, the findings being published in 
2001 (McLean, 2001). The medical profession responded to the recommendations 
made by these various reports and have improved the process of seeking and 
documenting informed consent such that relatives are fully aware of any retained 
tissues and give specific consent allowing the use of any retained tissues in medical 
research and education. Much of the discussion relating to retained organs focussed 
on autopsies that had been performed in cases outwith the authority of the Procurator 
Fiscal (or Coroner in England, Wales and Northern Ireland). There was, however, 
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considerable concern relating to retention of organs in cases which had been 
instructed by the Procurator Fiscal (or Coroner) and the subsequent use of tissues for 
medical research and education. A particularly high profile case resulted in a review 
of the practises by Her Majesty‟s Inspector of Anatomy (Metters, 2003) which 
coincided with a review of the Coroners system in England and Wales (Luce, 2003). 
There was some uncertainty in Scotland with regard to the use in medical research of 
tissue retained for diagnostic purposes under the authority of the Procurator Fiscal, 
and archived material which was retained in good faith using the appropriate 
mechanisms available at the time. There was a clear willingness that research which 
will benefit the general public should continue and as such, following a 12 month 
moratorium on research using human tissues during which time relatives could 
reclaim retained tissue if they so wished, research has been able to continue. The 
result of these investigations and discussions was the publication of the Human 
Tissue Act (2004) and the Human Tissue (Scotland) Act (2006), with activity 
relating to human tissues in England and Wales being overseen by the Human Tissue 
Authority. In Scotland all autopsy - derived tissues prior to 2006 are deemed as 
existing holdings, and they can be used for research with appropriate research ethical 
approval. All tissues derived from autopsies after this time require explicit consent 
from relatives for their use in research. All work undertaken in this study has full 
ethical approval. The local research ethics committee (LREC) number for the current 




2.3 Animal study 
2.3.1 Piglet injury 
Studies using a piglet animal model were performed with head rotational 
acceleration in the axial plane using the HYGE pneumatic actuator (Figure 2.1 and 
2.2) at University of Pennsylvania with our collaborator, Professor Susan Margulies 
(Raghupathi and Margulies, 2002). All animal protocols were approved by the 
Institutional Animal Care and Use Committee of the University of Pennsylvania. 
Neonatal (3-5 day old) and 4-week old (corresponding in brain development and 
myelination to a 2-4 year old human), farm piglets were studied.  All littermates were 
acquired from the University of Pennsylvania swine facility to ensure uniformity in 
birthing, handling and physical and social environment prior to arrival. Animals were 
subjected to rapid, purely impulsive, non-impact rotations. Brain injury was induced 
using a well-characterized head rotational acceleration device to impart a rapid, 
single 110° axial rotation with its center in the cervical spine. To achieve this motion, 
the animals‟ heads were secured to a padded snout clamp, which, in turn, was 
mounted to the linkage assembly of a HYGE pneumatic actuator (Bendix Corp) that 
converts the impulsive linear motion to an angular (rotational) motion. Axial angular 
velocities of 214–286 rad/sec have been used previously in the adult pig producing 
unconscious periods from 2 hours to over 8 hours. Applying a relationship proposed 
by Ommaya and colleagues (Ommaya et al., 1967) with a scaling factor defined as 
the inverse ratio of the brain masses raised to the one-third power, and using average 
brain mass in the piglet and adult, target angular velocities were developed for the 3-
5 day and 4 week piglets with their smaller brains. In the 3-5 day animal angular 
velocities ranged from 170 rad/s (low) to 205 rad/s (high), and in the 4 week animal 
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from 130 rad/s (low) to 177 rad/s (high). Immediately prior to inducing brain injury 
the animals were taken off anesthesia. Controls (sham) were anesthetized, but were 
not surgically prepared and did not receive injury. Immediately following the 
rotational load, the snout of the animal was removed from the bite plate, and the 
animal was placed on heating blankets to maintain core body temperatures between 
36°C and 38°C. Upon return of the pinch reflex, anesthesia was re-administered (3% 
isofluorane for induction and 1.5% for maintenance). When the diastolic BP fell 
below 25 mm Hg, animals received an intravenous fluid bolus of normal saline (10 





















Figure 2.2: Directions of injury produced in the piglets. A= Sagittal, B= 
Axial, and C= Coronal. Adapted from (Raghupathi and Margulies, 2002). 
  
 
Figure 2.3: HYGE mechanism producing a non-impact controlled injury. 
Adapted from (Raghupathi and Margulies, 2002). 
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2.3.2 Piglet brain removal, fixation, and processing 
The piglet was euthanized by sodium pentobarbital overdose (150mg/kg IV + 
small amount of heparin) and a transcardiac perfusion was performed, first with ~2L 
normal saline followed by 2.5-3L unbuffered formalin. The head was separated from 
the body and the scalp was reflected from the skull. The cranium was removed in 
pieces with bone rongeurs until the whole brain was exposed. The dura was then 
reflected and the brain including olfactory bulbs was gently teased away from the 
base of the skull, severing cranial nerves along the way. Once the brain was 
removed, photos were taken; the brain was weighed, and after that placed in 
unbuffered formalin for one week. After one week, the formalin was replaced with 
PBS until the brain was cut for pathology. 
Prior to cutting, the brain was rinsed with water and photographed.  It was then 
placed in a brain matrix and serial slices (~3mm section thickness) were cut through 
the length of the brain. Photographs of the slices were taken, and the slices were 
placed in labelled histology cassettes for processing. The tissue was processed using 
Shandon Excelsior ES processor (Thermo Electron Corporation, UK) with 21 hour 
protocol and embedded into paraffin wax. 5 µm sections were cut from the 
embedded blocks to be used in this study. 
2.3.3 Identification of piglet cases 
 Sixteen cases of TAI and 11 control cases were selected from two different 
age groups (3-5 day old and 4 weeks old) for this study. The group of 3–5 day old 
piglets consisted of 6 injured cases and 4 control cases with 6 hours survival and 3 
injured cases and 3 shams cases with a survival time of 6 days. A second group of 4 
week old piglets consisted of 4 cases with traumatic injury and 2 control cases with a 
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survival time of 6 days as well as 3 injured cases and 2 sham cases with 6 hours 
survival. From each case, two regions were chosen to be stained and evaluated in this 
part of the project (Figure 2.4); the regions selected being based on previous studies 
which demonstrated areas of maximal traumatic axonal injury. All piglet cases used 
in the immunohistochemical study are listed in table 2.2.  
 
  
Figure 2.4: Representative images showing the regions examined in the 
piglet study. Coronal sections from 4-week old animal (level 6 and level 8) [A+B] 
and from 3-5 day animal (level 6 and level 8) [C+D]. A and C correspond to level 












Table 2.2: Details of piglet cases used in the immunohistochemistry 
study. 
 Shams Injured 




6 hrs survival 6 day 
survival 




































Legend: Low= Low velocity injury 








2.4 Immunohistochemistry (IHC) 
2.4.1 General principles of immunohistochemistry 
The concept behind IHC is the localization of antigens by means of specific 
antibodies that can then be demonstrated through a coloured histochemical reaction 
(Ramos-Vara, 2005). Immunohistochemical staining has become widely used in 
morphological analysis in histopathology diagnosis (Dodson, 2002). Immunostaining 
may be affected by factors involved in the different steps of tissue processing such as 
the fixation procedure, and the dehydration and embedding processes, leading to loss 
or variable expression of antigens. Specificity and sensitivity of the antibody, buffer 
solutions, detection system, chromogen and antigen retrieval system are important 
variables that need to be considered when optimising immunohistochemical methods 
(Bussolati and Leonardo, 2008).    
2.4.1.1 Antigen-antibody interaction 
The antibodies are immunoglobulins that consist of two heavy and two light 
polypeptide chains forming a Y-shaped structure (Montero, 2003). They have been 
identified as bifunctional molecules (Ritter, 1986), in that they have two reactive 
antigen-binding sites at one end (Fab region) and allow linking to other antibody, 
complement, or inflammatory cells through the other end (Fc region).   
Monoclonal and polyclonal antibodies are the two major types of antibodies 
used in immunocytochemical studies. Monoclonal antibodies are mostly developed 
in mice whereas polyclonal antibodies are produced by antigenic stimulation in 
multiple animal species, particularly rabbit, horse, goat, chicken and pig (Bunea and 
Zarnescu, 2001). It has been reported that monoclonal antibodies have higher 
specificity, but lower affinity and narrower reactivity when compared with 
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polyclonal antibodies (Hayat, 2002). In immunohistochemical studies, high 
specificity and affinity for the antigen of interest and the production in high titre are 
considered to be the major criteria of a useful antibody. A number of features, which 
influence the antibody-antigen interaction, have been described including time of 
incubation with the primary antibody, the temperature, tissue antigens accessibility 
and buffer pH and ionic strength (Mao et al., 1994).  
2.4.1.2 Fixation 
Fixation of tissue is essential to preserve cellular morphology and antigenicity 
(Hayat, 2002). Two types of fixatives have been used in histopathology; cross-
linking (non-coagulating) fixatives such as formalin, and coagulating fixatives such 
as alcoholic solutions (Bussolati and Leonardo, 2008). 
The current gold standard of fixative for routine histology and 
immunohistochemistry is formaldehyde which maintains the general structure of 
cellular organelles and peptides (Montero, 2003). It has a little effect on 
carbohydrates and interacts with nucleic acids (Eltoum et al., 2001). Lipids are well 
preserved by formaldehyde if the fixative contains calcium (Jones, 2002). 
Formaldehyde has the ability to bind to amino acids such as lysine, tyrosine, 
asparagine, histidine, arginine, cystein, and glutamine if they found in solution (Shi 
et al., 2000). The formation of additional products between the formalin and 
uncharged reactive amino groups (-NH or NH2), forming cross-links is the basic 
mechanism of fixation with formaldehyde (Dapson, 1993). 
A profound change in the conformation of macromolecules is the ultimate 
result of formaldehyde fixation. This can make the detection of proteins by 
antibodies impossible or at best difficult due to conformational changes “hiding” the 
70 
 
epitope of interest (Arnold et al., 2006). These changes have an effect on the primary 
and secondary structures, and the three dimensional (tertiary and quaternary) 
structures of proteins are modified (Mason and O‟Leary, 1991). The process of 
formalin fixation is known to be progressive, and to be temperature and time-
dependent. The results of the immunostaining process can be affected by the length 
of fixation, by both under-fixation and over-fixation (Dapson, 1993). 
2.4.1.3 Antigen Retrieval 
The purpose of antigen retrieval is to recover the antigenicity of tissue sections 
that has been masked by the process of fixation. Enzymatic and heat-based retrieval 
are the two most common antigen retrieval procedures used in 
immunohistochemistry (Shi et al., 2001). 
Antigen retrieval with enzymes: Protease-induced epitope retrieval (PIER) 
was the most commonly used antigen retrieval method before the advent of heat –
based method‟s (Huang, 1975; Huang et al., 1976). Subsequent studies have used 
different enzymes for the same purposes including trypsin, proteinase K, pronase, 
ficin, and pepsin (Battifora and Kopinski, 1986; Jacobsen et al., 1980; Miettinen, 
1989; Ordonez et al., 1988; Pinkus et al., 1985). Although the mechanism of PIER is 
still unclear, it is thought that it might be related to the non-specific cleavage of the 
protein (Van Hecke, 2002). There are factors that influence the effect of PIER 
including the duration of fixation, the concentration and type of enzymes and 
incubation parameters specifically, time, temperature and pH (Battifora and 
Kopinski, 1986; Miettinen, 1989; Pinkus et al., 1985). The drawbacks of PIER are 
possible alteration of tissue morphology, possible destruction of epitope, and the low 
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number of antigens optimally detected by this method (Ordonez et al., 1988; Van 
Hecke, 2002).  
Heat-induced epitope retrieval: The concept of antigen retrieval by means of 
heating was initially introduced by Shi et al (1991). The final effect of heat-induced 
epitope retrieval (HIER) is the reversal of conformational modifications produced 
during fixation, but the mechanism is unknown (Ramos-Vara, 2005). Epitopes might 
be unmasked with heating via hydrolysis of methylene cross-links (Van Hecke, 
2002). Other molecular mechanisms have been suggested including precipitation of 
proteins, extraction of diffusible blocking proteins, heat mobilization of trace 
paraffin and rehydration of tissue sections allowing better penetration of antibody 
(Sompuran et al., 2004). 
Heat and antigen retrieval buffer are the two major elements of HIER (Pileri et 
al., 1997; Taylor et al., 1996; Shi et al., 2001). As a source of heating, microwave 
ovens (Shi et al., 1991) or pressure cookers (Norton et al., 1994) have been widely 
utilized producing the sufficiently long heating time required to achieve maximal 
results (Balaton, 1999). The most commonly used antigen retrieval buffers are citrate 
and ethylenediamine-tetraacetic acid (EDTA) (Dodson, 2002). It has been reported 
that the use of 0.01 M sodium citrate buffer (ph 6.0) can give acceptable results and 
good cellular morphology for most antigens when compared with buffer with high 
pH or solution containing EDTA (Battifora, 1999; Ehara et al., 1996). The pH of the 
solution is recognized to influence the antigen retrieval process (Shi et al., 1995). 
Other antigen retrieval methods: Another antigen retrieval method reported 
is incubation of slides in concentrated formic acid, which seems to improve the 
signal in some immunohistochemical tests (Kitamoto et al., 1987). Pre-treatment 
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with strong alkaline solution, urea, acid solutions, borohydride and a solution of 
sucrose has also been used (Shi et al., 1997; Shi et al, 2000). 
2.4.1.4 Detection systems 
Labelling the antigen-antibody reaction is necessary to allow the reaction to be 
seen with light microscope. Therefore, the antigen-antibody reaction can be 
visualized by attaching labels (reporter molecules) to the primary, secondary or 
tertiary antibodies of a detection system. Fluorescent compounds, enzymes, and 
metals are illustrations of the variety of labels that have been used (Taylor et al., 
2002). Enzymes are the most commonly used labels including peroxidise, alkaline 
phosphatase and glucose oxidase. In the presence of a specific substrate and a 
chromogen, enzymes are able to produce a coloured precipitation at the site of the 
antigen- antibody reaction (Ramos-Vara, 2005). There are two major types of 
detection systems; direct and indirect methods (Bunea and Zarnescu, 2001). 
Direct methods: This is the simplest process to visualise the antigen-antibody 
interaction. A primary antibody conjugated with a reporter molecule (label) forming 
a one-step reaction (Coons and Kaplan, 1950). Fluorochromes, enzymes, colloidal 
gold and biotin have been used as different labels for detection via this process. 
Although this method is quick, its sensitivity for the detection of most antigens in 
routinely processed tissue is low (Haines et al., 1991). 
Indirect methods: Coons et al were able to develop a two step method for 
more sensitive antigen detection (Coons et al., 1955). The second layer raised against 
the primary antibody is labelled but the first layer of antibodies is unlabelled. This 
method has a higher sensitivity when compared with a direct method because it has 
high numbers of labels per molecule of primary antibody leading to an increase in 
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the intensity of reaction. Further, it can produce a strong signal by retaining the 
activity of unlabelled primary antibody. With this process, different primary 
antibodies raised in the same species can also be detected with the same secondary 
antibody (Polak and Van Noorden, 2003).  
There are different types of indirect methods employed including the avidin-
biotin methods, the peroxidise-antiperoxidase (PAP) method, the polymeric labelling 
two-step method and the tyramine amplification method. The avidin-biotin complex 
(ABC) method is one of the most widely used detection systems. Avidin is a large 
glycoprotein extracted from egg white which has been shown to bind a low-
molecular mass vitamin called biotin with high affinity. Biotin has been shown to 
have one binding site for avidin and can attach to antibody through other sites 
(biotinylated antibody) or any other macromolecules such as an enzyme, 
fluorochromes or other labels (Chen et al, 2010). The large number of biotin 
molecules that can be attached to a primary antigen can increase the sensitivity of 
avidin-biotin methods (Guesdon et al., 1979; Hsu and Raine, 1981; Hus et al., 1981). 
In the process of the ABC method, the second antibody is biotinylated and the 
mixture of avidin and biotin forms the third layer which links with appropriate label 
(Haines et al., 1991). 
2.4.2 -APP immunohistochemistry 
The antibodies used in the immunohistochemistry studies are listed in table 2.3. 
These antibodies are known to recognise epitopes in both human and porcine tissues. 
Initially, optomisation of each antibody was performed using a range of antibody 
concentrations and different pretreatments to be able to determine an optimal 
condition where the antibody reaction is proper and the results are correct. 
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Immunohistochemistry was carried out for the marker of axonal transport 
dysfunction beta-amyloid precursor protein (ß-APP) (mouse monoclonal antibody; 
clone 22C11, cat # MAB348, Millipore, 1:12000 and 1:1000 diluted in TBS, for 
human and animal sections respectively). The high dilution of ß-APP antibody with 
human tissue is a reflection of how the NovoLink Polymer Detection System Kit is 
very sensitive to such antibody. Human sections were pre-treated with citric acid 
(1.05 g citric acid, 500 ml distilled water, pH 6) using a Menarini pressure cooker 
(Menarini Diagnostic Limited, Berkshire, UK) and they were stained using 
NovoLink Polymer Detection System Kit (cat # RE7150-K, Novocastra laboratories 
Ltd, Newcastle, UK). Animal sections were pre-treated with citric acid (1.05 g citric 
acid, 500 ml distilled water, pH 6) using a Menarini pressure cooker (Menarini 
Diagnostic Limited, Berkshire, UK), and then 96% formic acid (Fisher Scientific) for 
5 minutes. Avidin and biotin blocking kit (Vector Laboratories, Peterborough, UK) 
was required to block non-specific binding of avidin and biotin for both animal and 
human sections before the primary antibody was applied for 30 minutes. The 
biotinylated antibody (polyclonal rabbit anti-mouse immunoglobulin/biotinylated 
antibody; Dako, 1:200 diluted in TBS) was labelled using the ABC kit (Vecta stain, 
Vector Laboratories, Peterborough, UK) and visualized with 3,3'-diaminobenzidine 
(DAB) (Vector Laboratories, Peterborough, UK).  
2.4.3 NF-160 immunohistochemistry 
Immunohistochemistry was undertaken for NF-160 (mouse monoclonal 
antibody; clone NN18, cat # N 5264, Sigma, 1:40 diluted in TBS). Animal and 
human sections were pre-treated with trypsin (0.1 g trypsin, 0.1 gm calcium chloride, 
100 ml TBS, pH 7.8) for 20 minutes in a 37°C water bath before applying the 
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antibody for 30 minutes at room temperature. The biotinylated antibody (polyclonal 
rabbit anti-mouse immunoglobulin/biotinylated antibody; Dako, 1:200 diluted in 
TBS) was labelled using the ABC kit (Vecta stain, Vector Laboratories, 
Peterborough, UK) and visualized with 3,3'-diaminobenzidine (DAB) (Vector 





Table 2.3: Primary antibodies used for the immunohistochemical staining of human and piglet brain sections.  
Antibody Source Tissue tested Primary antibody concentration and 
incubation 





 cat# MAB348  
Piglet 1:1000 
30 minutes incubation 
Citric acid 














cat# N 5264  
Piglet 1:40 



















30 minutes incubation 









30 minutes incubation 




















Citric acid  
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2.4.4 NF-200 immunohistochemistry 
Immunohistochemistry was carried out for NF-200 (mouse monoclonal 
antibody; cat # N 0142, Sigma, 1:250 diluted in TBS). This antibody reacts with both 
phosphorylated and non-phosphorylated forms of NF-200, and labels the 
neurofilaments of molecular weight 200 kDa. It was applied for 30 minutes at room 
temperature after pre-treating animal and human section with citric acid (1.05 g citric 
acid, 500 ml distilled water, pH 6) using a Menarini pressure cooker (Menarini 
Diagnostic Limited, Berkshire, UK). The biotinylated antibody (polyclonal rabbit 
anti-mouse immunoglobulin/biotinylated antibody; Dako, 1:200 diluted in TBS) was 
labelled using the ABC kit (Vecta stain, Vector Laboratories, Peterborough, UK) and 
visualized with 3,3'-diaminobenzidine (DAB) (Vector Laboratories, Peterborough, 
UK).  
2.4.5 SMI-34 immunohistochemistry 
Immunohistochemistry was undertaken for a marker of phosphorylated 
neurofilaments (mouse monoclonal antibody; clone SMI 34, cat # ab24571, abcam, 
1:500 and 1:1000 diluted in TBS, for animal and human respectively). This antibody 
recognises a phosphorylated epitope in extensively phosphorylated 200 kDa and to a 
lesser extent in 160 kDa neurofilament. Animal and human sections were pre-treated 
with citric acid (1.05 g citric acid, 500 ml distilled water, pH 6) using a Menarini 
pressure cooker (Menarini Diagnostic Limited, Berkshire, UK). Avidin and biotin 
blocking kit (Vector Laboratories, Peterborough, UK) was used with human sections 
and the primary antibody was applied overnight (18 hours) at 4°C for both animal 
and human sections. The biotinylated antibody (polyclonal rabbit anti-mouse 
immunoglobulin/biotinylated antibody; Dako, 1:200 diluted in TBS) was labelled 
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using the ABC kit (Vecta stain, Vector Laboratories, Peterborough, UK) and 
visualized with 3,3'-diaminobenzidine (DAB) (Vector Laboratories, Peterborough, 
UK).  
2.4.6 Optimisation of caspase-3 and calpain antibodies 
Immunohistochemistry was performed for markers of active caspase-3 (Rabbit 
polyclonal antibody; cat # ab2302, abcam) and calpain activation (Ab37 and Ab38, 
Rabbit polyclonal antibodies, both antibodies were gifts of Dr. Robert Siman, 
University of Pennsylvania). While the caspase antibody preferentially detects the 
p17 fragment of the active caspase-3, Ab37 and Ab38 recognise a proteolytic 
fragment of α-spectrin cleaved by activated calpain. For the purpose of optimising 
the antibodies, animal and human sections were pre-treated with different treatments 
including citric acid (1.05 g citric acid, 500 ml distilled water, pH 6) using a 
menarini pressure cooker (Menarini Diagnostic Limited, Berkshire, UK); EDTA 
(0.37g EDTA per litre distilled water, pH 8) using a Menarini pressure cooker, and 
trypsin (0.1 g trypsin, 0.1 gm calcium chloride, 100 ml TBS, pH 7.8) for 20 minutes 
in a 37°C water bath. Avidin and biotin blocking kit (Vector Laboratories, 
Peterborough, UK) was used with human and animal sections, whereas the primary 
antibodies were applied for a range of time interval including 30 minutes at room 
temperature, 1 hour at room temperature, and overnight (18 hours) at 4°C. The 
biotinylated antibody (polyclonal swine anti-rabbit immunoglobulin/biotinylated 
antibody; Dako, 1:200 diluted in TBS) was labelled using the ABC kit (Vecta stain, 
Vector Laboratories, Peterborough, UK) and visualized with 3,3'-diaminobenzidine 




2.4.7 Immunofluorescence  
2.4.7.1 Identification of cases for immunofluorescent study 
Eighteen cases (9 piglet cases and 9 human cases) with TAI were selected for 
this study in which the immunoreactivities of β-APP and each marker of NFs were 
observed in the same anatomical region. 
2.4.7.2 Double immunofluorescent staining protocol 
The double immunofluorescent staining was carried out using a vector Mouse-
On-Mouse (MOM) immunodetection kit (Cat # FMK-2201, Vector Laboratories 
Inc.) where both primary antibodies came from mice. The sections were pre-treated 
with citric acid using a Menarini pressure cooker and subsequently incubated with 
formic acid for 5 minutes. Endogenous avidin/biotin was blocked using Avidin and 
Biotin blocking kit (Vector Laboratories, Peterborough, UK).  
Slides were incubated with the first primary antibody (β-APP, clone 22C11, cat 
# MAB348, Millipore, 1:100 for human and piglet sections) for 30 minutes and 
subsequently incubated with working solution of MOM biotinylated anti-mouse IgG 
as a secondary antibody for 10 minutes. The immunoreaction was visualized by 
Fluorescein Avidin DCS for 5 minutes.  
For staining the second antigen, the human and piglet sections were incubated 
with the second primary antibodies (NF-160, clone NN18, cat # N 5264, Sigma, 
1:40, for human and piglet sections; NF-200, cat # N 0142, Sigma, 1:250 for human 
and piglet sections; SMI 34, cat # ab24571, abcam, 1:500 and 1:1000 for human and 
piglet sections respectively) overnight at 4ºC except for NF-200 which was applied 
for 30 minutes at room temperature, then incubating with the same secondary 
antibody for 10 minutes. Texas Red Avidin DCS (Cat # A-2016, Vector Laboratories 
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Inc.) was applied for 30 minutes to visualize the second reaction. Slides were viewed 
with a fluorescence microscope and subsequently processed to adjust the black level, 
and image intensity was performed using Microsoft Office Picture Manager. The 
sections were kept at 4 ºC in the dark if not viewed immediately. 
2.5 Image analysis 
Image analysis is a technique that allows capture and manipulation of digital 
images. Image analysis was carried out to assess the immunostaining load within 
defined anatomical region in cases of TAI and to compare these with control cases. 
In human cases the regions of interest were the corpus callosum, internal capsule and 
pons.  
2.5.1 Image capture and generation of tiled images 
The morphometric study used an image analysis system consisting of a digital 
CCD-Camera (CoolSnap-Pro®) linking an Olympus BX 40 Light Microscope to a 
PC with the image analysis software (Image-Pro® Plus 6.3, Media Cybernetics). 
Immunostained sections were placed on an automated stage (Prior®) which 
could move in both X- and Y- axes.  Multiple non-overlapping colour images of the 
area of interest were captured using x 4 stage objective lens and the images were 
tiled together automatically to give a large composite image. Images were stored 
using the RGB 24 (red, green, blue) colour model. This system allows the production 
of colour images as every colour can be produced by varying levels of red, green, 
and blue. The brightness values range from 0 to 225 for each colour and allow colour 
images to be created digitally.  
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The composite image was stored as a data file in jpeg format. Lamp intensity, 
digital camera set-up, and calibration were kept constant throughout the capture of 
images.  
2.5.2 Area of interest function 
Using the stored image an „„area of interest‟‟ (AOI) could be defined for data 
generation. The AOI too allowed a freehand or geometric area to be defined; the area 
defined was dependent on the anatomical area being studied. Each AOI was defined 
in terms of pixels such that the number of pixels forming the X- and Y- axes of the 
shape was known. The system was calibrated such that this figure could be converted 
to microns (µm) or millimetres (mm). 
2.5.3 Assessment of immunostaining load 
The image analysis software (Image-Pro® Plus 6.3, Media Cybernetics) used 
in this study allowed the definition of immunoreactive profiles based on a defined 
threshold (segmentation). Segmentation is a process that allows the isolation of 
certain colours from an image as a whole. In this study, the immunoreaction was 
developed by DAB which produces a brown precipitate. A manual segmentation 
technique was used to isolate the brown immunostaining in the captured image. The 
sections were all weakly counterstained with haematoxylin to allow greater 
differentiation between the brown immunostaining reaction and the bluish 
background. The stored images were magnified to allow greater sensitivity during 
the segmentation process. The colour cube-based model was used for these images. 
This allows a square measuring 3x3 pixels to be assessed for segmentation; this 
produces greater sensitivity in differentiating between an area of brown 
immunostaining and adjacent haematoxylin counterstaining.     
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While this programme allowed the threshold setting to be applied as a constant 
to all images this was not done due to immunostaining intensity variation between 
batches of immunostaining. Therefore, each slide had unique parameters set for 
segmentation based on the intensity of immunostaining. While this was more labour 
intensive it allowed greater sensitivity in the segmentation process. All results were 
generated by one analyst to remove an inter-observer variation. To assess intra-
observer variation, the same field of the same slide was analysed at the start of each 
session and the load scores checked to see if they were similar. This showed less than 
5% variation over a ten day period.  
The „„Per Area‟‟ function found in the measurements tool was used to 
determine immunostaining load within a given AOI. This gave information regarding 
the ratio between the area of the counted object (the immunostained area) to that of 
the entire area of the pre-defined AOI.  
2.6 Statistical analysis  
2.6.1 Analysis of the Lothian and Borders data 
This study consisted of 406 autopsy cases with a diagnosis of TBI. In order to 
assess the common associated neuropathologies amongst cases, a pairwise 
comparison between groups was made using a Mann Whitney test with a Bonferroni 
correction.    
2.6.2 Analysis of the immunohistochemistry results 
Injured and sham animal cases were included in this study and each animal was 
assigned a specific group defined by age, injury and survival time. The initial step 
was to see if there was any consistency within each group. The effect of age, velocity 
and survival time was then evaluated. Taken together, for each antibody one-way 
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Analysis Of Variance (ANOVA) was used to try to answer the following questions in 
which a p value of less than 0.05 was considered significant:  
Question 1- sham vs injured  
(6 hour survival) 
 3-5 day old sham vs 3-5 day old injured (low velocity) 
 3-5 day old sham vs 3-5 day old injured (high velocity) 
 4 week old sham vs 4 week old injured (low velocity) 
 4 week old sham vs 4 week old injured (high velocity) 
(6 day survival) 
 3-5 day old sham vs 3-5 day old injured 
 4 week old sham vs 4 week old injured 
   Question 2- effect of age 
(6 hour survival) 
 3-5 day old injured (low velocity) vs 4 week old injured (low velocity) 
 3-5 day old injured (high velocity) vs 4 week old injured (high velocity) 
(6 day survival) 
 3-5 day old injured vs 4 week old injured 
 Question 3- effect of velocity 
(3-5 day old, 6 hour survival) 
 low velocity vs high velocity 
(4 week old, 6 hour survival) 
 low velocity vs high velocity 
Question 4- effect of survival time 
(3-5 day old) 
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 6 hour survival low velocity vs 6 day survival 
 6 hour survival high velocity vs 6 day survival 
(4 week old) 
 6 hour survival low velocity vs 6 day survival 
 6 hour survival high velocity vs 6 day survival 
For the human cases, statistical analysis was carried out to see whether there 
was any difference for each antibody for each region between TAI and ischaemia. 
This was done using parametric analysis namely the Two-Sample T-test with 
significance defined at p<0.05. Then, the two-way ANOVA test was used to look if 
there was difference in the staining of each antibody in three anatomical regions 
including corpus callosum, internal capsule and brainstem. A p value of less than 
0.05 was considered significant. 
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3. Results  
3.1 The Lothian and Borders database 
This was a retrospective study based on existing data from the Academic 
Department of Pathology (Neuropathology), University of Edinburgh. 406 
consecutive cases were selected and reviewed from 1982 to 2005. The data recorded 
included the case number, sex, age, survival time, type of trauma, skull fracture, 
contusions, intracranial haematoma, brain swelling, ischaemia and TAI. The data 
was gathered from the neuropathological report of each case and from the police and 
forensic autopsy reports if available. The intention of this study was to build a 
pathological database of TBI by reviewing cases with TBI, to build a picture of the 
common pathological findings amongst Edinburgh population.   
3.1.1 Histological study 
Of the 406 cases, a histological study was not done in 12 cases (3%) while 
limited histology was carried out in 27 cases (7%). However, there were 364 cases 
(90%) that had a comprehensive histological examination. The histology was 
unknown in 3 cases. 
3.1.2 Gender and age 
280 cases (69%) were male and 126 (31%) were female. Of the study cases, 
there were 4 cases (1%) below 12 months of age and 74 cases (7.7%) aged 80 years 
or older. The most common age group affected was 20-39 years (26.7%), followed 













3.1.3 Type of injury 
From a total number of 406 cases, road traffic accidents (RTA) were the 
leading mode of injury accounting for 48.5% (196 cases) (Figure 3.2). Other modes 
of injury consisted of fall from height in 99 cases (24.5%), and assault in 24 injuries 
(5.9%). 15 cases had different types of injury including work or home accident and 
gunshot. In 72 cases (17.8%), the mechanism of injury was unknown, due to limited 

































Figure 3.2: Pie chart representing the frequency of types of injury. RTA= 




3.1.4 Survival time 
208 (51.4%) out of 406 cases had a survival time of less than 24 hours, 
amongst which 84 cases were said to have died instantaneously, 79 cases had a 
survival time between > 0 and ≤ 3 hours, 17 cases survived from > 3 hours up to 6 
hours, 12 cases had a survival time ranging from > 6 hours up to 12 hours, 12 cases 
with survival time between > 12 hours and 18 hours, and in 4 cases the survival time 













Review of the survival times of other cases revealed that 21 cases (5.2%) were 
≤ 48 hours survival, 6 cases (1.5%) were between > 48- ≤ 72 hours survival, 16 cases 
(4%) were between > 3- ≤ 7 days survival, 12 cases (3%) were between > 7- ≤ 14 
days survival, 10 cases (2.5%) were between >14- ≤ 28 days survival, 4 cases (1%) 
were between > 28 days- ≤ 3 months survival, and 3 cases (0.7%) were between > 3- 
≤ 6 months survival. For survivors more than one year (4.2%), 3 survived between 
1and 5 years, 4 survived from 5 up to 10 years, and 10 survived over 10 years. Out of 
the 406 cases reviewed, the survival times of one hundred and nine cases (26.7%) 
were unknown due to limited documentation. 
 
 
Table 3.1: Distribution by survival.  
Duration of survival Number of cases 
≤ 24 hours 208 
> 24- ≤ 48 hours 21 
> 48- ≤ 72 hours 6 
3- ≤ 7 days 16 
>7- ≤ 14 days 12 
>14- ≤ 28 days 10 
> 28 days- ≤ 3 months 4 
> 3- ≤ 6 months 3 
> 6- ≤ 12 months 0 
> 12 months 17 






3.1.5 Skull fracture and contusion 
281 cases (69.2%) had no skull fractures. However, a total of 123 cases 
(30.3%) had fractures of skull. There was no documented information about skull 
fracture in 2 cases. Of the 406 cases reviewed in the current study, contusions were 
seen in 219 cases (53.9%). 
3.1.6 Diffuse ischaemic brain damage 
136 cases (33.5%) were observed to have evidence of diffuse ischaemic brain 
injury (global ischaemia), whereas this was absent in 269 cases (66.3%). The 
evidence of ischaemic injury was unknown in only one case.    
3.1.7 Intracranial haematomas 
There were 255 individuals with a supratentorial haematoma. Of them, 5 cases 
(2%) had haematomas with size of ≤ 2 cm diameter, 9 cases (3.5%) had haematomas 
of > 2 cm diameter in size, and the vast majority of cases (89.4%) had haematomas 
of unknown size. There were also 13 individuals (5.1%) who had haematomas 
removed at operation. Amongst the cases with supratentorial haematomas, 18 cases 
had left sided EDH, 11 cases had right sided EDH, 78 cases had left sided SDH, and 
76 cases had right sided SDH. However, in 187 cases supratentorial haematomas 
were localized to the subarachnoid space and were considered to be clinically 
insignificant. 
There were 55 cases with ICH in which 33 cases (60%) had ICH of unknown 
size, 16 cases (29.1%) had ICH of ≤ 2 cm diameter in size, and in 6 cases (10.9%) 
there were ICH with size of > 2 cm diameter. The review of the areas where ICH was 
found revealed that such haematomas were localized to the left frontal lobe in 16 
cases, the right frontal lobe in 13 cases, the left temporal lobe in 10 cases, and the 
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right temporal lobe in 13 cases. ICH was also seen in the left parietal lobe in 5 cases, 
in the right parietal lobe in 4 cases, in the left occipital lobe in 3 cases, and in 4 cases 
ICH was seen in the right occipital lobe. In 10 cases ICH was localized to the basal 
ganglia. Out of the total cases in the current study, only four individuals were 
identified with a burst lobe. Haemorrhage in the infratentorial region was seen in 5 
cases.  
Taken together, the current review revealed that 270 out of 406 cases had some 
form of haematoma wherein the majority of cases (88.2%) developed haematomas of 
unknown size, 11 cases (4.1%) had haematoma of more than 2 cm diameter in size, 
and haematoma with size of ≤ 2 cm diameter was seen in 8 cases (3%). 
3.1.8 Raised intracranial pressure 
This study showed that 186 cases had some pathological indication of raised 
ICP, amongst which 180 cases (96.8%) were diagnosed macroscopically, 3 cases 
(1.6%) were diagnosed microscopically, and in 3 cases there were microscopic and 
macroscopic descriptions of raised ICP. Out of 180 cases, 34 had supracallosal 
hernia (18 left only, 11 right only and 5 bilateral), 162 had tentorial hernia (24 left 
only, 13 right only and 125 bilateral), and tonsillar hernia was seen in the right side 
in only 65 individuals.  
Raised intracranial pressure pathology was associated with secondary 
brainstem haemorrhage in 34 cases. Secondary brainstem haemorrhage was 
identified grossly in 22 cases (64.7%), 8 cases (23.5%) were diagnosed 
microscopically and in 4 cases (11.8%) there were macroscopic and microscopic 
evidences of such haemorrhage. In 217 cases, no pathological evidence of increased 
ICP was observed. Three case had no available information about raised ICP.   
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3.1.9 Diffuse traumatic axonal injury and acute vascular injury 
The records of all 406 cases revealed that 360 cases (88.6%) had no evidence 
of TAI. However, TAI was seen in 46 cases of which 41 cases (10.1%) had grade 1, 
only one case (0.2%) was considered to have grade 2, and grade 3 was seen in 4 
cases (1%).  
Diffuse vascular injury was seen in 30 cases which accounted for 7.4%, and 
absent in 376 cases (92.3%). 
3.1.10 Brain swelling 
Of the 406 cases examined, 129 cases (31.8%) had no brain swelling. There 
were 274 cases with bilateral brain swelling and 3 cases with unilateral brain 
swelling. In cases with brain swelling, the causes of the brain swelling were 
described as being secondary to contusions in 21 cases (5.2%), intracranial 
haematoma in 92 cases (22.7%), ischaemic brain damage in 11 cases (2.7%), and a 
combination of pathologies in 98 cases (24.1%). The cause of the brain swelling 
could not be ascertained for a number of cases.
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3.2 Critical evaluation of TAI literature  
TAI remains an evolving concept, and as such the historical literature needs to 
be assessed critically. The older literature, prior to the introduction of 
immunohistochemistry, was based on the identification of axonal spheroids using 
silver stains and H&E stains. It is well established that such changes require many 
hours to develop and are much less sensitive than immunohistochemistry, which can 
identify axonal flow dysfunction within 35 minutes (Hortobagyi et al., 2007). We 
reviewed several large cohorts published by the Glasgow group, recognised experts 
in the field of TAI diagnosis, and compared these with the Edinburgh cohort. The 
data is presented in table 3.2.  
 
Table 3.2: Data regarding the incidence of TAI across 4 separate 
cohorts. As discussed in the text, different methods of identification of TAI were 
used across the cohorts.   
TAI grade 1968-1972 
(Adams et al 
1977) 
1981-1982 










Absent 130 (86%) 75 (67%) 312 (71%) 134 (59%) 359 (88.75%) 
Grade 1   10 (2%) 38 (17%) 41 (10%) 
Grade 2   29 (7%) 16 (7%) 1 (0.25%) 
Grade 3   83 (20%) 38 (17%) 4 (1%) 
Present but 
not graded 
21 (14%) 37 (33%)
 









This table clearly demonstrates how the sensitivity of identification of axonal 
dysfunction has improved since the introduction of immunohistochemistry. The 
cohorts reported between 1968 and 1982 were based on histological examination of 
both celloidin and paraffin blocks, and used palmgren staining on the paraffin 
sections, a silver stain technique which requires survival of 12-18 hours before 
damaged axons can be seen. Identification of axonal injury in celloidin sections is 
difficult and no specific stains were developed. This technique is now no longer 
used.  
Damaged axons are seen in greater numbers of cases when 
immunohistochemistry is employed (1987-1999 Glasgow cohort and the 1982-2005 
Edinburgh cohort). However, a significant difference is seen between the most recent 
Glasgow cohort (1987-1999) and the Edinburgh cohort. All cases in the Edinburgh 
cohort used histological criteria to differentiate between ischaemic and traumatic 
axonal injury. This data suggests that older immunohistochemistry studies were 
incorrectly identifying ischaemic axonal inujury as TAI, and this has been recognised 
in other published studies (Smith et al., 2002; Smith et al., 2003). However, previous 
published data in Glasgow should be reviewed immunohistochemically to confirm 
such suggested misinterpretations. This review clearly highlights how important it is 
to critically evaluate historical literature, particularly as new techniques are 
developed and new concepts evolve.  It is likely that the development of new 
protocols for the immunohistochemical analysis of TAI will further modify our 
understanding and diagnosis of this entity. The presence of an uneven accrual rate of 
cases over the timeframe is also noticed which might be explained by the different 
regulations of the procurator fiscal practice throughout the years.     
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3.3 Immunohistochemistry Results  
3.3.1 Immunoreactivity profile of β-APP and neurofilament markers in 
piglet 
Immunohistochemistry for β-APP, NF-160, NF-200 and SMI-34 was 
undertaken on selected sections for the piglet study looking at specific groups 
defined by age, injury, and survival time. The first part of the study looked to see if 
there were differences in immunoreactivity between the sham and injured groups. 
The effects of age, velocity, and survival time among injured piglets were then 
investigated based on the immunostaining of the listed antibodies. The last part of the 
animal study aimed to assess the association between the presence of axonal 
swellings and /or axonal bulbs with the immunoloading for each antibody, 
comparing the control and trauma cases.  
3.3.1.1 Sham v injured piglets 
A comparison of sham cases and injured cases immunostained for β-APP 
revealed significantly increased β-APP immunoreactivity in the 4 week old injured 
piglets (p=0.01) when compared to sham (Figure 3.3), but no significant difference 
was noted between other groups.  
NF-160, showed decreased immunostaining in the 3-5 day old injured animals 
when compared to control (sham) animals (p=0.02) (Figure 3.4). SMI-34 
immunoreactivity was increased in the 3-5 day old piglets with a low velocity impact 
(6 hour survival) when compared to control cases (p=0.03) (Figure 3.5). There was 














Figure 3.3: Accumulation of β-APP in injured and sham piglets. Plot with 
representative images demonstrating increase β-APP immunoreactivity in the 4 week 
old piglets with TAI (A) compared to the sham piglets (B). β-APP immunostaining 








Figure 3.4: Accumulation of NF-160 in injured and sham piglets. Plot with 
representative images demonstrating increase NF-160 immunoreactivity in the 3-5 
day old sham piglets with 6 hours survival (A) compared to the low (B) and high (C) 












Figure 3.5: Accumulation of SMI-34 in injured and sham piglets. Plot 
represents increased SMI-34 immunostaining after low velocity injury in the 3-5 day 









3.3.1.2 Effect of age 
One-way ANOVA did not show any significant differences in β-APP, NF-160, 
NF-200 or SMI-34 immunoreactivity between 3-5 day and 4 week old injured 
animals. The effect of age on the immunostaining for each antibody is illustrated on 
figure 3.6.  
3.3.1.3 Effect of velocity 
None of the antibodies gave a significant result for the one-way ANOVA when 
comparing low and high velocity injury in the 3-5 day old group. In the older injured 
group (4 week old), there was no significant difference between low and high 
velocity injury according to the immunoload of NF-160, NF-200 and SMI-34 (Figure 
3.7). Iincreased immunoreactivity of β-APP was observed in piglets sustaining high 
velocity injury but it did not reach significance (Figure 3.8).   
3.3.1.4 Effect of survival time  
One-way ANOVA with Dunnett‟s test was used to test the effect of survival 
time comparing 6 hours survival against 6 day survival. The current study revealed 
that there were no significant differences in the immunostaining for any of the 















Figure 3.6: Effect of age on β-APP, NF-160, NF-200 and SMI-34. The y-








































































Figure 3.7: Effect of the velocity of injury on NF-160, NF-200 and SMI-34. 





















































Figure 3.8: Effect of velocity on β-APP immunoreactivity. Plot with 
representative images demonstrating the accumulation of β-APP in the brains of 
















Figure 3.9: Effect of survival time on β-APP, NF-160, NF-200 and SMI-34 



















Effect of Survival Time (3 - 5 day old animals)
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Effect of Survival Time (3 - 5 day old animals)


























Figure 3.10: Effect of survival time on β-APP, NF-166, NF-200 and SMI-
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Effect of Survival Time (4 week old animals)
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3.3.1.5 Correlation of the antibodies with the presence of axonal 
swellings and terminal bulbs 
β-APP positive axonal swellings or terminal bulbs were not seen in any sham 
cases. However, a majority of injured piglets showed evidence of β-APP positive 
axonal swelling and/or axonal bulb formation, this pathology being seen in 10 out of 
16 cases. Control piglet brains exhibited normal staining for NF-160 and NF-200 
proteins. Axonal swelling and retraction bulbs, indicative of axonal injury were 
observed less commonly (5 out of 16 animals) in the brains of injured piglets when 
immunohistochemistry for NF-160 and NF-200 was employed. Normal patterns of 
immunoreactivity for the SMI-34 antibody were demonstrated in control brains, 
indicated by the absence of axonal swellings and terminal bulbs. Interestingly, axonal 
swellings were highlighted by SMI-34 immunohistochemistry in 2 out of 16 injured 
piglets. The various immunoreactivities of the different antibodies within the axonal 



















Figure 3.11: Traumatic evidences of axonal injury. Representative images 
demonstrating the range of TAI, based on the presence of axonal swelling and 
terminal bulbs. TAI is detected using β-APP (A), NF-160 (B), NF-200 (C) and SMI-







3.3.2 Immunoreactivities of β-APP and neurofilament markers in human 
3.3.2.1 Trauma vs ischaemia 
To assess the differences between ischaemic cases and cases with TAI, an 
antibody panel including β-APP, NF-160, NF-200 and SMI-34, was applied to 
trauma cases and to ischaemic cases. Boxplots for each of the antibodies in each 
region (corpus callosum, internal capsule and brain stem) for traumatic and 
ischaemic cases are shown (Figures 3.12 and 3.13). Statistical analysis of the 
immunohistochemistry results revealed no significant differences when comparing 
TAI cases with ischaemia cases. 
3.3.2.2 The anatomical distribution of immunoloading in the brain 
The human study assessed the distribution of the immunoreactivity of the 
different markers in each tested region (corpus callosum, internal capsule and brain 
stem) and comparisons were made between traumatic and control cases. The level of 
β-APP immunostaining was significantly increased (p=0.004) in the brain stem 
compared with corpus callosum or internal capsule (Figure 3.14). The brain stem 
displayed elevated NF-160 immunostaining when compared to other regions, but did 
not reach statistical significance (Figure 3.15). There were no significant regional 














Figure 3.12: Accumulation of β-APP and NF-160 after TAI and 
ischaemia. Boxplots for β-APP and NF-160 antibodies in different regions of 
traumatic and control cases. 1= T1 (TAI), 2= C2 (Control), cc= corpus callosum, ic= 







































Figure 3.13: Accumulation of β-APP and NF-160 after TAI and 
ischaemia. Boxplots for NF-200 and SMI-34 antibodies in different regions of 
traumatic and control cases. 1= T1 (TAI), 2= C2 (Control), cc= corpus callosum, ic= 







































Figure 3.14: Anatomical distribution of β-APP immunostaining. 
Scatterplot of β-APP immunoreactivity in three regions for each case, with 
representative images showing higher accumulation of β-APP in pons (A) when 
compared to corpus callosum (B) or internal capsule (C) of the same case. 1= corpus 
callosum, 2= internal capsule, 3= brainstem, FITS1=fitted value, RESI1=residual 





























Figure 3.15: Anatomical distribution of NF-160 immunostaining. 
Scatterplot of NF-160 immunoreactivity in three regions for each case. 1= corpus 
































Figure 3.16: Anatomical distribution of NF-200 and SMI-34 
immunostainings. Scatterplots of NF-200 and SMI-34 immunoreactivities in three 
regions for each case. 1= corpus callosum, 2= internal capsule, 3= brainstem, FITS3 











































Scatterplot of RESI4 vs FITS4
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3.3.3 Active caspase-3 and calpain in piglet and human brains 
The purpose of this section of the study was to determine the activity of 
caspase-3 and calpain in human and piglet brains with TAI. To assess this, three 
antibodies were employed: active caspase-3 antibody as a marker of activated 
caspase-3, and two antibodies (Ab37 and Ab38) to detect the activation of calpain by 
recognizing a proteolytic fragment of α-spectrin cleaved by activated calpain. These 
antibodies were a gift from Dr R Siman and have been well characterised and used 
for western blotting studies. However, the current study failed to show any 
significant staining by any of these antibodies in the injured brains of animal or 
human, when citric acid and different dilutions of the primary antibodies were used. 
To investigate the possibility that the antibodies were not responsive to such pre-
treatment, the immunohistochemical procedure was repeated under conditions where 
EDTA and trypsin were employed. However, despite multiple antigen pre-treatments 
and differing staining protocols there was no detectable immunopositive staining of 
caspase-3 and calpain markers in piglet and human cases with TAI. In addition, a 
formalin-fixed paraffin embedded human lymph node with high levels of apoptosis 
was used as a control tissue and this also failed to show any significant 
immunostaining. There was also no alternative antibody available to active caspase-3 
to be tested in the present study.           
3.3.4 Double labelling studies 
 In this part of the study, double immunofluorescence labelling was carried out 
to examine whether β-APP and each of the neurofilament markers co-localised, 
highlighting the same population of axons. In all images acquired, β-APP staining 
was indicated by the green chromogen, while the red chromogen was the signal for 
113 
 
the neurofilament (NF-160, NF-200 or SMI-34) staining. The co-localisation was 
observed as a yellow colour, the combination of green and red signals.  
3.3.4.1 Co-localisation of β-APP and NF-160 in piglet and human  
Two cases of injured piglets with TAI were selected for double labelling. They 
revealed evidence of co-localisation of stained axons with β-APP and NF-160 
antibodies in both case, one case showing strong co-localisation (Figure 3.17: A, B, 
and C) and the second showing less consistent co-localisation. All human cases of 
TAI showed β-APP immunoreactivity co-localising with NF-160 immunostaining 
(Figure 3.17: D, E, and F), but to a lesser degree in one case. In addition, there was a 
significant population of NF-160 immunopositive axonal swellings which did not co-
localise with β-APP, although the vast majority of the β-APP immunopositive axons 
did co-localise with NF-160 stained axons. In summary, while β-APP did co-localise 
with NF-160 in all piglet and human cases, there was an obvious second population 
of axonal swellings that were NF-160 positive, β-APP negative. There was a much 
















Figure 3.17: Co-localisation of β-APP and NF-160. Representative images of 
double-label immunofluorescence of traumatically injured axons in corpus callosum 
showing intra-axonal β-APP accumulation (green) in piglet (A) and in human (D), 
NF-160 immunoreactivity (red) in piglet (D) and in human (E), and co-localisation 




3.3.4.2 Co-localisation of β-APP and NF-200 in piglet and human  
In injured piglets with TAI, there was strong co-localisation between β-APP 
and NF-200 positive axons, although there was also a prominent second population 
of damaged axons which were β-APP immunoreactive only. Only a very small NF-
200 positive β-APP negative population of axons was seen (Figure 3.18: A, B, and 
C). However, as can be seen from figure 3.18 (D, E, and F), the results obtained from 
the human cases of TAI show that antibodies to β-APP and NF-200 appear to stain 
predominantly separate populations of damaged axons, with only focal co-
localisation.   
3.3.4.3 Co-localisation of β-APP and SMI-34 in piglet and human  
In piglets, co-localisation of β-APP and SMI-34 markers was observed in both 
cases albeit to a lesser degree in one case (Figure 3.19: A, B, and C). Virtually all β-
APP positive axons co-localised with SMI-34, although there was a small population 
of SMI-34 positive β-APP negative axons. In human cases with TAI, there was a 
similar pattern of co-localisation of β-APP and SMI-34 (Figure 3.19: D, E, and F), 
although SMI-34 positive β-APP negative axons were numerous. Only very 















Figure 3.18: Co-localisation of β-APP and NF-200. Representative images of 
double-label immunofluorescence of traumatically injured axons in corpus callosum 
showing intra-axonal β-APP accumulation (green) in piglet (A) and in human (D), 
NF-200 immunoreactivity (red) in piglet (D) and in human (E), and co-localisation 








Figure 3.19: Co-localisation of β-APP and SMI-34. Representative images of 
double-label immunofluorescence of traumatically injured axons in corpus callosum 
showing intra-axonal β-APP accumulation (green) in piglet (A) and in human (D), 
SMI-34 immunoreactivity (red) in piglet (D) and in human (E), and co-localisation 




4.1 Pathological database of the Lothian and Borders cohort  
The current study described retrospectively the neuropathological findings 
associated with TBI among people living in the Lothian and Borders region 
(Scotland, United Kingdom) over the period 1982 to 2005. This population-based 
cohort study reviewed the data of 406 cases from the archive of the Academic 
Department of Pathology (Neuropathology), University of Edinburgh. This is the 
first study of its kind to document the neuropathological features of TBI amongst this 
population, although previous studies have described cohorts from the West of 
Scotland (Adams et al., 1977; Graham et al., 1989; Adams et al., 1989; Smith et al., 
2006). Based on ethnicity there is an expectation that the findings would be very 
similar to those seen in the West of Scotland, and there is unlikely to be any 
significant genetic or cultural influence to cause significant differences.   
4.1.1 Sampling of the brain 
A comprehensive histological examination had been carried out in almost 90% 
of the cases, whereas 27 cases (7%) had a limited histological study. No histology 
had been done in only 12 cases (3%). When sampling the brain for histology a 
routine protocol should be applied, modified to specific focal pathology or 
clinicopathological question (Kalimo et al., 2004). It has been reported that a 
minimum of at least 12 different brain regions require to be sampled in trauma cases, 
particularly for the assessment of TAI (Geddes et al., 2000). In cases of ischaemic 
injury, selected areas should include the neocortical border-zone region, hippocampi 
with subiculum, basal ganglia, thalamus and cerebellum (Graham, 1977). For 
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verification of axonal injury, sampling of the corpus callosum just rostral to the 
splenium with parasagittal white matter, the body of the corpus callosum with 
parasagittal white matter, posterior limb of the internal capsule, midbrain, pons and 
medulla is required (Geddes et al., 1997). Bilateral sampling is encouraged especially 
if TAI is being considered (Dolinak and Reichard, 2006), as it has been demonstrated 
that a significant number of cases of TAI can be missed without bilateral sampling 
(Geddes et al., 1997). As for many other neurological disorders, it is recommended to 
follow internationally accepted sampling protocols for the neuropathological 
investigation of various conditions since the accuracy of diagnosis is dependent on 
the representative adequacy of the retained tissue and the quality of the histology 
(Love, 2004). In addition, retrospective assessment of cases is entirely dependent on 
appropriate sampling and description of pathology at the time of examination. In this 
cohort it was not possible to provide a detailed assessment of contusional injury due 
to the limited description available from the archived reports. 
4.1.2 Gender differences 
The incidence of TBI was shown to be higher in males than females, with 69% 
of TBI cases within the cohort being males (Summers et al., 2009). This is consistent 
with other studies. Chau et al (2007) reported that the risk of TBI in males is 3 to 4 
times higher than in females. In the UK, an epidemiological study of individuals with 
a head injury attending an emergency department revealed that males were more at 
risk than females (Yates et al., 2006). In the USA, national emergency department 
studies have uniformly found that males are at higher risk of TBI than females where 
the male-to-female (M/F) ratios were 1.5:1 and 1.7:1(Guerrero et al., 2000; Jager et 
al., 2000). The M/F ratios were also reported to be > 2:1 and 2:1in Olmsted Country 
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and San Diego respectively (Annegers et al., 1980; Kraus et al., 1984). Other studies 
have also supported the current findings by reporting that the TBI incidence in males 
exceeded TBI incidence in females in Australia, France and China with M/F ratios of 
2.7:1, 2:1 and 1.3:1 correspondingly (Tate et al., 1998; Tiret et al., 1990; Wang et al., 
1986). The reason for this consistent male predominance may be attributed to 
participation in particular occupational and leisure activities which put the individual 
at higher risk for sustaining TBI, or may reflect an inherent predisposition to risk 
taking in males (Yates et al., 2006).  
4.1.3 Age-specific incidence  
The current study revealed that the highest number of cases were in the second 
and the third decades comprising 26.7% of the cohort. This is similar to other studies 
which showed that the peak incidence of TBI was seen in the age group between 15-
19 years old in the United Kingdom (Yates et al., 2006) and 15-24 years old in the 
United States (Thurman et al., 1999). The incidence was also reported to be highest 
in the 16-25 year age group in San Diego (Kraus et al., 1984), 15-24 year age group 
in Olmsted Country (Annegers et al., 1980), and 16-30 year group in the Bronx, NY 
(Cooper et al., 1983). The age-specific TBI incidence peaked in those aged 16-25 
years in France (Tiret et al., 1990) and 15-24 years in Australia (Tate et al., 1998). 
This peak incidence suggests that the age group 20-39 engages in activities that make 
them more vulnerable to accidents.  
A second peak of TBI incidence in the present results was seen in the elderly 
(25.7%), namely those above 60 years of age. This is in keeping with the findings of 
a large number of previous studies in this field. Specifically, several research groups 
have indicated that the second most common age group sustaining TBI is the over 
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65-year-old age group (Bruns and Hauser, 2003; Yates et al., 2006; Chua et al., 2007; 
Summers et al., 2009). The study reported by Chua et al has suggested that the 
incidence of TBI in those aged 65 years or older increases with increasing age (Chua 
et al., 2007). In those older than 74 years, an increased frequency of TBI has been 
reported in France and Australia (Tiret et al., 1990; Tate et al., 1998), and a recent 
publication (Bener et al., 2010) further supports these findings, reporting that, in a 
cohort of 1919 cases, the peak rate of TBI was amongst the over 65 years old group. 
There are several explanations for these results among elderly people. A possible 
explanation for this might be the medical co-morbidities and frailty associate with 
elderly people (Chua et al., 2007), or may be due to a combination of sensory and 
motor decline, de-conditioning and cognitive or conscious impairments (Bruns and 
Hauser, 2003). Most of the episodes of TBI in this older age group are attributed to 
falls and motor vehicle accidents (Thurman et al., 1999; Bruns and Hauser, 2003). It 
has been reported that falls are the most common cause of TBI in older adults since 
approximately 10% of falls in older people result in injuries such as TBI (Thompson 
et al., 2006). Other studies have confirmed that falls were the leading mechanism of 
TBI for older adults, accounting for 51% of cases (Langlois et al., 2004). 
In the current study, the rate of TBI-associated cases from the ages of 40-59 
years was observed to include the third largest group with an incidence of 20.5%. 
The lower incidence in this age group is in keeping with other published studies, 
since incidence rates for TBI have been reported to decrease throughout adulthood to 
a lower point in middle-aged individuals after the high-risk adolescent and young 
adult years (Bruns and Hauser, 2003). Despite the slight variation in age groups 
studied between this study and previous publications, a similar trend was seen in 
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several studies done in Olmsted Country, France, Australia, and the Bronx (Annegers 
et al., 1980; Tiret et al., 1990; Tate et al., 1998; Cooper et al., 1983). It seems that the 
trend of lower rates in adult and middle-aged cohorts is almost universal, although 
TBI incidence varies with population and locale. It precedes the increase in TBI seen 
in the geriatric population and may results from a decline in the impulsivity of the 
younger years (Bruns and Hauser, 2003). 
The incidence rate of TBI in the age group 1-19 years was observed to be 
18.3% of the cohort. This finding is consistent with other studies assessing the risk of 
TBI in children and adolescents (Guerrero et al., 2000; Greenwald et al., 2003). The 
rates of TBI in children have been observed to be generally low in Northern 
Manhattan as well as Australia (Tiret et al., 1990; Durkin et al., 1998). Rates of brain 
injury have been reported to be mostly steady during childhood, but to increase 
significantly at the age of 15 years (Adekoya et al., 2002; McCarthy et al., 2002; 
Kraus et al., 1990). Childhood injuries may be attributed to various important risk 
factors including behavioural features, levels of physical and sporting activity, 
socioeconomic status, neighbourhood characteristics and family type (Lalloo and 
Sheiham, 2003). 
The Lothian and Borders cohort revealed that the number of infant cases (<1 
year) were the lowest (4 cases, 1%), and consequently the lowest rate when 
compared to the overall population. This is in accord with previous studies 
performed in Northern Manhattan, France, and Olmsted Country, all of which found 
low incidence rates of TBI in those younger than 1 year (Durkin et al., 1998; 
Annegers et al., 1980). Infants tend not to be exposed to high risk situations and 
society tends to protect this vulnerable group. However, we also see the situation of 
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non-accidental injury within this age group, although the incidence of this type of 
injury is low. 
Collectively, brain injury has generally been accepted, in population-based 
studies, to show a trimodal distribution: early childhood; late adolescence/early 
adulthood; and the elderly. Although these same general trends described in previous 
studies are seen in the Lothian and Borders cohort, comparison of age-specific 
incidence between studies is often difficult. This might be because of non-
consistency of age grouping throughout studies; different case-ascertainment 
schemes; and confounders like gender, socioeconomic status and race. Therefore, a 
unified system of categorization should be adopted for future studies in order to help 
the health and safety authorities in developing an understanding of the external 
causes accountable for TBI and to assess vulnerable populations (Tagliaferri et al., 
2006). This goal may be achieved through creating a standard protocol which then 
can be published in the international journals and presented in the international 
meetings.   
4.1.4 Mechanism of injury 
A World Bank report entitled “The Global Burden of Disease” has stated that 
traffic injuries are expected to become the third highest disease burden by the year 
2020 (Dash et al., 2010). Road traffic accident (RTA) was revealed in the Lothian 
and Borders study to be the most common cause of TBI (48.5%). This was followed 
by a fall from height (24.5%) and assault (5.9%). Gunshot wound was the 
mechanism of injury in only four cases (1%). These findings are in line with about 
thirteen European studies reviewed in 2006, which found in most reports that motor 
vehicle related causes were the most common event leading to a TBI, but with 
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considerable variations from place to place (Tagliaferri et al., 2006; Murray et al., 
1999). The same review also revealed that falls were second in frequency although in 
some reports falls were found to be similar in incidence to RTA as cause of TBI. 
However, violence/assault was reported to be a very common cause in Glasgow, 
Scotland (Thornhill et al., 2000; MacCallum et al., 2000). This high incidence of 
violence-related TBI in may be attributed to alcohol use and social deprivation 
(Wright and Kariya, 1997; Hutchison et al., 1998; Midford et al., 1998). The Lothian 
and Borders cohort results provide further evidence that gunshot wound to the head 
is uncommon in the UK as well as Europe in contrast to some other continents (Kay 
and Teasdale, 2001). In contrast, according to the National Center for Injury 
Prevention and Control (NCIPC) in the United States, falls were responsible for the 
largest proportion (28%) of TBI, followed by motor vehicle-traffic crashes (20%), 
struck by/against events (19%) and assaults (11%) (Langlois et al., 2006). In 
Australia, 40% of TBI was attributed to RTA, 25% to sports or recreation injuries 
and 21% to falls (Tate et al., 1998). In China, RTA accounted for 32% of TBI, 
occupational accidents 24%, falls from height 22%, recreational activities 16%, and 
gunshot wounds 1.4% (Wang et al., 1986).  
Taken together, it seems that there are variations between centres and regions 
around the world when identifying the causes of TBI. This variation is likely to be 
due to the individual‟s demographic, reflecting the surrounding environment and 
culture. Although there is a high incidence of RTA-related TBI in western cultures, 
the actual numbers are numerically much lower than those seen in developing 
countries, presumably reflecting a better attitude towards traffic flow, maintenance of 
vehicles, driving under the influence of alcohol or drugs and obedience of traffic 
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laws. One should consider the fact that, in the UK, it has been reported that 60% of 
those with fatal head injuries from road accidents are often pedestrians and 40% are 
vehicle occupants (Jennett, 1996). In Glasgow, Scotland, pedestrian victims of head 
injury were found to be more intoxicated than injured drivers (Galbraith et al., 1976) 
and, therefore, the influence of alcohol might also be considered to contribute to 
RTA-related TBI. Falls and assaults were seen to be other significant causes of head 
injury amongst the Lothian and Borders cohort. This may be also related to the 
alcohol consumption in some cases, or may reflect an older population more prone to 
falls. It has been reported that alcohol is a common characteristic of victims of 
assaults and of falls. Alcohol excess was observed four times more often in falls and 
assaults than after road accidents in admissions for head injury in Scotland (Jennett, 
1996). 
4.1.5 Survival time 
In one third to one half of all trauma-related deaths, TBI is estimated to be the 
primary cause of death (Sosin et al., 1995). A number of studies have reported the 
association between TBI and significant mortality in the acute period after head 
injury (Kraus et al., 1984; Masson et al., 1997; McGarry et al., 2002; Thurman, 1999; 
Vazquez-Barquero et al., 1992, Pentland et al., 2004; McMillan and Teasdale, 2007; 
Harrison-Felix et al., 2009). This view has been supported by the current findings, 
which have demonstrated that more than half of the cases (51.4%) had a survival 
time of less than 24 hours. In 65 cases the survival period ranged from more than 24 
hours to 28 days, and a few individuals (7 cases) in the Lothian and Borders cohort 
survived between one month and 12 months. Similarly, other studies have shown that 
death occurs at the scene, during ambulance transport phase or during the emergency 
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medical stage of treatment in about half of all TBI fatalities (Bruns and Hauser, 
2003). This high rate of mortality in the acute period may be explained by the severe 
neurological and functional deficits in TBI victims that are sustained from the 
primary injury to the brain, such as cerebral contusions, lacerations and diffuse 
vascular injury. In addition, there is often associated non-neurological trauma which 
can be associated with various injuries such as fractures with associated hypotension, 
cardiopulmonary or visceral injuries, spinal cord injuries and peripheral nerve 
injuries in 70% of cases affected (Chua et al., 2007). The association between 
mortality in the acute period after head injury and secondary insults due to evolving 
pathology or delayed treatment has also been demonstrated in multiple studies 
(Luerssen et al., 1988; Conroy and Kraus, 1988; Klauber et al., 1989; Marshall et al., 
1991; Lang et al., 1997; Signorini et al., 1999; Fiedler et al., 2000; Lannoo et al., 
2000; Peek-Asa et al., 2001; Jiang et al., 2002; Mosenthal et al., 2002; Schreiber et 
al., 2002; Fabbri et al., 2008).  
17 cases in the Lothian and Borders study were found to have survival time of 
more than 12 months; 3 survived less than 5 years, 4 survived from 5 up to 10 years, 
and 10 survived over 10 years. In contrast, all 479 patients included in the study of 
Lewin and colleagues (Lewin et al., 1979) had experienced coma or post-traumatic 
amnesia and most cases died within 1 year and no cases survived beyond 10 years. 
Previous studies have also confirmed the significant reduction in survival after 
moderate to severe injuries (Kraus et al., 1984; Thurman, 1999; Masson et al., 2001; 
Adekoya et al., 2002) when compared to mild injuries. In persons who survived six 
months after moderate to severe injury, most studies reported a decrease in long-term 
survival when compared to mildly injured cases (Walker et al., 1971; Weiss et al., 
127 
 
1982; Rish et al., 1983; Baguley et al., 2000; Shavelle et al., 2001). It is difficult to 
make a direct comparison in our long-term survivors with previously published 
studies in that we had very limited clinical information from our cases and, in 
particular, little information relating to the severity of injury on hospital admission 
and subsequent clinical state. 
An Australian study has supported the current view by demonstrating that the 
length of time between injury and death ranged from 45 days to 9 years (Baguley et 
al., 2000). The existing literature relating to long-term survival after TBI has 
revealed that the mortality rates were reported to be 6.7% after 15 years survival 
(Rish et al., 1983) and 4% with 9 years survival (Strauss et al., 1998). Therefore, 
there is a degree of correlation between the Lothian and Borders data and some 
previous publications. An increased mortality rate has been documented in survivors 
of mild TBI at 1 year post-injury (Thornhill et al., 2000), although the mortality rate 
in this group is, as expected, much lower than that seen during the acute period 
(Shavelle et al., 2001; Pentland et al., 2004). In the literature, risk factors for later 
mortality have also been proposed including old age and male sex, as for the general 
population (Harrison-Felix et al., 2009). Alcohol use, time since injury, verbal and 
cognitive functions, education, initial TBI severity, and maladaptive behaviours such 
as drug use and criminal behaviour are among other factors studied in relation to 
later mortality (Shavelle et al., 2007). After head injury, the primary causes of death 
were similar to those seen in the general population (Pentland et al., 2004; Shavelle 
et al., 2007; McMillan and Teasdale, 2007; Harrison-Felix et al., 2009), although 
sudden unexpected death in epilepsy (SUDEP) has a high incidence in the post-
traumatic seizure group. 
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4.1.6 Skull fracture  
Skull fracture can be an additional cause of morbidity and mortality, especially 
when associated with complications like haemorrhage or contusion to the underlying 
brain or spinal cord (Kalimo et al., 2004). Almost a third (30%) of all TBI cases 
reviewed in this study had evidence of fractures of the skull. The present findings 
were in contrast to study carried out in Glasgow, which reviewed a series of 151 
cases and showed an incidence of 79% for skull fracture in fatal head injury (Adams 
et al., 1980a). Data from a consecutive series of 635 fatal non-missile head injuries 
over a 25-year period (1968-1982) revealed that fracture of skull was seen in 75% of 
cases (Graham et al., 1988). In clinical practice, the incidence of skull fracture was 
3% in mild head injury presenting to the emergency room, rising to 65% in those 
requiring neurosurgical admission (Masters et al., 1987). Although the present results 
differ from the published studies mentioned above, they are to some extent in line 
with those described by Osborn and co-workers who reported an incidence of 25% of 
skull fractures in fatal head injuries at autopsy (Osborn et al., 2002). In Edinburgh, 
Miller reviewed the head injury admissions in 1981, 1986, and 1989, and he found 
that 20% of cases had skull fracture (Miller, 1993). The explanation of the different 
incidence rates between studies may be related to the severity of injury. It has been 
reported that the frequency of fracture of the skull is associated with the severity of 
the head injury (Graham and Gennarelli, 2000). Equally, it may be a reflection of the 
study populations; the Lothian and Borders study was all fatalities with pathological 
evidence of head injury, whereas the Glasgow studies were all fatalities in which 
there had been an admission to a neurosurgical unit. This second population is much 
more selective, and is focused on patients whose primary pathology is head injury 
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rather than individuals who have some degree of head injury potentially in 
association with significant systemic pathology which has been the cause of the 
death. 
4.1.7 Contusion 
In the present study, analysis of the results showed that contusions were 
observed in 219 (53.9%) cases, while in 187 cases they were absent. The findings are 
in contrast to the findings published by Adams and colleagues (Adams et al., 1985). 
They demonstrated that contusions were seen in more than 90% of fatal cases of TBI 
and they were absent in some 6% of fatal cases. This inconsistency may be related to 
different indexes in skull fractures between the Lothian and Borders study and 
published Glasgow studies. Another possible explanation for this discrepancy might 
relate to the broad range of severity of the cases used in the current research, rather 
than focusing on TBI cases which had neurosurgical admission. Despite these 
differences it is still obvious that contusions are one of the more commonly seen 
hallmarks of brain damage secondary to head injury. 
4.1.8 Diffuse ischaemic brain damage (global ischaemia) 
Ischaemic brain injury is a common pathology seen in autopsy series of fatal 
traumatic brain injury, being seen in 91% of cases in one study (Graham et al., 1978). 
In the current Lothian and Borders study, it has been shown that 130 (33.5%) cases 
were associated with global ischaemic brain damage. Global ischaemic was found in 
the brains of 80% and 92% of two series of fatal cases (Graham et al., 1989). A 
possible explanation for the lower incidence in the current study may be related to 
the modern measures of the management of head injured patients which perhaps 
have an effect in avoiding the occurrence of ischaemic brain damage. However, 
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another potential reason for this may be related to the fact that ischaemic damage can 
be identified microscopically only after a survival of at least several hours. The 
hallmark of ischaemic injury is so-called “ischaemic cell change”.  There is 
shrinkage of the nucleus and cytoplasmic eosinophilia. Several hours survival post-
ischaemic injury is required for histological changes to develop (Adams et al., 1980; 
Graham et al., 1978; Graham et al., 1989). As a consequence it is important to note 
that not all the cases in the present study survived their head injury long enough to be 
transferred to the hospital, and as such did not survive long enough for histological 
changes to develop. Therefore, the current low incidence of ischaemic brain injury in 
this study when compared to other studies where patients are transferred to hospital 
and ventilated prior to death would be expected.  
4.1.9 Intracranial haematomas 
One of the most frequent and best known complications of head injury is 
intracranial haematoma (Jennett et al., 1977; Adams et al., 1980a). The current 
Lothian and Borders study revealed that 270 cases (66%) had intracranial 
haematomas; they were supratentorial in 255 (62%) and infratentorial in 4 (1%). 
These findings are consistent with those of Adams and colleagues who found that 
supratentorial haematoma was seen in 58% of patients whereas infratentorial 
haematoma was observed in 5 cases (3.3%) (Adams et al., 1980a). Data from a 
consecutive series of 635 fatal non-missile head injuries over a 25-year period has 
also supports the current analysis with a reported incidence of 60% of intracranial 
haematomas (Adams et al., 1986).    
 When considering the distribution of the supratentorial haematomas previous 
studies have reported an incidence of 10% for extradural haematomas, between 18% 
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and 20% for subdural haematoma, between 16% and 22% for intracerebral 
haematoma, and burst lobe with an incidence of between 22% and 23% (Adams et 
al., 1980a; Adams et al., 1986). In line with these earlier studies, subdural 
haematoma was reported in approximately 18% of the Lothian and Borders cases. 
However, in the current study extradural and intracerebral haematomas were seen in 
about 7% and 13% consecutively. It seems also that the lower incidence (1%) of 
burst lobe in the current study differs from previous publications. 
In patients with head injury, traumatic subarachnoid haemorrhage has been 
reported to be a common autopsy finding (Freytag, 1963; Lindenberg and Freytag, 
1970; Tatsuno and Lindenberg, 1974). It is also clear from the present study that 
subarachnoid haemorrhage is common in patients sustaining brain injury, being seen 
in approximately 46% of cases. Although medical and surgical advancements are 
improving survival rates, subarachnoid haemorrhage has been reported to be the 
fourth most common intracranial cause of death (Leon-Carrion et al., 2005). The 
current findings seem to fall within the range of other studies which showed an 
incidence of traumatic subarachnoid haemorrhage ranging from 5 to 57% (Martin et 
al., 1992; Eisenberg et al., 1990; Kakarieka et al., 1993; Abraszko et al., 1996; 
Weber et al., 1990). The variation in these studies probably represents different 
methods of reporting and assessing subarachnoid blood.  
4.1.10 Raised intracranial pressure 
For many intracranial problems, raised ICP is known to be the final common 
pathway and has a profound influence on outcome (Pickard and Czosnyka, 1993). 
The current study revealed that almost 186 (45%) out of 406 cases had some form of 
raised ICP, 217 did not have evidence of any such pathology and no information was 
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available in 3 cases. This was in contrast with earlier work carried out in Glasgow 
which found that 75% of 434 patients dying with TBI had such lesions (Graham et 
al., 1987). Other studies have shown that there was evidence of a high ICP in 125 
(83%) cases of fatal head injury (Adams et al., 1980a). It has been reported that fifty 
percent of patients with head injury seen in Accident and Emergency Departments in 
the United Kingdom every year have an ICP greater than 20 mm Hg (Jennett and 
Teasdale, 1981; Miller et al., 1992). A possible reason for the lower incidence of ICP 
in the current Lothian and Borders study may be related to the much lower incidence 
of severe contusions and intracranial haematomas in the current cases when 
compared to previous publications. 
Brainstem haemorrhage is reported to be a common autopsy finding among 
severely head injured patients (Adams et al., 1977; Tomlinson, 1970). In 
craniocerebral trauma victims, secondary haemorrhage of the brainstem has been 
reported to occur at a later stage as a result of axial displacement of diencephalic 
structures (Graham et al., 1987). In the present study, there was evidence of 
secondary brainstem haemorrhage in 34 (18%) cases and in four of these the damage 
could be seen only microscopically. Previous studies have shown that raised ICP was 
associated with secondary brainstem damage in 51% (221cases) of an autopsy series 
of 434 patients with non-missile head injury (Graham et al., 1987). They also report 
44 (20%) cases where such lesions were identified only microscopically. In addition, 
in a post mortem study of 132 fatal head injuries, brainstem haemorrhage was 
observed in 37% of cases (Tandon, 1964). 
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4.1.11 Diffuse traumatic axonal injury  
TAI is believed to be an important cause of morbidity and mortality in the 
absence of any other obvious intracranial lesions. The analysis of two previous 
cohorts in Glasgow revealed that the incidence of TAI among cases with head 
injuries was approximately 14% (Adams et al., 1980a) and 22% (Graham et al., 
1989). In one series of 434 fatal non-missile head injuries which were subjected to 
comprehensive histological studies, TAI was identified in 122 (28%) cases in which 
10 had grade 1, 29 had grade 2 and 83 had grade 3 (Adams et al., 1989). However, 
analysis of TAI in the present series showed a different incidence (46 cases, 11.4%) 
when compared to those published previously. Grade 1 was seen in 41 cases, grade 2 
was seen in 1 case and in 4 cases there was evidence of grade 3. Prior to the advent 
of immunohistochemistry axonal pathology was identified as eosinophilic axonal 
bulbs which could be highlighted by silver stains. However, with the advent of 
immunohistochemistry it became apparent that there was greatly increased sensitivity 
with this technique. In the current group, immunohistochemistry was used for the 
diagnosis of TAI in only 73 cases (18%) between 1994 and 2005 and all cases 
identified between 1982 and1993 having TAI diagnosed using Palmgren‟s silver 
impregnation technique. So, it is possible that through the histological examination 
of the current cases the diagnosis of TAI has been underestimated in cases where 
classic silver stain is only employed. As a result of this, there was an overall decrease 
in the total number of cases diagnosed with TAI. This is supported by previously 
published data, which  showed that immunohistochemistry resulted in a marked 
increase in the number of cases of Grade 1 TAI when compared to the silver 
impregnation technique (Gentleman et al., 1995). In the present Lothian and Borders 
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study, it is additionally noted that there was a reduction in the number of cases 
diagnosed with Grade 3 TAI. This may be in part due the greater sensitivity afforded 
by immunohistochemistry since this technique was used in 18% of the cases. 
However, it may be that there is increased awareness that much of the axonal 
pathology seen in TBI is in fact secondary to ischaemia, as discussed earlier.    
4.1.12 Brain swelling 
Brain swelling is particularly feared by neurosurgeons as it results in a 
significant increase in the volume of the intracranial contents and is very difficult to 
control. It is well recognized to be an important complication of head injury (Adams 
et al., 1980a), and can be either diffuse, involving one or both hemispheres, or focal 
as in relation to contusions. Ischaemia is the most common underlying pathology of 
diffuse brain swelling, although diffuse TAI can be associated with such swelling 
(Smith, 2005). The present results indicated that 275 out of 406 cases had evidence 
of bilateral brain swelling whereas only 3 cases had unilateral brain swelling. Brain 
swelling was considered to be a consequence of contusions (5.2%), intracranial 
haematoma (22.7%), hypoxic brain damage (2.7%) or a combination of pathologies 
(24.1%). In the other cases it was not possible to assign a cause. Other studies have 
reported that unilateral enlargement of a cerebral hemisphere was seen in 11% of 
cases (Sarabia et al., 1988), in contrast to the current study. However, the study by 
Sarabia and colleagues was a CT based study, and examined a series of 589 severe 
head injury cases of adults, while the current study was autopsy based and included 
cases with different degrees of severity amongst all age groups. In the Sarabia et al 
study, the cerebral swelling was seen to be associated in 88% of cases with an 
ipsilateral haematoma, in 7% with a large epidural haematoma, and with isolated 
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cerebral swelling in 4% of cases. Another study performed by Kobayashi et al 
reported that the incidence of diffuse brain swelling was 16% in severely head-
injured patients of all ages (Kobayashi et al., 1983). CT and MRI scans will identify 
brain swelling with greater sensitivity than autopsy studies, particularly focal low 
volume areas of swelling and, therefore, results are not directly comparable. 
In a study of 151 cases of fatal head injury, unilateral brain swelling was seen 
in 17 cases whereas in 9 cases there was evidence of bilateral brain swelling (Adams 
et al., 1980a). A review of fatal non-missile head injury without clinically 
documented raised ICP showed that brain swelling was seen in 13 cases out of a total 
cohort of 434, and the swelling was bilateral in 10 cases and unilateral in 3 cases 
(Graham et al., 1988). In the same study, bilateral brain swelling was attributed to 
contusions in 3 cases, to ischaemic damage in 2 cases and in 5 cases it was thought to 
be caused by a combination of ischaemic damage and contusions. The unilateral 
hemispheric swelling was related to contusions in the remaining three cases.  
4.2 Axonal pathology in piglet brains 
4.2.1 Sham vs injured piglets 
In this study, a significant increase of β-APP immunoreactivity has been 
demonstrated in the brains of the 4 week old injured piglets (6hour survival) when 
compared to the sham group. β-APP is transported by fast transport mechanisms 
(Koo et al., 1990), and is shown to accumulate within axons at the site of injury when 
there is axonal transport interruption (Yam et al., 1997). The current results are 
consistent with previous studies in that there was no significant positive staining of 
β-APP in any of the sham piglets tested (Raghupathi and Margulies, 2002; 
Raghupathi et al., 2004; Friess et al., 2007). Also, evidence of traumatic axonal 
136 
 
injury, as demonstrated by β-APP, has been reported following diffuse brain trauma 
in the 3-5 day old piglets (Raghupathi and Margulies, 2002; Raghupathi et al., 2004) 
and 17 day old rat (Adelson et al., 2001; Raghupathi and Huh, 2007). The present 
findings are therefore consistent with previous studies which have shown the ability 
of this marker to detect axonal injury after trauma in the brains of human (Cochran et 
al., 1991 Gentleman et al., 1993) and experimental animals (Otsuka et al., 1991; 
Nakamura et al., 1992; Kawarabayashi et al., 1993).  
 The accumulation of the medium subunit of neurofilaments, NF160, has been 
reported after inertial brain injury in the pig (Chen et al., 1999). The current study 
revealed that, when compared to the baseline levels of NF-160 immunoreactivity in 
the 3-5 day old control animals surviving for 6 hours, piglets sustaining low or high 
velocity injury showed a reduced expression of NF-160. This is at odds with a 
previous study carried out by Yaghmai and Povlishock (1992) which found that there 
was modest enhancement of immunoreactivity associated with the medium NF 
subunit in comparison to the control situation. Unfortunately, little is known in the 
literature about the response of NF-160 with TAI in the brains of humans and 
animals. However, there are some potential reasons which may explain the 
observation that there is reduced expression of NF-160 after rotational non-impact 
trauma. It may be that an acute response in the axons to the evolving axonal injury is 
down-regulation of NF-160 expression. A second possibility is that a survival time of 
6 hours was not enough for up-regulated NF-160 to be immunohistochemically 
detected in the injured animals. This potential is supported by previous studies which 
have not demonstrated the accumulation of NFM and NFH until after at least 24 
hours following trauma (Chen et al., 1999; Smith et al., 1999). The current study has 
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also shown no significant difference between sham and injured piglets with regard to 
the level of expression of NF-200.        
The regulation of NF phosphorylation and dephosphorylation has been 
reported to occur mainly within the axonal compartment, utilising different 
phosphate acceptor sites on the NFs (Dewaegh et al., 1992; Nguyen et al., 2001). 
Sternberger and Sternberger (1983) have suggested that the compactness and order in 
NF structure can be increased by phosphorylation. However, the degree of 
phosphorylation is correlated inversely with the velocity of axonal transport in that 
the dephosphorylated forms of NF are more easily transported along the microtubule 
tracks (Watson et al., 1989). After rotational acceleration trauma, the phosphorylated 
heavy NFs have been shown to decrease significantly within the axonal compartment 
(Hamberger et al., 2003). In contrast to earlier findings, however, the current study 
revealed a significant increase of the hyperphosphorylated NF marker, SMI-34, at 6 
hours post-injury in the piglet group aged between 3 and 5 days compared to the 
sham animals. It is not clear why the immunostaining of SMI-34 increased after 
injury. The metabolism of NF-200 has been shown to be affected by its degree of 
phosphorylation (Goldstein et al., 1987; Greenwood et al., 1993). Greenwood et al 
(1993) observed that there was a significant increase in the rate of degradation of 
NF-200 by calpain if the protein was dephosphorylated, suggesting that 
phosphorylation state can alter the activity of calpain. Therefore, one could speculate 
that degradation of the hyperphosphorylated NF-200 in the current study may have 
been reduced and, if the rate of synthesis remains unchanged, this could lead to an 
increased accumulation, or that rapid hyperphosphorylation of NF-200 is a protective 
mechanism after TBI.  
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It is thought that axonal injury can lead to misalignment or compaction of NFs, 
and studies of experimental TAI have shown a decrease of axonal NFs after injury 
secondary to sidearm modification (Yaghmai and Povlishock, 1992; Okonkwo et al., 
1998; Maxwell et al., 2003). The findings of the current study are consistent with 
previous studies which show decreased levels of NF protein. Whether this is due to 
proteolysis or the pathological reorganization of NF protein is uncertain. The results 
of this study have provided further evidence of the complexity of the pathology of 
NFs and the difficulty in their assessment particularly when TAI is evaluated.  
4.2.2 Effect of age, velocity, and survival time 
The effect of different variable factors including age of animals, velocity of 
injury and survival time was also examined in the current study among injured 
piglets. No significant effect of age on the accumulation of the various proteins was 
observed between injured neonatal (3-5 day old) and juvenile (4 week old) pigs. Data 
from animal studies have shown the considerable decrease of the rate of fast 
anterograde axonal transport in old age (Geinisman et al., 1977; Viancour and 
Kreiter, 1993). It has been suggested that β-APP may concentrate more quickly and 
in greater quantity in younger cases (Sherriff et al., 1994a; Hortobágyi et al., 2007). 
Although this has not been observed in the current animal study, this may be a 
reflection of the relatively young age of both groups.   
The velocity of the injury did not significantly influence the expression of the 
markers used in this study. Although some brains of piglets receiving high velocity 
injury appeared to have greater accumulation of β-APP compared to piglets receiving 
low velocity injury, this failed to reach significance.  
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In paediatric TBI cases, β-APP has been shown to be detected within 35-45 
minutes after injury (Gorrie et al., 2002). Hortobágyi and co-workers demonstrated 
β-APP immunoreactivity in adult cases who survive as little as 35 minutes 
(Hortobágyi et al., 2007). β-APP was also detectable in patients surviving as long as 
99 days after mild head injury (Blumbergs et al., 1994), although the potential effect 
of perimortem ischaemia was not considered in this report. In animal models, 
accumulation of β-APP can be detected as early as 30 minutes to 1 hour (Pierce et 
al., 1996; Stone et al., 2004). The immunopositive axons highlighted by β-APP 
antibody have been identified for several months to a year following injury in rodents 
(Pierce et al., 1998) and pigs (Chen et al., 2004), suggesting an evolving pathology 
over many months. The immunostaining of NF has been also reported after TAI in 
different studies. It has been demonstrated in humans with survivals as short as 6 
hours in damaged swollen axons, and by 1 week in axonal bulbs (Grady et al., 1993; 
Christman et al., 1994). Robust NF immunoreactivity within several hours after TBI 
has been reported in numerous animal models (Yaghmai and Povlishock, 1992; 
Povlishock et al., 1997; Saatman et al., 1998; Chen et al., 1999; Smith et al., 1999). 
Therefore, the short and long term accumulations of β-APP and NF markers shown 
in previous studies have been supported by the current study which found no 
significant effect of survival time when the proteins were assessed.  
4.2.3 Association between the antibodies and the presence of axonal 
swellings and terminal bulbs 
Axonal swelling and axonal bulbs have been observed in the injured piglet 
brain after TAI (Raghupathi and Margulies, 2002; Raghupathi et al., 2004). These 
axonal pathologies were also seen in both porcine and non-human primate models of 
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diffuse brain trauma and in human cases (Smith et al., 1997; Smith et al., 2000; 
Maxwell et al., 1993; Maxwell et al., 1997; Adams et al., 1982; Gennarelli et al., 
1982; McKenzie et al., 1996). The current study revealed that accumulation of β-
APP was observed commonly in association with both contiguous and disconnected 
axons, being seen in almost 11 out of the 16 cases of injured piglets examined. The 
remaining 5 cases are amongst animals aged between 3 and 5 days in which 4 
survived 6 hours and 1 had a survival time of 6 days. These results are consistent 
with previous animal and human studies of TAI, which found β-APP 
immunostaining in most injured axons throughout the brains (Smith et al., 1999; 
McKenzie et al., 1996). Axonal bulbs and varicose axonal swelling have been also 
demonstrated but are less commonly seen when the antibodies to NF-160 and NF-
200 were used. Similar observations have been reported when antibodies specific for 
the sidearm domains of NFM and NFH were used following brain injury in the pig 
(Chen et al., 1999). Raghupathi et al (2004) have evaluated the brains of the injured 
piglets for the presence of TAI using the heavy subunit of the neurofilament (NF-
200). They reported an increase of the NF-200 immunoreactivity in both axonal 
swellings and axonal bulbs at 6 hours after injury in all injured animals. More 
interestingly, evidence of axonal injury was further demonstrated using the antibody 
against the hyperphosphorylated NF-200, SMI-34, but to a much lesser extent 
compared to other markers. This finding corroborates the concepts highlighted in the 
literature which suggest that the accumulating NF in damaged axons is non-
phosphorylated (Postmantur et al., 1994; Wang et al., 1994; Nixon and Sihag, 1991) 
since transported forms of NF are predominately non-phosphorylated (Hollenbeck, 
1989; Nixon and Sihag, 1991; Meller et al., 1993). Other studies have also reported 
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similar results in which the accumulated NF is mainly but not exclusively 
dephosphorylated (Chen et al., 1999; Saatman et al., 2003). This part of the current 
study showed the usefulness of antibody targeting β-APP for detecting changes in 
axonal function in brain-injured piglets when compared to NF-160, NF-200 and 
SMI-34 markers. However, caution must be exercised in interpreting the presence of 
β-APP immunoreactivity as the heterogeneity of the responses of individual cases 
after injury has previously been demonstrated in animal and human studies (Yaghmai 
and Povlishock, 1992; Grady et al., 1993).  
4.3 Axonal pathology in human brains 
4.3.1 Trauma vs ischaemia 
This study has assessed β-APP immunoreactivity in different anatomical 
regions in ischaemic cases and in cases with TAI. No significant difference was 
observed between ischaemic and traumatic cases. Immunostaining for β-APP is the 
most widely used and most reliable method in detecting axonal injury (Gentleman et 
al., 1993; Sherriff et al., 1994a).  
Axonal injury is a frequent finding in cases of fatal head injury (Gentleman et 
al., 1995). Identification of axonal injury through utilizing antibody against β-APP 
has also allowed damage axons to be seen in mild head injured cases (Blumbergs et 
al., 1994) and in severely disabled or vegetative patients (Adams et al., 1999; Kinney 
and Samuels, 1994). Therefore, the current study further supports previous studies 
which found evidence of axonal injury by means of β-APP immunopositive staining 
after traumatic brain injury in humans. Also in keeping with the present findings, 
previous studies revealed β-APP immunoreactivity in non-mechanically injured 
tissue of patients who sustained cerebral ischaemia or hypoxia (Kaur et al., 1999; 
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Oehmichen et al., 1999; Shannon et al., 1998). Another study has reported positive 
axonal staining in control cases with ishaemia and other metabolic insults such as 
hypoglycaemia (Dolinak et al., 2000a). An explanation of this may be related to the 
fact that the accumulation of β-APP is an active, energy-dependent process (Ferreira 
et al., 1993). Thus, we now know that β-APP will accumulate in the absence of TAI 
in cases of severe metabolic dysfunction (Harrington et al., 2000; Hortobagyi et al., 
2007). It may even be that β-APP expression in axons may be transient and may 
represent a population of axons that can be salvaged with appropriate metabolic 
intervention.  
The presence of axonal injury is important in forensic practice (Geddes, 1997; 
Oehmichen et al., 1998; Sherriff et al., 1994b). However, caution must be used as β-
APP appears to be a useful general marker of axonal damage and is specifically a 
marker indicative of axonal transport interruption, but is not a marker of traumatic 
injury per se.  
Neurofilaments are composed of three subunits (NF-68, NF-160, and NF-200) 
and are found in high concentrations in axons (Nixon and Sihag, 1991). The current 
study revealed that there were no differences in the staining of NF-200 or NF-160 
between ischaemic and traumatic cases. This is in agreement with previous reports 
which showed that antibody to NF-200 labelled injured axons as well as un-injured 
axons, in human brain (Grady et al., 1993). Although NF-160 antibody has not been 
tested using autopsy materials in earlier studies, it seems that this protein has the 
tendency also to stain normal axons. This observation is supported by previous 
studies which found that NF-68 can stain most axons (Sherriff et al., 1994a), 
although NFs are different in their characteristics. Regional increases in NF 
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immunostaining may be seen due to accumulation of NF proteins resulting from 
impaired axonal transport. This can be caused by alterations in phosphorylation or 
structural changes of sidearm structures that increase antigenicity (Serbest et al., 
2007). Thus, it can be postulated that antibodies to NF-160 and NF-200 might 
underestimate the extent of axonal injury, when evaluated in human cases. 
The current study demonstrated no significant differences between traumatic 
and ischaemic cases in the expression of hyperphosphorylated heavy neurofilament 
subunit. This contrasts with a previous report by Hamberger et al (2003). Hamberger 
et al reported dramatic decrease of the phosphorylated form of the heavy 
neurofilament subunit in the axons after rotational trauma, while axons were 
immunopositive for the same antibody throughout the brain in control animals.  
Although there is a significant difference in the amount of phosphorylation for 
each subunit of NFs (Jones and Williams, 1982), they are the most highly 
phosphorylated proteins in the brain (Nixon, 1993). Various studies have shown that 
antigenicity can be altered by changes in the degree of phosphorylation of NF 
(Carden et al., 1985; Shaw et al., 1986; Schmidt et al., 1987; Banerjee et al., 1990). 
One could suggest that phosphorylation-specific PCR can be used to find evidence to 
support this explanation. Hence, some of the discrepancies between the current and 
previous findings may be linked to the selection of the antibody used to detect the 
amount of NF. When the NF is either dephosphorylated or the degree of 
phosphorylation is altered, antibodies that bind to phosphorylated NF are unable to 
bind. Other antibodies are phosphate independent, that is, they will not be affected by 
the amount of protein phosphorylation (Mink and Johnston, 2000). This might affect 
NF-200 most significantly because of its high level of phosphorylation (Carden et al., 
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1985). It is likely that the reduced levels of NF-200 that were reported actually 
represent a change in phosphorylation, rather than a true reduction in the amount of 
the protein, since the specificity of the antibody is unknown or is not described in 
most studies (Mink and Johnston, 2000). McCracken et al (1999) reported reductions 
in NF-200 immunoreactivity by 80% and 40% after traumatic injury of human brain, 
when employing a phosphate-dependent antibody and a phosphate-independent 
antibody respectively. They hypothesised that there was dephosphorylation as well as 
a decrease in the amount of NF-200.   
4.3.2 Anatomical distribution of axonal injury                      
Sherriff et al (1994b) reported that the corpus callosum was the most 
commonly affected region, but the extent and the distribution of axonal β-APP 
immunoreactivity varied between cases when examined in different brain areas. The 
current data however provided evidence that the most severely affected region was 
the brain stem, which was shown to have significantly greater immunoload of β-APP 
compared with corpus callosum or internal capsule. This was in agreement with a 
previous report by Niess et al (2002) which found that injured axons were seen in the 
pons in almost 89% of traumatic cases, although much of the aetiology was likely to 
be ischaemic (Smith et al., 2002). In addition, other authors reported that the 
incidence of axonal injury, as demonstrated by β-APP positivity, was found through 
qualitative and quantitative measurements to be most prominent in the pons when 
compared to the corpus callosum, consistent with the present findings (Oehmichen et 
al., 1998).  
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4.4 Expression of caspase-3 and calpain 
The antibodies used in the current study had been well characterised for 
western blotting and are specific to the activated forms of caspase-3 (active caspase-
3 antibody) and calpain (Ab37 and Ab38 antibodies). However, despite multiple 
attempts with different protocols, there was no significant immunostaining associated 
with TAI in the brains of the piglet and human. In addition, a control section of 
human lymph node with widespread apoptosis showed no positive staining. 
Therefore it was not possible to assess caspase-3 or calpain activity in the formalin 
fixed paraffin-embedded tissues studied.  
Previously published data was based on immunoblotting studies and frozen 
sections only. The activity of calpain was first reported in traumatically injured axons 
after lateral fluid percussion brain injury in rats (Saatman et al., 1996). They 
employed a combination of immunoblotting and immunohistochemical analyses of 
frozen sections to detect calpain-specific cleavage of the cytoskeletal protein 
spectrin. Calpain activation has also been reported in injured axons using impact 
acceleration injury in the rat and optic nerve stretch in the mouse, with calpain-
mediated SBDPs being seen within minutes after injury (Buki et al., 1999; Saatman 
et al., 2003). In human tissues, McCracken et al (1999) have demonstrated the 
detection of SBDPs specifically generated by calpain in the corpus callosum after 
blunt head injury. Injured axons immunoreactive for active caspase-3 have been 
demonstrated in the brainstem following impact acceleration brain injury in rats 
(Buki et al., 2000). The current negative findings for active caspase-3, Ab37 and 
Ab38 antibodies almost certainly relates to the tissue fixation, with formalin fixation 
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presumably cross-linking important epitopes, hiding them from primary antibodies 
and, therefore, preventing immunohistochemical staining.  
4.5 Co-localisation of β-APP and different neurofilament 
isoforms, in piglet and human cases associated with TAI  
The results of the double-labelling immunofluorescence studies revealed that, 
although there was some co-localisation between β-APP immunopositive axons and 
the various NF subtypes studied, there were, in addition, populations of damaged 
axons which did not co-localise. In general, most -APP positive axonal swellings 
co-localised with NF immunopositive swellings, but there was a substantial 
population of NF (NF-160, NF-200, SMI-34) immunostained axonal swellings which 
did not show any expression of -APP staining. 
While in this study both piglet and human brain tissues revealed strong 
evidence of co-localisation of β-APP and each form of NFs, there were, in addition, 
different and distinct classes of TAI in all the cases examined. Previous studies used 
β-APP and RM014 markers to study the relationship between impaired axonal 
transport and neurofilament compaction in adult and paediatric rat models of diffuse 
brain injury. This is the first study to examine the association between β-APP 
accumulation and the immunoreactivity of different subunits of neurofilament (NF-
160, NF-200 and NFH phosphoform) in an experimental model of non-impact head 
injury (piglet model) and in human autopsy material. 
Traumatically induced axonal damage is thought to cause subtle intra-axonal 
changes that can lead consistently to local cytoskeletal alterations and axonal 
transport disruption, resulting in local axonal swelling, detachment and bulb 
formation (Povlishok, 1992; Povlishock et al., 1992; Povlishock, 1993; Povlishock 
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and Christman, 1995; Maxwell et al., 1997; Saatman et al., 1998; Smith et al., 1999; 
Maxwell et al., 2003). A correlation between neurofilament compaction and swelling 
has been shown in previous reports (Maxwell et al., 1991; Yaghmai and Povlishock, 
1992; Grady et al., 1993). It has been hypothesized that impaired axonal transport 
can result from structural changes in the axon such as axolemmal disruption and/or 
NFC (Maxwell and Graham, 1997).  
The present findings are similar to previous studies that showed, through 
quantitative analysis, that 25% of the total population of damaged axons in the 
medial lemniscus of the brain stem of the adult rat exhibited co-localisation of 
impaired axonal transport and neurofilament compaction (Marmarou et al., 2005), 
but no correlation between neurofilament compaction and impaired axonal transport 
in the majority of damaged axons. Using two antibodies, β-APP to detect impaired 
axonal transport and RM014 to identify neurofilament compaction, Stone et al 
demonstrated that neurofilament compaction could take place independently of 
impaired axonal transport in pyramidal and corticospinal tracts (Stone et al., 2001). 
The relationship between impaired axonal transport and neurofilament compaction 
has also been investigated recently in the immature rat but no evidence of co-
localisation of compacted neurofilament and β-APP was found (Dileonardi et al., 
2009). Administration of FK506 treatment, the calcineurin inhibitor, was shown to 
decrease the extent of impaired axonal transport (Marmarou and Povlishock, 2006) 
but no effect was noticed on NFC (Reeves et al., 2007). 
Based upon the present findings, it appears that cytoskeletal alterations can 
occur in piglets and in humans in the absence of subsequent disruption of axonal 
transport. This observation was unexpected since these distinct forms of intra-axonal 
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change have been postulated to represent stages in the progressive axonal failure that 
would eventually result in delayed disconnection (Stone et al., 2001); RMO14 was 
thought to correspond to areas of NFC, mitochondrial swelling and microtubular 
loss, whereas -APP accumulation was thought to correspond to areas of organelle 
accumulation. Although distinct these changes were thought to form part of 
continuum in the disconnection and ultimate degeneration of the axon. Dramatic 
cytoskeletal misalignment such as NFC would be expected to cause local anterograde 
transport disruption and upstream swelling. However, it is a possible that more 
severely damaged axons may undergo the process of anterograde to retrograde 
conversion of axonal transport (Martz et al., 1989; Sahenk and Lasek, 1988), a 
process thought to be associated with the activation of the cysteine protease calpain 
(Nevin, 1967; Sahenk and Lasek, 1988; Buki et al., 1999a; Buki et al., 1999b). 
Therefore, it is possible that the severe structural damage caused by NFC results in 
conversion to retrograde transport within the axon, such that -APP does not 
accumulate (Stone et al., 2001), although accumulation of this protein is expected in 
the soma. An additional explanation for the present observation is that there is axonal 
damage at different sections of the same axon.   
In the current investigation, some forms of TAI did not seem to undergo the 
established sequence of axonal demise including focally impaired axonal transport, 
swelling and disconnection of a proximal axonal bulb. Although the mechanism that 
may underlie these distinct events remains unclear, other issues should be taken into 
consideration. It appears in the current study that β-APP as a marker may 
underestimate the full extent of traumatically induced axonal injury. This is in 
keeping with the previous reports which have raised this possibility (Stone et al., 
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2001; Marmarou et al., 2005). Buki and colleagues also demonstrated through a 
quantitative single labelling strategy that β-APP antibody was able to stain only 30-
50% of axons from the total axonal numbers identified by the use of the antibody to a 
calcium-activated calpain-mediated proteolytic break-down product of α-spectrin 
(Ab38) (Buki et al., 1999). This suggests that either there is some functional recovery 
taking place within the axon prior to organelle accumulation and disconnection 
which may, in part, contribute to the absence of β-APP staining within some regions 
exhibiting neurofilament immunopositive axons (Stone et al., 2001), or that there is a 
temporal pattern of marker expression, with -APP accumulation being a terminal 
event.   
The present data appear to have important implications for therapeutic studies 
focusing on TAI. It is recognized that antibodies to β-APP are often used to measure 
the efficacy of therapeutic interventions to attenuate TAI, or to detect and then 
determine the full extent of axonal pathology following TBI (Bramlett et al., 1997; 
Stone et al., 2000; Singleton et al., 2001). The current observations, however, offer 
convincing proof that using this will underestimate the full extent of TAI and, 
therefore, will provide an incomplete insight into the full therapeutic potential for 
any given pharmacological agent.  
Of further importance is the implication of the results of this study in 
evaluating diffuse axonal injury in humans. β-APP has been used as the only marker 
of axonal injury in the majority of post-mortem and forensic assessments of TBI 
(Gentlman et al., 1993; Sherriff et al., 1994a; Sherriff et al., 1994b; Stone et al., 
2000). Since the antibody to β-APP stains only a subset of traumatically injured 
axons as demonstrated in the current study, a broader panel should be employed 
150 
 
utilizing multiple markers of TAI to evaluate the full extent of axonal damage 
following TBI. This needs to be correlated with detailed clinical studies to assess 
which populations of damaged axons are actually clinically relevant, and which 
axons are potentially salvageable by therapeutic intervention. Developing broader 
antibody panels to more completely assess axonal injury in experimental and 
diagnostic forensic neuropathology may result in more reliable diagnoses.   
In summary, our data has indicated that co-localisation of β-APP 
immunoreactivity with axonal accumulation of NFs was not a consistent feature of 
TAI in piglets and humans. These findings raise the possibility that several 
mechanisms may be involved in TAI due to the heterogeneity of traumatically 
induced axonal injury in piglet and human brains. As our understanding of the 
intrinsic mechanisms associated with “programmed axonal death” increases we may 
develop a fuller understanding of the different molecular pathways defining different 














5. Conclusion   
In summary, in rrelation to the hypotheses outlined at the beginning of this 
thesis: 
1. A database of autopsy human traumatic brain injury cases from 
Lothian and Borders has been developed and critically evaluated against published 
data. The current neuropathological findings seem to be different from those 
observed in the west of Scotland. This will serve as a valuable resource for all future 
human TBI research studies undertaken in Edinburgh. The published data relating to 
human traumatic axonal injury has been critically evaluated. This has demonstrated 
how the concept of TAI has evolved over time, and how introduction of 
immunohistochemsitry has altered our understanding of the diagnosis of TAI, 
initially by improving diagnostic sensitivity and then by identifying different patterns 
associated with trauma and metabolic insults. Interpretation of -APP 
immunoreactivity continues to evolve and it is likely that a wider panel will be 
introduced to assess axonal injury. 
2. Immunohistochemical analysis of -APP and a range of NF 
antibodies was undertaken in both an experimental model of non-impact head injury 
(piglet model) and in human autopsy material. These studies demonstrated some co-
localisation between -APP, a marker of axonal flow dysfunction, and NF subtypes, 
as markers of structural changes to the axon. However, there were clearly 
demonstrable separate populations of axons that showed structural alterations, but 
with no axonal flow dysfunction. This is in line with previously published rodent 
models and points towards a much more complex process than simply 
mechanoporation with subsequent axonal degeneration. The use of -APP alone in 
152 
 
diagnostic assessment of TAI is likely to under-represent the population of damaged 
axons, and supports the concept of the use of an antibody panel to fully assess axonal 
injury. The suggested antibody panel include β-APP as a marker of axonal transport 
dysfunction, three antibodies targeting various subunits of NF (NFL, NFM and NFH) 



















6. Future studies  
A disappointing aspect of this study was the inability to successfully 
immunostain formalin fixed paraffin embedded sections with antibodies to markers 
of calpain and caspase activation. To fully address the issue of activation of these 
enzymes in human tissues in trauma a prospective archive of fresh human TBI tissue 
will need to be developed to allow frozen section immunostaining and western 
blotting. In addition such a resource would allow for proteomics studies to provide 
greater detail at a protein level as to the mechanisms activated by mechanical trauma. 
In addition, with increased understanding of the orchestrated death pathways 
within the axonal component (Figure 6.1) there is an opportunity to carefully assess 
at which points trauma activate the pathway and at which points other injurious 




















Figure 6.1: A pictorial representation of the possible molecular 
mechanism underlying programmed axonal degeneration. In addition, the 
point of activation of many toxic insults are highlighted, although where trauma 
initiates the death programme is uncertain. Adapted from (Coleman, 2005). 
 
 
The roles of Nmnat-1, Nmnat-2 and nicotinamide deaminase (NAD) in TAI 
are of particular interest (Figure 6.2). Mitochondria clearly play a major role in 
axonal degeneration and a range of antibodies are now available to assess 
mitochondrial function in axonal compartments, although again fresh frozen tissue is 
optimal in this assessment. Novel drugs are being developed which can modify these 
pathways and potentially alleviate axonal degeneration and possibly limit symptoms 
associated with TAI. The piglet model can be used as a model to assess the 
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molecular pathways and to subsequently test the effects of pharmacological 
intervention targeted to focal points of the molecular pathway to alleviate the 




Figure 6.2: The potential role of NAD and NAD-consuming factors in 










Abraszko, R., Zurynski, Y. & Dorsch, N. 1996, "The importance of traumatic subarachnoid 
haemorrhage", Journal of clinical neuroscience : official journal of the Neurosurgical 
Society of Australasia, vol. 3, no. 1, pp. 21-25.  
Adams, H., Mitchell, D.E., Graham, D.I. & Doyle, D. 1977, "Diffuse brain damage of 
immediate impact type. Its relationship to 'primary brain-stem damage' in head injury", 
Brain : a journal of neurology, vol. 100, no. 3, pp. 489-502.  
Adams, J.H., Doyle, D., Ford, I., Gennarelli, T.A., Graham, D.I. & McLellan, D.R. 1989, 
"Diffuse axonal injury in head injury: definition, diagnosis and grading", 
Histopathology, vol. 15, no. 1, pp. 49-59.  
Adams, J.H., Doyle, D., Graham, D.I., Lawrence, A.E. & McLellan, D.R. 1986, "Deep 
intracerebral (basal ganglia) haematomas in fatal non-missile head injury in man", 
Journal of neurology, neurosurgery, and psychiatry, vol. 49, no. 9, pp. 1039-1043.  
Adams, J.H., Doyle, D., Graham, D.I., Lawrence, A.E., McLellan, D.R., Gennarelli, T.A., 
Pastuszko, M. & Sakamoto, T. 1985, "The contusion index: a reappraisal in human and 
experimental non-missile head injury", Neuropathology and applied neurobiology, vol. 
11, no. 4, pp. 299-308.  
Adams, J.H., Gennarelli, T.A. & Graham, D.I. 1982, "Brain damage in non-missile head 
injury: observations in man and subhuman primates" in Recent Advances in 
Neuropathology, eds. W.T. Smith & J.B. Cavanagh, Churchill Livingston, New York, 
pp. 165-190.  
Adams, J.H. & Graham, D.I. 1976, "The relationship between ventricular fluid pressure and 
neuropathology of raised intracranial pressure", vol. 2, pp. 323-332.  
Adams, J.H., Graham, D.I., Scott, G., Parker, L.S. & Doyle, D. 1980a, "Brain damage in 
fatal non-missile head injury", Journal of clinical pathology, vol. 33, no. 12, pp. 1132-
1145.  
Adams, J.H., Jennett, B., McLellan, D.R., Murray, L.S. & Graham, D.I. 1999, "The 
neuropathology of the vegetative state after head injury", Journal of clinical pathology, 
vol. 52, no. 11, pp. 804-806.  
Adams, J.H., Scott, G., Parker, L.S., Graham, D.I. & Doyle, D. 1980b, "The contusion index: 
a quantitative approach to cerebral contusions in head injury", Neuropathology and 
applied neurobiology, vol. 6, no. 4, pp. 319-324.  
Adekoya, N., Thurman, D.J., White, D.D. & Webb, K.W. 2002, "Surveillance for traumatic 
brain injury deaths--United States, 1989-1998", MMWR.Surveillance summaries : 
Morbidity and mortality weekly report.Surveillance summaries / CDC, vol. 51, no. 10, 
pp. 1-14.  
157 
 
Adelson, P.D., Jenkins, L.W., Hamilton, R.L., Robichaud, P., Tran, M.P. & Kochanek, P.M. 
2001, "Histopathologic response of the immature rat to diffuse traumatic brain injury", 
Journal of neurotrauma, vol. 18, no. 10, pp. 967-976.  
Al-Chalabi, A. & Miller, C.C. 2003, "Neurofilaments and neurological disease", BioEssays : 
news and reviews in molecular, cellular and developmental biology, vol. 25, no. 4, pp. 
346-355.  
Alimehmeti, R. & Locatelli, M. 2002, "Epidural B cell non-Hodgkin's lymphoma associated 
with chronic subdural hematoma", Surgical neurology, vol. 57, no. 3, pp. 179-182.  
Almenar-Queralt, A. & Goldstein, L.S. 2001, "Linkers, packages and pathways: new 
concepts in axonal transport", Current opinion in neurobiology, vol. 11, no. 5, pp. 550-
557.  
Annegers, J.F., Grabow, J.D., Kurland, L.T. & Laws, E.R.,Jr 1980, "The incidence, causes, 
and secular trends of head trauma in Olmsted County, Minnesota, 1935-1974", 
Neurology, vol. 30, no. 9, pp. 912-919.  
Arai, A., Vanderklish, P., Kessler, M., Lee, K. & Lynch, G. 1991, "A brief period of hypoxia 
causes proteolysis of cytoskeletal proteins in hippocampal slices", Brain research, vol. 
555, no. 2, pp. 276-280.  
Arnold, M.M., Srivastava, S. & Fredenburgh, J. 2006, "Effects of fixation and tissue 
processing on immunohistochemical demonstration of specific antigens", vol. 71, pp. 
224-230.  
Baguley, I., Slewa-Younan, S., Lazarus, R. & Green, A. 2000, "Long-term mortality trends 
in patients with traumatic brain injury", Brain injury : [BI], vol. 14, no. 6, pp. 505-512.  
Balaton, A.J. 1999, "A systemic approach to quality in immunohistochemistry", , no. 19, pp. 
299-308.  
Banerjee, A., Roach, M.C., Trcka, P. & Luduena, R.F. 1990, "Increased microtubule 
assembly in bovine brain tubulin lacking the type III isotype of beta-tubulin", The 
Journal of biological chemistry, vol. 265, no. 3, pp. 1794-1799.  
Banki, K., Hutter, E., Gonchoroff, N.J. & Perl, A. 1999, "Elevation of mitochondrial 
transmembrane potential and reactive oxygen intermediate levels are early events and 
occur independently from activation of caspases in Fas signaling", Journal of 
immunology (Baltimore, Md.: 1950), vol. 162, no. 3, pp. 1466-1479.  
Barlow, A. & Stewart, W. 2007, "The Pathology of Raised Intracranial Pressure", Advances 
in Clinical Neuroscience & Rehabilitation, vol. 7, no. 5.  
Barry, D.M., Millecamps, S., Julien, J.P. & Garcia, M.L. 2007, "New movements in 
neurofilament transport, turnover and disease", Experimental cell research, vol. 313, 
no. 10, pp. 2110-2120.  
Bartus, R. 1997, "The calpain hypothesis of neurodegeneration: evidence for a common 
pathway", vol. 3, pp. 314-327.  
158 
 
Battifora, H. 1999, "Quality assurance issues in immunohistochemistry", , no. 22, pp. 169-
175.  
Battifora, H. & Kopinski, M. 1986, "The influence of protease digestion and duration of 
fixation on the immunostaining of keratins. A comparison of formalin and ethanol 
fixation", The journal of histochemistry and cytochemistry : official journal of the 
Histochemistry Society, vol. 34, no. 8, pp. 1095-1100.  
Bazarian, J. J., Blyth, B., Cimpello, L. 2006, "Bench to bedside: evidence for brain injury 
after concussion: looking beyond the computed tomography scan", Acad Emerg Med, 
vol. 13, pp. 199–214. 
Beer, R., Franz, G., Srinivasan, A., Hayes, R.L., Pike, B.R., Newcomb, J.K., Zhao, X., 
Schmutzhard, E., Poewe, W. & Kampfl, A. 2000, "Temporal profile and cell subtype 
distribution of activated caspase-3 following experimental traumatic brain injury", 
Journal of neurochemistry, vol. 75, no. 3, pp. 1264-1273.  
Bener, A., Omar, A.O., Ahmad, A.E., Al-Mulla, F.H. & Abdul Rahman, Y.S. 2010, "The 
pattern of traumatic brain injuries: a country undergoing rapid development", Brain 
injury : [BI], vol. 24, no. 2, pp. 74-80.  
Betts, J.C., Blackstock, W.P., Ward, M.A. & Anderton, B.H. 1997, "Identification of 
phosphorylation sites on neurofilament proteins by nanoelectrospray mass 
spectrometry", The Journal of biological chemistry, vol. 272, no. 20, pp. 12922-12927.  
Bevers, M.B. & Neumar, R.W. 2008, "Mechanistic role of calpains in postischemic 
neurodegeneration", Journal of cerebral blood flow and metabolism : official journal of 
the International Society of Cerebral Blood Flow and Metabolism, vol. 28, no. 4, pp. 
655-673.  
Blumbergs, P.C., Scott, G., Manavis, J., Wainwright, H., Simpson, D.A. & McLean, A.J. 
1995, "Topography of axonal injury as defined by amyloid precursor protein and the 
sector scoring method in mild and severe closed head injury", Journal of neurotrauma, 
vol. 12, no. 4, pp. 565-572.  
Blumbergs, P.C., Scott, G., Manavis, J., Wainwright, H., Simpson, D.A. & McLean, A.J. 
1994, "Staining of amyloid precursor protein to study axonal damage in mild head 
injury", Lancet, vol. 344, no. 8929, pp. 1055-1056.  
Bouma, G.J., Muizelaar, J.P., Stringer, W.A., Choi, S.C., Fatouros, P. & Young, H.F. 1992, 
"Ultra-early evaluation of regional cerebral blood flow in severely head-injured patients 
using xenon-enhanced computerized tomography", Journal of neurosurgery, vol. 77, 
no. 3, pp. 360-368.  
Bramlett, H.M. & Dietrich, W.D. 2004, "Pathophysiology of cerebral ischemia and brain 
trauma: similarities and differences", Journal of cerebral blood flow and metabolism : 
official journal of the International Society of Cerebral Blood Flow and Metabolism, 
vol. 24, no. 2, pp. 133-150.  
159 
 
Breen, K.C., Bruce, M. & Anderton, B.H. 1991, "Beta amyloid precursor protein mediates 
neuronal cell-cell and cell-surface adhesion", Journal of neuroscience research, vol. 28, 
no. 1, pp. 90-100.  
Brihaye, J., Frowein, R.A., Lindgren, S., Loew, F. & Stroobandt, G. 1978, "Report on the 
meeting of the W.F.N.S. neurotraumatology committee, Brussels, 19-23 September 
1976", vol. 40, pp. 181-186.  
Brown, A. 2003, "Axonal transport of membranous and nonmembranous cargoes: a unified 
perspective", The Journal of cell biology, vol. 160, no. 6, pp. 817-821.  
Bruns, J.,Jr & Hauser, W.A. 2003, "The epidemiology of traumatic brain injury: a review", 
Epilepsia, vol. 44 Suppl 10, pp. 2-10.  
Buki, A., Okonkwo, D.O., Wang, K.K. & Povlishock, J.T. 2000, "Cytochrome c release and 
caspase activation in traumatic axonal injury", The Journal of neuroscience : the official 
journal of the Society for Neuroscience, vol. 20, no. 8, pp. 2825-2834.  
Buki, A. & Povlishock, J.T. 2006, "All roads lead to disconnection?--Traumatic axonal 
injury revisited", Acta Neurochirurgica, vol. 148, no. 2, pp. 181-93; discussion 193-4.  
Buki, A., Siman, R., Trojanowski, J.Q. & Povlishock, J.T. 1999, "The role of calpain-
mediated spectrin proteolysis in traumatically induced axonal injury", Journal of 
neuropathology and experimental neurology, vol. 58, no. 4, pp. 365-375.  
Bullock, R. & Teasdale, G. 1990, "ABC of major trauma. Head injuries--II", BMJ (Clinical 
research ed.), vol. 300, no. 6739, pp. 1576-1579.  
Bunea, M. & Zarnescu, O. 2001, "New Current Aspects on the Immunohistochemical 
Techniques", Romanian Biotechnological Letters, vol. 6, no. 3, pp. 177-206.  
Burns, R.G. 1991, "Alpha-, beta-, and gamma-tubulins: sequence comparisons and structural 
constraints", Cell motility and the cytoskeleton, vol. 20, no. 3, pp. 181-189.  
Bussolati, G. & Leonardo, E. 2008, "Technical pitfalls potentially affecting diagnoses in 
immunohistochemistry", Journal of clinical pathology, vol. 61, no. 11, pp. 1184-1192.  
Cai, J., Yang, J. & Jones, D.P. 1998, "Mitochondrial control of apoptosis: the role of 
cytochrome c", Biochimica et biophysica acta, vol. 1366, no. 1-2, pp. 139-149.  
Carden, M.J., Schlaepfer, W.W. & Lee, V.M. 1985, "The structure, biochemical properties, 
and immunogenicity of neurofilament peripheral regions are determined by 
phosphorylation state", The Journal of biological chemistry, vol. 260, no. 17, pp. 9805-
9817.  
Cernak, I. 2005, "Animal models of head trauma", NeuroRx : the journal of the American 
Society for Experimental NeuroTherapeutics, vol. 2, no. 3, pp. 410-422.  




Chen, X.H., Meaney, D.F., Xu, B.N., Nonaka, M., McIntosh, T.K., Wolf, J.A., Saatman, 
K.E. & Smith, D.H. 1999, "Evolution of neurofilament subtype accumulation in axons 
following diffuse brain injury in the pig", Journal of neuropathology and experimental 
neurology, vol. 58, no. 6, pp. 588-596.  
Chen, X.H., Siman, R., Iwata, A., Meaney, D.F., Trojanowski, J.Q. & Smith, D.H. 2004, 
"Long-term accumulation of amyloid-beta, beta-secretase, presenilin-1, and caspase-3 
in damaged axons following brain trauma", The American journal of pathology, vol. 
165, no. 2, pp. 357-371.  
Chen, Y., Constantini, S., Trembovler, V., Weinstock, M. & Shohami, E. 1996, "An 
experimental model of closed head injury in mice: pathophysiology, histopathology, 
and cognitive deficits", Journal of neurotrauma, vol. 13, no. 10, pp. 557-568.  
Chevalier-Larsen, E. & Holzbaur, E.L. 2006, "Axonal transport and neurodegenerative 
disease", Biochimica et biophysica acta, vol. 1762, no. 11-12, pp. 1094-1108.  
Chowdhury, I., Tharakan, B. & Bhat, G.K. 2008, "Caspases - an update", Comparative 
biochemistry and physiology.Part B, Biochemistry & molecular biology, vol. 151, no. 1, 
pp. 10-27.  
Christman, C.W., Grady, M.S., Walker, S.A., Holloway, K.L. & Povlishock, J.T. 1994, 
"Ultrastructural studies of diffuse axonal injury in humans", Journal of neurotrauma, 
vol. 11, no. 2, pp. 173-186.  
Chua, K.S., Ng, Y.S., Yap, S.G. & Bok, C.W. 2007, "A brief review of traumatic brain 
injury rehabilitation", Annals of the Academy of Medicine, Singapore, vol. 36, no. 1, pp. 
31-42.  
Clifton, G.L., McCormick, W.F. & Grossman, R.G. 1981, "Neuropathology of early and late 
deaths after head injury", Neurosurgery, vol. 8, no. 3, pp. 309-314.  
Cloots, R.J., Gervaise, H.M., van Dommelen, J.A. & Geers, M.G. 2008, "Biomechanics of 
traumatic brain injury: influences of the morphologic heterogeneities of the cerebral 
cortex", Annals of Biomedical Engineering, vol. 36, no. 7, pp. 1203-1215.  
Cochran, E., Bacci, B., Chen, Y., Patton, A., Gambetti, P. & Autilio-Gambetti, L. 1991, 
"Amyloid precursor protein and ubiquitin immunoreactivity in dystrophic axons is not 
unique to Alzheimer's disease", The American journal of pathology, vol. 139, no. 3, pp. 
485-489.  
Coleman, M. 2005, "Axon degeneration mechanisms: commonality amid diversity", Nature 
reviews.Neuroscience, vol. 6, no. 11, pp. 889-898.  
Coleman, M.P. & Freeman, M.R. 2010, "Wallerian degeneration, wld(s), and nmnat", 
Annual Review of Neuroscience, vol. 33, pp. 245-267.  
Conroy, C. & Kraus, J.F. 1988, "Survival after brain injury. Cause of death, length of 
survival, and prognostic variables in a cohort of brain-injured people", 
Neuroepidemiology, vol. 7, no. 1, pp. 13-22.  
161 
 
Coons, A.H. & Kaplan, M.H. 1950, "Localization of antigen in tissue cells; improvements in 
a method for the detection of antigen by means of fluorescent antibody", The Journal of 
experimental medicine, vol. 91, no. 1, pp. 1-13.  
Coons, A.H., Leduc, E.H. & Connolly, J.M. 1955, "Studies on antibody production. I. A 
method for the histochemical demonstration of specific antibody and its application to a 
study of the hyperimmune rabbit", The Journal of experimental medicine, vol. 102, no. 
1, pp. 49-60.  
Cooper, K.D., Tabaddor, K., Hauser, W.A., Shulman, K., Feiner, C. & Factor, P.R. 1983, 
"The epidemiology of head injury in the Bronx", vol. 2, pp. 70-88.  
Cooper, R.P. 2000, "Pos-traumatic intracranial mass lesions" in Head injury, eds. P.R. 
Cooper & F. Golfinos, 4th edn, McGraw-Hill, New York, pp. 293-348.  
Cordobes, F., Lobato, R.D., Rivas, J.J., Munoz, M.J., Chillon, D., Portillo, J.M. & Lamas, E. 
1981, "Observations on 82 patients with extradural hematoma. Comparison of results 
before and after the advent of computerized tomography", Journal of neurosurgery, vol. 
54, no. 2, pp. 179-186.  
Cowan, D.H. 1975, "The platelet defect in alcoholism", Annals of the New York Academy of 
Sciences, vol. 252, pp. 328-341.  
Czogalla, A. & Sikorski, A.F. 2005, "Spectrin and calpain: a 'target' and a 'sniper' in the 
pathology of neuronal cells", Cellular and molecular life sciences : CMLS, vol. 62, no. 
17, pp. 1913-1924.  
Czosnyka, M. & Pickard, J.D. 2004, "Monitoring and interpretation of intracranial pressure", 
Journal of neurology, neurosurgery, and psychiatry, vol. 75, no. 6, pp. 813-821.  
Dapson, R.W. 1993, "Fixation for the 1990's: a review of needs and accomplishments", 
Biotechnic & histochemistry : official publication of the Biological Stain Commission, 
vol. 68, no. 2, pp. 75-82.  
Dash, P.K., Zhao, J., Hergenroeder, G. & Moore, A.N. 2010, "Biomarkers for the diagnosis, 
prognosis, and evaluation of treatment efficacy for traumatic brain injury", 
Neurotherapeutics : the journal of the American Society for Experimental 
NeuroTherapeutics, vol. 7, no. 1, pp. 100-114.  
Davis, A.E. 2000, "Mechanisms of traumatic brain injury: biomechanical, structural and 
cellular considerations", Critical care nursing quarterly, vol. 23, no. 3, pp. 1-13.  
De Waegh, S.M., Lee, V.M. & Brady, S.T. 1992, "Local modulation of neurofilament 
phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann 
cells", Cell, vol. 68, no. 3, pp. 451-463.  
DiMaio, V.J. & DiMaio, D. 2001, Forensic Pathology, Second edn, CRC Pres LLC, USA.  
Dixon, C.E., Clifton, G.L., Lighthall, J.W., Yaghmai, A.A. & Hayes, R.L. 1991, "A 
controlled cortical impact model of traumatic brain injury in the rat", Journal of 
neuroscience methods, vol. 39, no. 3, pp. 253-262.  
162 
 
Dodson, A. 2002, "Modern methods for diagnostic immunohistochemistry", vol. 8, pp. 113-
122.  
Dolinak, D. & Reichard, R. 2006, "An overview of inflicted head injury in infants and young 
children, with a review of beta-amyloid precursor protein immunohistochemistry", 
Archives of Pathology & Laboratory Medicine, vol. 130, no. 5, pp. 712-717.  
Dolinak, D., Smith, C. & Graham, D.I. 2000a, "Global hypoxia per se is an unusual cause of 
axonal injury", Acta Neuropathologica, vol. 100, no. 5, pp. 553-560.  
Dolinak, D., Smith, C. & Graham, D.I. 2000b, "Hypoglycaemia is a cause of axonal injury", 
Neuropathology and applied neurobiology, vol. 26, no. 5, pp. 448-453.  
Dolinskas, C.A., Zimmerman, R.A., Bilaniuk, L.T. & Gennarelli, T.A. 1979, "Computed 
tomography of post-traumatic extracerebral hematomas: comparison to 
pathophysiology and responses to therapy", The Journal of trauma, vol. 19, no. 3, pp. 
163-169.  
Duhaime, A.C. 2006, "Large animal models of traumatic injury to the immature brain", 
Developmental neuroscience, vol. 28, no. 4-5, pp. 380-387.  
Duhaime, A.C., Gennarelli, L.M. & Yachnis, A. 1994, "Acute subdural hematoma: is the 
blood itself toxic?", Journal of neurotrauma, vol. 11, no. 6, pp. 669-678.  
Duncan, J.E. & Goldstein, L.S. 2006, "The genetics of axonal transport and axonal transport 
disorders", PLoS genetics, vol. 2, no. 9, pp. e124.  
Dunn, L.T. 2002, "Raised intracranial pressure", Journal of neurology, neurosurgery, and 
psychiatry, vol. 73 Suppl 1, pp. i23-7.  
Durkin, M.S., Olsen, S., Barlow, B., Virella, A. & Connolly, E.S.,Jr 1998, "The 
epidemiology of urban pediatric neurological trauma: evaluation of, and implications 
for, injury prevention programs", Neurosurgery, vol. 42, no. 2, pp. 300-310.  
Echlin, F.A., SordIllo, S.V. & Garvey, T.Q.,Jr 1956, "Acute, subacute, and chronic subdural 
hematoma", Journal of the American Medical Association, vol. 161, no. 14, pp. 1345-
1350.  
Ehara, H., Deguchi, T., Koji, T., Yang, M., Ito, S., Kawada, Y. & Nakane, P.K. 1996, 
"Autoclave antigen retrieval technique for immunohistochemical staining of androgen 
receptor in formalin-fixed paraffin sections of human prostate", , no. 29, pp. 311-318.  
Eisenberg, H.M., Gary, H.E.,Jr, Aldrich, E.F., Saydjari, C., Turner, B., Foulkes, M.A., Jane, 
J.A., Marmarou, A., Marshall, L.F. & Young, H.F. 1990, "Initial CT findings in 753 
patients with severe head injury. A report from the NIH Traumatic Coma Data Bank", 
Journal of neurosurgery, vol. 73, no. 5, pp. 688-698.  
El-Kadi, A.M., Soura, V. & Hafezparast, M. 2007, "Defective axonal transport in motor 
neuron disease", Journal of neuroscience research, vol. 85, no. 12, pp. 2557-2566.  
163 
 
Eltoum, I., Fredenburgh, J., Myers, R.B. & Grizzle, W.E. 2001, "Introduction to the theory 
and practice of fixation of tissues", , no. 24, pp. 173-190.  
Fabbri, A., Servadei, F., Marchesini, G., Stein, S.C. & Vandelli, A. 2008, "Early predictors 
of unfavourable outcome in subjects with moderate head injury in the emergency 
department", Journal of neurology, neurosurgery, and psychiatry, vol. 79, no. 5, pp. 
567-573.  
Farkas, O. & Povlishock, J.T. 2007, "Cellular and subcellular change evoked by diffuse 
traumatic brain injury: a complex web of change extending far beyond focal damage", 
Progress in brain research, vol. 161, pp. 43-59.  
Felix, B., Leger, M-E. & Albe-Fessard, D. 1999, "Stereotaxic Atlas of the Pig Brain", Brain 
Res Bulletin, vol. 49, pp. 1-138.    
Ferguson, B., Matyszak, M.K., Esiri, M.M. & Perry, V.H. 1997, "Axonal damage in acute 
multiple sclerosis lesions", Brain : a journal of neurology, vol. 120 ( Pt 3), no. Pt 3, pp. 
393-399.  
Ferreira, A., Caceres, A. & Kosik, K.S. 1993, "Intraneuronal compartments of the amyloid 
precursor protein", The Journal of neuroscience : the official journal of the Society for 
Neuroscience, vol. 13, no. 7, pp. 3112-3123.  
Fiedler, R.C., Granger, C.V. & Russell, C.F. 2000, "UDS(MR)SM: follow-up data on 
patients discharged in 1994-1996. Uniform Data System for Medical Rehabilitation", 
American Journal of Physical Medicine & Rehabilitation / Association of Academic 
Physiatrists, vol. 79, no. 2, pp. 184-192.  
Finnie, J.W. & Blumbergs, P.C. 2002, "Traumatic brain injury", Veterinary pathology, vol. 
39, no. 6, pp. 679-689.  
Fishman, R.A. 1975, "Brain edema", The New England journal of medicine, vol. 293, no. 14, 
pp. 706-711.  
Flamm, E.S., Demopoulos, H.B., Seligman, M.L., Tomasula, J.J., De Crescito, V. & 
Ransohoff, J. 1977, "Ethanol potentiation of central nervous system trauma", Journal of 
neurosurgery, vol. 46, no. 3, pp. 328-335.  
Fleischer, A.S., Payne, N.S. & Tindall, G.T. 1976, "Continuous monitoring of intracranial 
pressure in severe closed head injury without mass lesions", Surgical neurology, vol. 6, 
no. 1, pp. 31-34.  
Fleminger, S., Oliver, D.L., Lovestone, S., Rabe-Hesketh, S. & Giora, A. 2003, "Head injury 
as a risk factor for Alzheimer's disease: the evidence 10 years on; a partial replication", 
Journal of neurology, neurosurgery, and psychiatry, vol. 74, no. 7, pp. 857-862.  
Foda, M.A. & Marmarou, A. 1994, "A new model of diffuse brain injury in rats. Part II: 
Morphological characterization", Journal of neurosurgery, vol. 80, no. 2, pp. 301-313.  
Freytag, E. 1963, "Autopsy findings in head injuries from blunt forces. Statistical evaluation 
of 1,367 cases", Archives of Pathology, vol. 75, pp. 402-413.  
164 
 
Freytag, E. & Lindenberg, R. 1957, "Morphology of cortical contusions", A.M.A.archives of 
pathology, vol. 63, no. 1, pp. 23-42.  
Friess, S.H., Ichord, R.N., Owens, K., Ralston, J., Rizol, R., Overall, K.L., Smith, C., 
Helfaer, M.A. & Margulies, S.S. 2007, "Neurobehavioral functional deficits following 
closed head injury in the neonatal pig", Experimental neurology, vol. 204, no. 1, pp. 
234-243.  
Galbraith, S., Murray, W.R., Patel, A.R. & Knill-Jones, R. 1976, "The relationship between 
alcohol and head injury and its effect on the conscious level", The British journal of 
surgery, vol. 63, no. 2, pp. 128-130.  
Galbraith, S.L. 1973, "Age-distribution of extradural haemorrhage without skull fracture", 
Lancet, vol. 1, no. 7814, pp. 1217-1218.  
Gando, S., Nanzaki, S. & Kemmotsu, O. 1999, "Coagulofibrinolytic changes after isolated 
head injury are not different from those in trauma patients without head injury", The 
Journal of trauma, vol. 46, no. 6, pp. 1070-6; discussion 1076-7.  
Gashegu, J., Ladha, R., Vanmuylder, N., Philippson, C., Bremer, F., Rooze, M. & Louryan, 
S. 2007, "HSP110, caspase-3 and -9 expression in physiological apoptosis and 
apoptosis induced by in vivo embryonic exposition to all-trans retinoic acid or 
irradiation during early mouse eye development", Journal of anatomy, vol. 210, no. 5, 
pp. 532-541.  
Geddes, J.F., Vowles, G.H., Beer, T.W. & Ellison, D.W. 1997, "The diagnosis of diffuse 
axonal injury: implications for forensic practice", Neuropathology and applied 
neurobiology, vol. 23, no. 4, pp. 339-347.  
Geddes, J.F., Whitwell, H.L. & Graham, D.I. 2000, "Traumatic axonal injury: practical 
issues for diagnosis in medicolegal cases", Neuropathology and applied neurobiology, 
vol. 26, no. 2, pp. 105-116.  
Geinisman, Y., Bondareff, W. & Telser, A. 1977, "Transport of [3H]fucose labeled 
glycoproteins in the septo-hippocampal pathway of young adult and senescent rats", 
Brain research, vol. 125, no. 1, pp. 182-186.  
Gennarelli, T.A. 1994, "Animate models of human head injury", Journal of neurotrauma, 
vol. 11, no. 4, pp. 357-368.  
Gennarelli, T.A. 1993, "Mechanisms of brain injury", The Journal of emergency medicine, 
vol. 11 Suppl 1, pp. 5-11.  
Gennarelli, T.A. & Meaney, D.F. 1996, "Mechanisms of primary head injury" in 
Neurosurgery, eds. R.H. Wilkins & S.S. Rengachary, Second edn, McGraw-Hill, , pp. 
11-21.  
Gennarelli, T.A. & Thibault, L.E. 1985, "Biomechanics of Head Injury" in Neurosurgery, 
eds. R.H. Wilkins & S.S. Rengachary, McGraw-Hill, New York, pp. 1531-1536.  
165 
 
Gennarelli, T.A., Thibault, L.E., Adams, J.H., Graham, D.I., Thompson, C.J. & Marcincin, 
R.P. 1982, "Diffuse axonal injury and traumatic coma in the primate", Annals of 
Neurology, vol. 12, no. 6, pp. 564-574.  
Gentleman, S.M., Nash, M.J., Sweeting, C.J., Graham, D.I. & Roberts, G.W. 1993, "Beta-
amyloid precursor protein (beta APP) as a marker for axonal injury after head injury", 
Neuroscience letters, vol. 160, no. 2, pp. 139-144.  
Gentleman, S.M., Roberts, G.W., Gennarelli, T.A., Maxwell, W.L., Adams, J.H., Kerr, S. & 
Graham, D.I. 1995, "Axonal injury: a universal consequence of fatal closed head 
injury?", Acta Neuropathologica, vol. 89, no. 6, pp. 537-543.  
Gerstenbrand, F. & Lucking, C.H. 1970, "Acute traumatic brainstem lesions", Archiv fur 
Psychiatrie und Nervenkrankheiten, vol. 213, no. 3, pp. 264-281.  
Gilley, J. & Coleman, M.P. 2010, "Endogenous Nmnat2 is an essential survival factor for 
maintenance of healthy axons", PLoS biology, vol. 8, no. 1, pp. e1000300.  
Giometto, B., An, S.F., Groves, M., Scaravilli, T., Geddes, J.F., Miller, R., Tavolato, B., 
Beckett, A.A. & Scaravilli, F. 1997, "Accumulation of beta-amyloid precursor protein 
in HIV encephalitis: relationship with neuropsychological abnormalities", Annals of 
Neurology, vol. 42, no. 1, pp. 34-40.  
Goldstein, M.E., Sternberger, N.H. & Sternberger, L.A. 1987, "Phosphorylation protects 
neurofilaments against proteolysis", Journal of neuroimmunology, vol. 14, no. 2, pp. 
149-160.  
Goll, D.E., Thompson, V.F., Li, H., Wei, W. & Cong, J. 2003, "The calpain system", 
Physiological Reviews, vol. 83, no. 3, pp. 731-801.  
Gorrie, C., Oakes, S., Duflou, J., Blumbergs, P. & Waite, P.M. 2002, "Axonal injury in 
children after motor vehicle crashes: extent, distribution, and size of axonal swellings 
using beta-APP immunohistochemistry", Journal of neurotrauma, vol. 19, no. 10, pp. 
1171-1182.  
Grady, M.S., McLaughlin, M.R., Christman, C.W., Valadka, A.B., Fligner, C.L. & 
Povlishock, J.T. 1993, "The use of antibodies targeted against the neurofilament 
subunits for the detection of diffuse axonal injury in humans", Journal of 
neuropathology and experimental neurology, vol. 52, no. 2, pp. 143-152.  
Graham, D.I. 1996, "Neuropathology head injury" in Neurotrauma, eds. R.K. Narayan, J.E. 
Wilberger & J.T. Povlishock, McGraw-Hill Companies Inc, New York, pp. 43.  
Graham, D.I. 1977, "Pathology of hypoxic brain damage in man", Journal of clinical 
pathology.Supplement (Royal College of Pathologists), vol. 11, pp. 170-180.  
Graham, D.I., Adams, J.H. & Doyle, D. 1978, "Ischaemic brain damage in fatal non-missile 
head injuries", Journal of the neurological sciences, vol. 39, no. 2-3, pp. 213-234.  
Graham, D.I., Adams, J.H. & Doyle, D. 1978, "Ischaemic brain damage in fatal non-missile 
head injuries", Journal of the neurological sciences, vol. 39, no. 2-3, pp. 213-234.  
166 
 
Graham, D.I., Adams, J.H., Murray, L.S. & Jennett, B. 2005, "Neuropathology of the 
vegetative state after head injury", Neuropsychological rehabilitation, vol. 15, no. 3-4, 
pp. 198-213.  
Graham, D.I., Ford, I., Adams, J.H., Doyle, D., Teasdale, G.M., Lawrence, A.E. & 
McLellan, D.R. 1989, "Ischaemic brain damage is still common in fatal non-missile 
head injury", Journal of neurology, neurosurgery, and psychiatry, vol. 52, no. 3, pp. 
346-350.  
Graham, D.I. & Gennarelli, T.A. 2000, "Pathology of brain damage after head injury" in 
Head Injury, eds. P.R. Cooper & J.G. Golfinos, 4th edn, McGraw-Hill, New York, pp. 
133-153.  
Graham, D.I., Gennarelli, T.A. & McIntosh, T.K. 2002, "Trauma" in Greenfield's 
Neuropathology , eds. D.I. Graham & P.L. Lantos, Arnold, London, pp. 823-898.  
Graham, D.I., Lawrence, A.E., Adams, J.H., Doyle, D. & McLellan, D.R. 1988, "Brain 
damage in fatal non-missile head injury without high intracranial pressure", Journal of 
clinical pathology, vol. 41, no. 1, pp. 34-37.  
Graham, D.I., Lawrence, A.E., Adams, J.H., Doyle, D. & McLellan, D.R. 1987, "Brain 
damage in non-missile head injury secondary to high intracranial pressure", 
Neuropathology and applied neurobiology, vol. 13, no. 3, pp. 209-217.  
Graham, D.I., McIntosh, T.K., Maxwell, W.L. & Nicoll, J.A. 2000, "Recent advances in 
neurotrauma", Journal of neuropathology and experimental neurology, vol. 59, no. 8, 
pp. 641-651.  
Graham, D.I. & Smith, C. 2001, "The pathology of head injury", CPD. Bulletin- Cellular 
Pathology, vol. 3, pp. 148-51.  
Graham, D.I., Smith, C., Reichard, R., Leclercq, P.D. & Gentleman, S.M. 2004, "Trials and 
tribulations of using beta-amyloid precursor protein immunohistochemistry to evaluate 
traumatic brain injury in adults", Forensic science international, vol. 146, no. 2-3, pp. 
89-96.  
Gralle, M. & Ferreira, S.T. 2007, "Structure and functions of the human amyloid precursor 
protein: the whole is more than the sum of its parts", Progress in neurobiology, vol. 82, 
no. 1, pp. 11-32.  
Grant, P. & Pant, H.C. 2000, "Neurofilament protein synthesis and phosphorylation", 
Journal of neurocytology, vol. 29, no. 11-12, pp. 843-872.  
Gray, J.T., Puetz, S.M., Jackson, S.L. & Green, M.A. 1999, "Traumatic subarachnoid 
haemorrhage: a 10-year case study and review", Forensic science international, vol. 
105, no. 1, pp. 13-23.  
Greenwald, B.D., Burnett, D.M. & Miller, M.A. 2003, "Congenital and acquired brain 
injury. 1. Brain injury: epidemiology and pathophysiology", Archives of Physical 
Medicine and Rehabilitation, vol. 84, no. 3 Suppl 1, pp. S3-7.  
167 
 
Greenwood, J.A., Troncoso, J.C., Costello, A.C. & Johnson, G.V. 1993, "Phosphorylation 
modulates calpain-mediated proteolysis and calmodulin binding of the 200-kDa and 
160-kDa neurofilament proteins", Journal of neurochemistry, vol. 61, no. 1, pp. 191-
199.  
Guan, R.J., Khatra, B.S. & Cohlberg, J.A. 1991, "Phosphorylation of bovine neurofilament 
proteins by protein kinase FA (glycogen synthase kinase 3)", The Journal of biological 
chemistry, vol. 266, no. 13, pp. 8262-8267.  
Guerrero, J.L., Thurman, D.J. & Sniezek, J.E. 2000, "Emergency department visits 
associated with traumatic brain injury: United States, 1995-1996", Brain injury : [BI], 
vol. 14, no. 2, pp. 181-186.  
Guesdon, J.L., Ternynck, T. & Avrameas, S. 1979, "The use of avidin-biotin interaction in 
immunoenzymatic techniques", The journal of histochemistry and cytochemistry : 
official journal of the Histochemistry Society, vol. 27, no. 8, pp. 1131-1139.  
Guidato, S., Tsai, L.H., Woodgett, J. & Miller, C.C. 1996, "Differential cellular 
phosphorylation of neurofilament heavy side-arms by glycogen synthase kinase-3 and 
cyclin-dependent kinase-5", Journal of neurochemistry, vol. 66, no. 4, pp. 1698-1706.  
Haines, D.M. & Chelack, B.J. 1991, "Technical considerations for developing enzyme 
immunohistochemical staining procedures on formalin-fixed paraffin-embedded tissues 
for diagnostic pathology", Journal of veterinary diagnostic investigation : official 
publication of the American Association of Veterinary Laboratory Diagnosticians, Inc, 
vol. 3, no. 1, pp. 101-112.  
Hall, E.D., Sullivan, P.G., Gibson, T.R., Pavel, K.M., Thompson, B.M. & Scheff, S.W. 
2005, "Spatial and temporal characteristics of neurodegeneration after controlled 
cortical impact in mice: more than a focal brain injury", Journal of neurotrauma, vol. 
22, no. 2, pp. 252-265.  
Hamberger, A., Huang, Y.L., Zhu, H., Bao, F., Ding, M., Blennow, K., Olsson, A., Hansson, 
H.A., Viano, D. & Haglid, K.G. 2003, "Redistribution of neurofilaments and 
accumulation of beta-amyloid protein after brain injury by rotational acceleration of the 
head", Journal of neurotrauma, vol. 20, no. 2, pp. 169-178.  
Hardman, J.M. & Manoukian, A. 2002, "Pathology of head trauma", Neuroimaging clinics of 
North America, vol. 12, no. 2, pp. 175-87, vii.  
Harrington, D., Rutty, G.N. & Timperley, W.R. 2000, "Beta -Amyloid Precursor Protein 
Positive Axonal Bulbs may Form in Non-Head-Injured Patients", Journal of Clinical 
Forensic Medicine, vol. 7, no. 1, pp. 19-25.  
Harrison-Felix, C.L., Whiteneck, G.G., Jha, A., DeVivo, M.J., Hammond, F.M. & Hart, 
D.M. 2009, "Mortality over four decades after traumatic brain injury rehabilitation: a 
retrospective cohort study", Archives of Physical Medicine and Rehabilitation, vol. 90, 
no. 9, pp. 1506-1513.  
168 
 
Hayat, M.A. 2002, "Fixation and embedding" in Microscopy, immunohistochemistry, and 
antigen retrieval methods for light and electron microscopy, ed. M.A. Hayat, Kluwer 
Academic, New York, pp. 71-93.  
He, X., Yi, S., Zhang, X., Fei, Z., Zhang, J., Yang, L. & Liang, J. 1999, "Intra-axonal 
overloading of calcium ion in rat diffuse axonal injury and therapeutic effect of calcium 
antagonist", Chinese journal of traumatology = Zhonghua chuang shang za zhi / 
Chinese Medical Association, vol. 2, no. 1, pp. 25-29.  
Henderson, R.D., Pittock, S.J., Piepgras, D.G. & Wijdicks, E.F. 2001, "Acute spontaneous 
spinal epidural hematoma", Archives of Neurology, vol. 58, no. 7, pp. 1145-1146.  
Hernesniemi, J. 1979, "Outcome following acute subdural haematoma", Acta 
Neurochirurgica, vol. 49, no. 3-4, pp. 191-198.  
Herrmann, L.L. & Zabramski, J.M. 2007, "Nonaneurysmal subarachnoid hemorrhage: a 
review of clinical course and outcome in two hemorrhage patterns", The Journal of 
neuroscience nursing : journal of the American Association of Neuroscience Nurses, 
vol. 39, no. 3, pp. 135-142.  
Hiramatsu, K., Kassell, N.F. & Lee, K.S. 1993, "Improved posthypoxic recovery of synaptic 
transmission in gerbil neocortical slices treated with a calpain inhibitor", Stroke; a 
journal of cerebral circulation, vol. 24, no. 11, pp. 1725-1728.  
Hirsch, T., Susin, S.A., Marzo, I., Marchetti, P., Zamzami, N. & Kroemer, G. 1998, 
"Mitochondrial permeability transition in apoptosis and necrosis", Cell biology and 
toxicology, vol. 14, no. 2, pp. 141-145.  
Hollenbeck, P.J. 1989, "The transport and assembly of the axonal cytoskeleton", The Journal 
of cell biology, vol. 108, no. 2, pp. 223-227.  
Holzbaur, E.L., Hammarback, J.A., Paschal, B.M., Kravit, N.G., Pfister, K.K. & Vallee, R.B. 
1991, "Homology of a 150K cytoplasmic dynein-associated polypeptide with the 
Drosophila gene Glued", Nature, vol. 351, no. 6327, pp. 579-583.  
Hoots, W.K. 1996, "Coagulation disorders in the head-injured patient" in Neurotrauma, eds. 
R.K. Narayan, J.E. Wilberger & J.T. Povlishock, McGraw-Hill, New York, pp. 673-
688.  
Hortobagyi, T. & Al-Sarraj, S. 2008, "The Significance of Diffuse Axonal Injury: how to 
diagnose it and what doea it tell us?", vol. 8, no. 2.  
Hortobagyi, T., Wise, S., Hunt, N., Cary, N., Djurovic, V., Fegan-Earl, A., Shorrock, K., 
Rouse, D. & Al-Sarraj, S. 2007, "Traumatic axonal damage in the brain can be detected 
using beta-APP immunohistochemistry within 35 min after head injury to human 
adults", Neuropathology and applied neurobiology, vol. 33, no. 2, pp. 226-237.  
Hsu, S.M. & Raine, L. 1981, "Protein A, avidin, and biotin in immunohistochemistry", The 
journal of histochemistry and cytochemistry : official journal of the Histochemistry 
Society, vol. 29, no. 11, pp. 1349-1353.  
169 
 
Hsu, S.M., Raine, L. & Fanger, H. 1981, "Use of avidin-biotin-peroxidase complex (ABC) in 
immunoperoxidase techniques: a comparison between ABC and unlabeled antibody 
(PAP) procedures", The journal of histochemistry and cytochemistry : official journal of 
the Histochemistry Society, vol. 29, no. 4, pp. 577-580.  
Huang, S.N. 1975, "Immunohistochemical demonstration of hepatitis B core and surface 
antigens in paraffin sections", Laboratory investigation; a journal of technical methods 
and pathology, vol. 33, no. 1, pp. 88-95.  
Huang, S.N., Minassian, H. & More, J.D. 1976, "Application of immunofluorescent staining 
on paraffin sections improved by trypsin digestion", Laboratory investigation; a 
journal of technical methods and pathology, vol. 35, no. 4, pp. 383-390.  
Huh, J.W., Franklin, M.A., Widing, A.G. & Raghupathi, R. 2006, "Regionally distinct 
patterns of calpain activation and traumatic axonal injury following contusive brain 
injury in immature rats", Developmental neuroscience, vol. 28, no. 4-5, pp. 466-476.  
Hutchison, I.L., Magennis, P., Shepherd, J.P. & Brown, A.E. 1998, "The BAOMS United 
Kingdom survey of facial injuries part 1: aetiology and the association with alcohol 
consumption. British Association of Oral and Maxillofacial Surgeons", The British 
journal of oral & maxillofacial surgery, vol. 36, no. 1, pp. 3-13.  
Jacobsen, M., Clausen, P.P. & Smidth, S. 1980, "The effect of fixation and trypsinization on 
the immunohistochemical demonstration of intracellular immunoglobulin in paraffin 
embedded material", Acta pathologica et microbiologica Scandinavica.Section A, 
Pathology, vol. 88, no. 6, pp. 369-376.  
Jager, T.E., Weiss, H.B., Coben, J.H. & Pepe, P.E. 2000, "Traumatic brain injuries evaluated 
in U.S. emergency departments, 1992-1994", Academic emergency medicine : official 
journal of the Society for Academic Emergency Medicine, vol. 7, no. 2, pp. 134-140.  
Jamieson, K.G. & Yelland, J.D. 1972, "Traumatic intracerebral hematoma. Report of 63 
surgically treated cases", Journal of neurosurgery, vol. 37, no. 5, pp. 528-532.  
Jamieson, K.G. & Yelland, J.D. 1968, "Extradural hematoma. Report of 167 cases", Journal 
of neurosurgery, vol. 29, no. 1, pp. 13-23.  
Jennett, B. 1996, "Epidemiology of head injury", Journal of neurology, neurosurgery, and 
psychiatry, vol. 60, no. 4, pp. 362-369.  
Jennett, B. & Teasdale, G. 1981, Management of head injuries, FA Davies, Philadelphia.  
Jennett, B., Teasdale, G., Galbraith, S., Pickard, J., Grant, H., Braakman, R., Avezaat, C., 
Maas, A., Minderhoud, J., Vecht, C.J., Heiden, J., Small, R., Caton, W. & Kurze, T. 
1977, "Severe head injuries in three countries", Journal of neurology, neurosurgery, 
and psychiatry, vol. 40, no. 3, pp. 291-298.  
Jiang, J.Y., Gao, G.Y., Li, W.P., Yu, M.K. & Zhu, C. 2002, "Early indicators of prognosis in 




Johnson, V.E., Stewart, W. & Smith, D.H. 2010, "Traumatic brain injury and amyloid-beta 
pathology: a link to Alzheimer's disease?", Nature reviews.Neuroscience, vol, 11, pp. 361-
370.  
Jones, M.L. 2002, "Lipids" in Theory and Practice of Histological techniques, eds. J.D. 
Bancroft & M. Gamble, 5th edn, Churchill-Livingstone, Edinburgh, Scotland.  
Jones, S.M. & Williams, R.C.,Jr 1982, "Phosphate content of mammalian neurofilaments", 
The Journal of biological chemistry, vol. 257, no. 17, pp. 9902-9905.  
Joshi, H.C. 1993, "Gamma-tubulin: the hub of cellular microtubule assemblies", BioEssays : 
news and reviews in molecular, cellular and developmental biology, vol. 15, no. 10, pp. 
637-643.  
Kakarieka, A., Braakman, R. & Schakel, E.H. 1993, Traumatic subarachnoid hemorrahge. 
Importance and treatment perspective with Nimodipine, Abstracts, Second International 
Neurotrauma Symposium, Glasgow, Scotland.  
Kalimo, H., Saukko, P. & Graham, D. 2004, "Neuropathological examination in forensic 
context", Forensic science international, vol. 146, no. 2-3, pp. 73-81.  
Kamal, A., Almenar-Queralt, A., LeBlanc, J.F., Roberts, E.A. & Goldstein, L.S. 2001, 
"Kinesin-mediated axonal transport of a membrane compartment containing beta-
secretase and presenilin-1 requires APP", Nature, vol. 414, no. 6864, pp. 643-648.  
Kampfl, A., Posmantur, R., Nixon, R., Grynspan, F., Zhao, X., Liu, S.J., Newcomb, J.K., 
Clifton, G.L. & Hayes, R.L. 1996, "Mu-Calpain Activation and Calpain-Mediated 
Cytoskeletal Proteolysis Following Traumatic Brain Injury", Journal of 
neurochemistry, vol. 67, no. 4, pp. 1575-1583.  
Karki, S. & Holzbaur, E.L. 1995, "Affinity chromatography demonstrates a direct binding 
between cytoplasmic dynein and the dynactin complex", The Journal of biological 
chemistry, vol. 270, no. 48, pp. 28806-28811.  
Kaur, B., Rutty, G.N. & Timperley, W.R. 1999, "The possible role of hypoxia in the 
formation of axonal bulbs", Journal of clinical pathology, vol. 52, no. 3, pp. 203-209.  
Kawarabayashi, T., Shoji, M., Yamaguchi, H., Tanaka, M., Harigaya, Y., Ishiguro, K. & 
Hirai, S. 1993, "Amyloid beta protein precursor accumulates in swollen neurites 
throughout rat brain with aging", Neuroscience letters, vol. 153, no. 1, pp. 73-76.  
Kay, A. & Teasdale, G. 2001, "Head injury in the United Kingdom", World journal of 
surgery, vol. 25, no. 9, pp. 1210-1220.  
Kennedy, I. 2001, The Report of the Public Inquiry into children's heart surgery at the 
Bristol Royal Infirmary 1984- 1995.  
Kibbey, M.C., Jucker, M., Weeks, B.S., Neve, R.L., Van Nostrand, W.E. & Kleinman, H.K. 
1993, "beta-Amyloid precursor protein binds to the neurite-promoting IKVAV site of 
laminin", Proceedings of the National Academy of Sciences of the United States of 
America, vol. 90, no. 21, pp. 10150-10153.  
171 
 
Kilinc, D., Gallo, G. & Barbee, K.A. 2009, "Mechanical membrane injury induces axonal 
beading through localized activation of calpain", Experimental neurology, vol. 219, no. 
2, pp. 553-561.  
King, G.D. & Scott Turner, R. 2004, "Adaptor protein interactions: modulators of amyloid 
precursor protein metabolism and Alzheimer's disease risk?", Experimental neurology, 
vol. 185, no. 2, pp. 208-219.  
King, S.J. & Schroer, T.A. 2000, "Dynactin increases the processivity of the cytoplasmic 
dynein motor", Nature cell biology, vol. 2, no. 1, pp. 20-24.  
King, S.M. 2000, "The dynein microtubule motor", Biochimica et biophysica acta, vol. 
1496, no. 1, pp. 60-75.  
Kinney, H.C. & Samuels, M.A. 1994, "Neuropathology of the persistent vegetative state. A 
review", Journal of neuropathology and experimental neurology, vol. 53, no. 6, pp. 
548-558.  
Kitamoto, T., Ogomori, K., Tateishi, J. & Prusiner, S.B. 1987, "Formic acid pretreatment 
enhances immunostaining of cerebral and systemic amyloids", Laboratory 
investigation; a journal of technical methods and pathology, vol. 57, no. 2, pp. 230-
236.  
Klatzo, I. 1994, "Evolution of brain edema concepts", Acta neurochirurgica.Supplementum, 
vol. 60, pp. 3-6.  
Klatzo, I. 1967, "Presidental address. Neuropathological aspects of brain edema", Journal of 
neuropathology and experimental neurology, vol. 26, no. 1, pp. 1-14.  
Klauber, M.R., Marshall, L.F., Luerssen, T.G., Frankowski, R., Tabaddor, K. & Eisenberg, 
H.M. 1989, "Determinants of head injury mortality: importance of the low risk patient", 
Neurosurgery, vol. 24, no. 1, pp. 31-36.  
Knoblach, S.M., Nikolaeva, M., Huang, X., Fan, L., Krajewski, S., Reed, J.C. & Faden, A.I. 
2002, "Multiple caspases are activated after traumatic brain injury: evidence for 
involvement in functional outcome", Journal of neurotrauma, vol. 19, no. 10, pp. 1155-
1170.  
Kobayashi, S., Nakazawa, S., Yano, M. & Otsuka, T. 1983, "Diagnostic value of serial 
computerized tomographic scanning in acute head injury]", No shinkei 
geka.Neurological surgery, vol. 11, no. 7, pp. 731-737.  
Koo, E.H., Sisodia, S.S., Archer, D.R., Martin, L.J., Weidemann, A., Beyreuther, K., 
Fischer, P., Masters, C.L. & Price, D.L. 1990, "Precursor of amyloid protein in 
Alzheimer disease undergoes fast anterograde axonal transport", Proceedings of the 
National Academy of Sciences of the United States of America, vol. 87, no. 4, pp. 1561-
1565.  
Kotapka, M.J., Graham, D.I., Adams, J.H. & Gennarelli, T.A. 1992, "Hippocampal 
pathology in fatal non-missile human head injury", Acta Neuropathologica, vol. 83, no. 
5, pp. 530-534.  
172 
 
Krajewski, S., Krajewska, M., Ellerby, L.M., Welsh, K., Xie, Z., Deveraux, Q.L., Salvesen, 
G.S., Bredesen, D.E., Rosenthal, R.E., Fiskum, G. & Reed, J.C. 1999, "Release of 
caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia", 
Proceedings of the National Academy of Sciences of the United States of America, vol. 
96, no. 10, pp. 5752-5757.  
Kraus, J.F., Black, M.A., Hessol, N., Ley, P., Rokaw, W., Sullivan, C., Bowers, S., 
Knowlton, S. & Marshall, L. 1984, "The incidence of acute brain injury and serious 
impairment in a defined population", American Journal of Epidemiology, vol. 119, no. 
2, pp. 186-201.  
Kraus, J.F., Rock, A. & Hemyari, P. 1990, "Brain injuries among infants, children, 
adolescents, and young adults", American Journal of Diseases of Children (1960), vol. 
144, no. 6, pp. 684-691.  
Kruman, I.I. & Mattson, M.P. 1999, "Pivotal role of mitochondrial calcium uptake in neural 
cell apoptosis and necrosis", Journal of neurochemistry, vol. 72, no. 2, pp. 529-540.  
Kubo, S., Kitamura, O., Orihara, Y., Ogata, M., Tokunaga, I. & Nakasono, I. 1998, 
"Immunohistochemical diagnosis and significance of forensic neuropathological 
changes", The journal of medical investigation : JMI, vol. 44, no. 3-4, pp. 109-119.  
Kumura, E., Sato, M., Fukuda, A., Takemoto, Y., Tanaka, S. & Kohama, A. 1987, 
"Coagulation disorders following acute head injury", Acta Neurochirurgica, vol. 85, no. 
1-2, pp. 23-28.  
Kurz, J.E., Parsons, J.T., Rana, A., Gibson, C.J., Hamm, R.J. & Churn, S.B. 2005, "A 
significant increase in both basal and maximal calcineurin activity following fluid 
percussion injury in the rat", Journal of neurotrauma, vol. 22, no. 4, pp. 476-490.  
Kvarnes, T.L. & Trumpy, J.H. 1978, "Extradural haematoma. Report of 132 cases", Acta 
Neurochirurgica, vol. 41, no. 1-3, pp. 223-231.  
Lalloo, R. & Sheiham, A. 2003, "Risk factors for childhood major and minor head and other 
injuries in a nationally representative sample", Injury, vol. 34, no. 4, pp. 261-266.  
Lamkanfi, M., Festjens, N., Declercq, W., Vanden Berghe, T. & Vandenabeele, P. 2007, 
"Caspases in cell survival, proliferation and differentiation", Cell death and 
differentiation, vol. 14, no. 1, pp. 44-55.  
Lang, E.W., Pitts, L.H., Damron, S.L. & Rutledge, R. 1997, "Outcome after severe head 
injury: an analysis of prediction based upon comparison of neural network versus 
logistic regression analysis", Neurological research, vol. 19, no. 3, pp. 274-280.  
Langlois, J.A., Rutland-Brown, W. & Thomas, K.E. 2004, "Traumatic Brain Injury in the 
United States: Emergency Department Visits, Hospitalizations, and Deaths", .  
Langlois, J.A., Rutland-Brown, W. & Wald, M.M. 2006, "The epidemiology and impact of 
traumatic brain injury: a brief overview", The Journal of head trauma rehabilitation, 
vol. 21, no. 5, pp. 375-378.  
173 
 
Lannoo, E., Van Rietvelde, F., Colardyn, F., Lemmerling, M., Vandekerckhove, T., Jannes, 
C. & De Soete, G. 2000, "Early predictors of mortality and morbidity after severe 
closed head injury", Journal of neurotrauma, vol. 17, no. 5, pp. 403-414.  
Lasek, R.J., Phillips, L., Katz, M.J. & Autilio-Gambetti, L. 1985, "Function and evolution of 
neurofilament proteins", Annals of the New York Academy of Sciences, vol. 455, pp. 
462-478.  
Lawrence, C.J., Dawe, R.K., Christie, K.R., Cleveland, D.W., Dawson, S.C., Endow, S.A., 
Goldstein, L.S., Goodson, H.V., Hirokawa, N., Howard, J., Malmberg, R.L., McIntosh, 
J.R., Miki, H., Mitchison, T.J., Okada, Y., Reddy, A.S., Saxton, W.M., Schliwa, M., 
Scholey, J.M., Vale, R.D., Walczak, C.E. & Wordeman, L. 2004, "A standardized 
kinesin nomenclature", The Journal of cell biology, vol. 167, no. 1, pp. 19-22.  
Lee, K.S., Yanamoto, H., Fergus, A., Hong, S.C., Kang, S.D., Cappelletto, B., Toyoda, T., 
Kassell, N.F., Bavbek, M. & Kwan, A.L. 1997, "Calcium-activated proteolysis as a 
therapeutic target in cerebrovascular disease", Annals of the New York Academy of 
Sciences, vol. 825, pp. 95-103.  
Lee, V.M., Carden, M.J., Schlaepfer, W.W. & Trojanowski, J.Q. 1987, "Monoclonal 
antibodies distinguish several differentially phosphorylated states of the two largest rat 
neurofilament subunits (NF-H and NF-M) and demonstrate their existence in the 
normal nervous system of adult rats", The Journal of neuroscience : the official journal 
of the Society for Neuroscience, vol. 7, no. 11, pp. 3474-3488.  
Lemasters, J.J., Nieminen, A.L., Qian, T., Trost, L.C., Elmore, S.P., Nishimura, Y., Crowe, 
R.A., Cascio, W.E., Bradham, C.A., Brenner, D.A. & Herman, B. 1998, "The 
mitochondrial permeability transition in cell death: a common mechanism in necrosis, 
apoptosis and autophagy", Biochimica et biophysica acta, vol. 1366, no. 1-2, pp. 177-
196.  
Leon-Carrion, J., Dominguez-Morales Mdel, R., Barroso y Martin, J.M. & Murillo-Cabezas, 
F. 2005, "Epidemiology of traumatic brain injury and subarachnoid hemorrhage", 
Pituitary, vol. 8, no. 3-4, pp. 197-202.  
Lew, J., Winkfein, R.J., Paudel, H.K. & Wang, J.H. 1992, "Brain proline-directed protein 
kinase is a neurofilament kinase which displays high sequence homology to p34cdc2", 
The Journal of biological chemistry, vol. 267, no. 36, pp. 25922-25926.  
Lewin, I.C.F., Update of Max, W., Mackenzie, E.J. & Rice, D.P. 1991, "Head injuries: costs 
and consequences", vol. 67, pp. 76-91.  
Lewin, W., Marshall, T.F. & Roberts, A.H. 1979, "Long-term outcome after severe head 
injury", British medical journal, vol. 2, no. 6204, pp. 1533-1538.  
Lifshitz, J., Sullivan, P.G., Hovda, D.A., Wieloch, T. & McIntosh, T.K. 2004, 
"Mitochondrial damage and dysfunction in traumatic brain injury", Mitochondrion, vol. 
4, no. 5-6, pp. 705-713.  
Lindenberg, R. 1971, "Trauma of the meninges and brain" in Pathology of the Nervous 
System, ed. J. Minkler, McGraw-Hill, New York, pp. 1705-1765.  
174 
 
Lindenberg, R. & Freytag, E. 1970, "Brainstem lesions characteristic of traumatic 
hyperextension of the head", Archives of Pathology, vol. 90, no. 6, pp. 509-515.  
Lindenberg, R. & Freytag, E. 1960, "The mechanism of cerebral contusions. A pathologic-
anatomic study", Archives of Pathology, vol. 69, pp. 440-469.  
Little, R.D. 2008, "Increased Intracranial Pressure", vol. 9, pp. 83-87.  
Liu, Q., Xie, F., Siedlak, S.L., Nunomura, A., Honda, K., Moreira, P.I., Zhua, X., Smith, 
M.A. & Perry, G. 2004, "Neurofilament proteins in neurodegenerative diseases", 
Cellular and molecular life sciences : CMLS, vol. 61, no. 24, pp. 3057-3075.  
Love, S. 2004, "Post mortem sampling of the brain and other tissues in neurodegenerative 
disease", Histopathology, vol. 44, no. 4, pp. 309-317.  
Luce, T. 2003, Death certification and investigation in England, Wales, and Northen 
Ireland. The report of a fundemental review 2003.  
Luerssen, T.G., Klauber, M.R. & Marshall, L.F. 1988, "Outcome from head injury related to 
patient's age. A longitudinal prospective study of adult and pediatric head injury", 
Journal of neurosurgery, vol. 68, no. 3, pp. 409-416.  
Lunn, E.R., Perry, V.H., Brown, M.C., Rosen, H. & Gordon, S. 1989, "Absence of Wallerian 
Degeneration does not Hinder Regeneration in Peripheral Nerve", The European 
journal of neuroscience, vol. 1, no. 1, pp. 27-33.  
MacCallum, H., Morrison, A., Stone, D.H. & Murray, K. 2000, "Non-fatal head injury 
among Scottish young people: the importance of assault", Journal of epidemiology and 
community health, vol. 54, no. 1, pp. 77-78.  
Mancini, M., Nicholson, D.W., Roy, S., Thornberry, N.A., Peterson, E.P., Casciola-Rosen, 
L.A. & Rosen, A. 1998, "The caspase-3 precursor has a cytosolic and mitochondrial 
distribution: implications for apoptotic signaling", The Journal of cell biology, vol. 140, 
no. 6, pp. 1485-1495.  
Mao, S.Y., Javois, L.C. & Kent, U.M. 1994, "Overview of antibody use in 
immunocytochemistry", Methods in molecular biology (Clifton, N.J.), vol. 34, pp. 3-11.  
Margulies, S.S., Thibault, L.E. & Gennarelli, T.A. 1990, "Physical model simulations of 
brain injury in the primate", Journal of Biomechanics, vol. 23, no. 8, pp. 823-836.  
Markwalder, T.M. 1981, "Chronic subdural hematomas: a review", Journal of neurosurgery, 
vol. 54, no. 5, pp. 637-645.  
Marmarou, A. 2007, "A review of progress in understanding the pathophysiology and 
treatment of brain edema", Neurosurgical focus, vol. 22, no. 5, pp. E1.  
Marmarou, A., Foda, M.A., van den Brink, W., Campbell, J., Kita, H. & Demetriadou, K. 
1994, "A new model of diffuse brain injury in rats. Part I: Pathophysiology and 
biomechanics", Journal of neurosurgery, vol. 80, no. 2, pp. 291-300.  
175 
 
Marmarou, A., Portella, G., Barzo, P., Signoretti, S., Fatouros, P., Beaumont, A., Jiang, T. & 
Bullock, R. 2000, "Distinguishing between cellular and vasogenic edema in head 
injured patients with focal lesions using magnetic resonance imaging", Acta 
neurochirurgica.Supplement, vol. 76, pp. 349-351.  
Marmarou, A., Signoretti, S., Aygok, G., Fatouros, P. & Portella, G. 2006, "Traumatic brain 
edema in diffuse and focal injury: cellular or vasogenic?", Acta 
neurochirurgica.Supplement, vol. 96, pp. 24-29.  
Marmarou, C.R., Walker, S.A., Davis, C.L. & Povlishock, J.T. 2005, "Quantitative analysis 
of the relationship between intra- axonal neurofilament compaction and impaired 
axonal transport following diffuse traumatic brain injury", Journal of neurotrauma, vol. 
22, no. 10, pp. 1066-1080.  
Marshall, L., Gautille, T. & Klauber, M.R. 1991, "The outcome of severe closed head 
injury", vol. 75, pp. 28-36.  
Marshall, L.F., Toole, B.M. & Bowers, S.A. 1983, "The National Traumatic Coma Data 
Bank. Part 2: Patients who talk and deteriorate: implications for treatment", Journal of 
neurosurgery, vol. 59, no. 2, pp. 285-288.  
Martin, N.A., Doberstein, C., Zane, C., Caron, M.J., Thomas, K. & Becker, D.P. 1992, 
"Posttraumatic cerebral arterial spasm: transcranial Doppler ultrasound, cerebral blood 
flow, and angiographic findings", Journal of neurosurgery, vol. 77, no. 4, pp. 575-583.  
Mason, J.T. & O'Leary, T.J. 1991, "Effects of formaldehyde fixation on protein secondary 
structure: a calorimetric and infrared spectroscopic investigation", The journal of 
histochemistry and cytochemistry : official journal of the Histochemistry Society, vol. 
39, no. 2, pp. 225-229.  
Masson, F., Vecsey, J., Salmi, L.R., Dartigues, J.F., Erny, P. & Maurette, P. 1997, 
"Disability and handicap 5 years after a head injury: a population-based study", Journal 
of clinical epidemiology, vol. 50, no. 5, pp. 595-601.  
Masters, S.J., McClean, P.M., Arcarese, J.S., Brown, R.F., Campbell, J.A., Freed, H.A., 
Hess, G.H., Hoff, J.T., Kobrine, A. & Koziol, D.F. 1987, "Skull x-ray examinations 
after head trauma. Recommendations by a multidisciplinary panel and validation 
study", The New England journal of medicine, vol. 316, no. 2, pp. 84-91.  
Mattson, M.P. 1997, "Cellular actions of beta-amyloid precursor protein and its soluble and 
fibrillogenic derivatives", Physiological Reviews, vol. 77, no. 4, pp. 1081-1132.  
Maxwell, W.L., Domleo, A., McColl, G., Jafari, S.S. & Graham, D.I. 2003, "Post-acute 
alterations in the axonal cytoskeleton after traumatic axonal injury", Journal of 
neurotrauma, vol. 20, no. 2, pp. 151-168.  
Maxwell, W.L. & Graham, D.I. 1997, "Loss of axonal microtubules and neurofilaments after 
stretch-injury to guinea pig optic nerve fibers", Journal of neurotrauma, vol. 14, no. 9, 
pp. 603-614.  
176 
 
Maxwell, W.L., McCreath, B.J., Graham, D.I. & Gennarelli, T.A. 1995, "Cytochemical 
evidence for redistribution of membrane pump calcium-ATPase and ecto-Ca-ATPase 
activity, and calcium influx in myelinated nerve fibres of the optic nerve after stretch 
injury", Journal of neurocytology, vol. 24, no. 12, pp. 925-942.  
Maxwell, W.L., Povlishock, J.T. & Graham, D.L. 1997, "A mechanistic analysis of 
nondisruptive axonal injury: a review", Journal of neurotrauma, vol. 14, no. 7, pp. 419-
440.  
Maxwell, W.L., Watt, C., Graham, D.I. & Gennarelli, T.A. 1993, "Ultrastructural evidence 
of axonal shearing as a result of lateral acceleration of the head in non-human 
primates", Acta Neuropathologica, vol. 86, no. 2, pp. 136-144.  
McCarthy, M.L., Serpi, T., Kufera, J.A., Demeter, L.A. & Paidas, C. 2002, "Factors 
influencing admission among children with a traumatic brain injury", Academic 
emergency medicine : official journal of the Society for Academic Emergency Medicine, 
vol. 9, no. 7, pp. 684-693.  
McCracken, E., Hunter, A.J., Patel, S., Graham, D.I. & Dewar, D. 1999, "Calpain activation 
and cytoskeletal protein breakdown in the corpus callosum of head-injured patients", 
Journal of neurotrauma, vol. 16, no. 9, pp. 749-761.  
McGarry, L.J., Thompson, D., Millham, F.H., Cowell, L., Snyder, P.J., Lenderking, W.R. & 
Weinstein, M.C. 2002, "Outcomes and costs of acute treatment of traumatic brain 
injury", The Journal of trauma, vol. 53, no. 6, pp. 1152-1159.  
McIntosh, T.K., Saatman, K.E., Raghupathi, R., Graham, D.I., Smith, D.H., Lee, V.M. & 
Trojanowski, J.Q. 1998, "The Dorothy Russell Memorial Lecture. The molecular and 
cellular sequelae of experimental traumatic brain injury: pathogenetic mechanisms", 
Neuropathology and applied neurobiology, vol. 24, no. 4, pp. 251-267.  
McIntosh, T.K., Vink, R., Noble, L., Yamakami, I., Fernyak, S., Soares, H. & Faden, A.L. 
1989, "Traumatic brain injury in the rat: characterization of a lateral fluid-percussion 
model", Neuroscience, vol. 28, no. 1, pp. 233-244.  
McKee, A.C., Cantu, R.C., Nowinski, C.J., Hedley-Whyte, E.T., Gavett, B.E., Budson, A.E., 
Santini, V.E., Lee, H.S., Kubilus, C.A. & Stern, R.A. 2009, "Chronic traumatic 
encephalopathy in athletes: progressive tauopathy after repetitive head injury", Journal 
of neuropathology and experimental neurology, vol. 68, no. 7, pp. 709-735.  
McKenzie, K.J., McLellan, D.R., Gentleman, S.M., Maxwell, W.L., Gennarelli, T.A. & 
Graham, D.I. 1996, "Is beta-APP a marker of axonal damage in short-surviving head 
injury?", Acta Neuropathologica, vol. 92, no. 6, pp. 608-613.  
McLean, S. 2001, Independent review group on retention of organs at post mortem. Final 
Report.  
McMillan, T.M. & Teasdale, G.M. 2007, "Death rate is increased for at least 7 years after 
head injury: a prospective study", Brain : a journal of neurology, vol. 130, no. Pt 10, 
pp. 2520-2527.  
177 
 
Medana, I.M. & Esiri, M.M. 2003, "Axonal damage: a key predictor of outcome in human 
CNS diseases", Brain : a journal of neurology, vol. 126, no. Pt 3, pp. 515-530.  
Meller, D., Bellander, B.M., Schmidt-Kastner, R. & Ingvar, M. 1993, 
"Immunohistochemical studies with antibodies to neurofilament proteins on axonal 
damage in experimental focal lesions in rat", Journal of the neurological sciences, vol. 
117, no. 1-2, pp. 164-174.  
Metters, J.S. 2003, Isaacs Report. The investigation of events that followed the death of Cyril 
Mark Isaacs.  
Midford, R., Masters, L., Phillips, M., Daly, A., Stockwell, T., Gahegan, M. & Philp, A. 
1998, "Alcohol consumption and injury in Western Australia: a spatial correlation 
analysis using geographic information systems", Australian and New Zealand Journal 
of Public Health, vol. 22, no. 1, pp. 80-85.  
Miettinen, M. 1989, "Immunostaining of intermediate filament proteins in paraffin sections. 
Evaluation of optimal protease treatment to improve the immunoreactivity", Pathology, 
research and practice, vol. 184, no. 4, pp. 431-436.  
Miki, H., Okada, Y. & Hirokawa, N. 2005, "Analysis of the kinesin superfamily: insights 
into structure and function", Trends in cell biology, vol. 15, no. 9, pp. 467-476.  
Miller, C.C., Ackerley, S., Brownlees, J., Grierson, A.J., Jacobsen, N.J. & Thornhill, P. 
2002, "Axonal transport of neurofilaments in normal and disease states", Cellular and 
molecular life sciences : CMLS, vol. 59, no. 2, pp. 323-330.  
Miller, J.D. 1993, "Head injury", Journal of neurology, neurosurgery, and psychiatry, vol. 
56, no. 5, pp. 440-447.  
Miller, J.D., Jones, P.A., Dearden, N.M. & Tocher, J.L. 1992, "Progress in the management 
of head injury", The British journal of surgery, vol. 79, no. 1, pp. 60-64.  
Miller, K.E. & Heidemann, S.R. 2008, "What is slow axonal transport?", Experimental cell 
research, vol. 314, no. 10, pp. 1981-1990.  
Miner, M.E., Kaufman, H.H., Graham, S.H., Haar, F.H. & Gildenberg, P.L. 1982, 
"Disseminated intravascular coagulation fibrinolytic syndrome following head injury in 
children: frequency and prognostic implications", The Journal of pediatrics, vol. 100, 
no. 5, pp. 687-691.  
Mink, R.B. & Johnston, J.A. 2000, "Changes in brain neurofilament and beta-tubulin 
proteins after cerebral hypoxia-ischemia in rabbits", Pathobiology : journal of 
immunopathology, molecular and cellular biology, vol. 68, no. 1, pp. 43-52.  
Miyamoto, O. & Auer, R.N. 2000, "Hypoxia, hyperoxia, ischemia, and brain necrosis", 
Neurology, vol. 54, no. 2, pp. 362-371.  
Montal, M. 1998, "Mitochondria, glutamate neurotoxicity and the death cascade", 
Biochimica et biophysica acta, vol. 1366, no. 1-2, pp. 113-126.  
178 
 
Montero, C. 2003, "The antigen-antibody reaction in immunohistochemistry", The journal of 
histochemistry and cytochemistry : official journal of the Histochemistry Society, vol. 
51, no. 1, pp. 1-4.  
Morales, D.M., Marklund, N., Lebold, D., Thompson, H.J., Pitkanen, A., Maxwell, W.L., 
Longhi, L., Laurer, H., Maegele, M., Neugebauer, E., Graham, D.I., Stocchetti, N. & 
McIntosh, T.K. 2005, "Experimental models of traumatic brain injury: do we really 
need to build a better mousetrap?", Neuroscience, vol. 136, no. 4, pp. 971-989.  
Morganti-Kossmann, M.C., Yan, E. & Bye, N. 2010, "Animal models of traumatic brain 
injury: is there an optimal model to reproduce human brain injury in the laboratory?", 
Injury, vol. 41 Suppl 1, pp. S10-3.  
Mortimer, J.A., French, L.R., Hutton, J.T. & Schuman, L.M. 1985, "Head injury as a risk 
factor for Alzheimer's disease", Neurology, vol. 35, no. 2, pp. 264-267.  
Mosenthal, A.C., Lavery, R.F., Addis, M., Kaul, S., Ross, S., Marburger, R., Deitch, E.A. & 
Livingston, D.H. 2002, "Isolated traumatic brain injury: age is an independent predictor 
of mortality and early outcome", The Journal of trauma, vol. 52, no. 5, pp. 907-911.  
Muresan, V. 2000, "One axon, many kinesins: What's the logic?", Journal of neurocytology, 
vol. 29, no. 11-12, pp. 799-818.  
Murray, C.J. & Lopez, A.D. 1996, "Global Health Statistics", Cambridge, MA, Harvard 
School of Public Health, Global Burden of Disease and Injury Series, vol. II.   
Murray, G.D., Teasdale, G.M., Braakman, R., Cohadon, F., Dearden, M., Iannotti, F., 
Karimi, A., Lapierre, F., Maas, A., Ohman, J., Persson, L., Servadei, F., Stocchetti, N., 
Trojanowski, T. & Unterberg, A. 1999, "The European Brain Injury Consortium survey 
of head injuries", Acta Neurochirurgica, vol. 141, no. 3, pp. 223-236.  
Nag, S., Manias, J.L. & Stewart, D.J. 2009, "Pathology and new players in the pathogenesis 
of brain edema", Acta Neuropathologica, vol. 118, no. 2, pp. 197-217.  
Nakamura, Y., Takeda, M., Niigawa, H., Hariguchi, S. & Nishimura, T. 1992, "Amyloid 
beta-protein precursor deposition in rat hippocampus lesioned by ibotenic acid 
injection", Neuroscience letters, vol. 136, no. 1, pp. 95-98.  
National Center for Injury Prevention and Control (NCIPC) 2006, "Traumatic Brain Injury 
in the United States: Emergency Department Visits, Hospitalizations, and Deaths", 
Centers for Disease Control and Prevention, National Center for Injury Prevention and 
Control. Atlanta, GA, http://www.cdc.gov/traumaticbraininjury/  
Newcomb, J.K., Kampfl, A., Posmantur, R.M., Zhao, X., Pike, B.R., Liu, S.J., Clifton, G.L. 
& Hayes, R.L. 1997, "Immunohistochemical study of calpain-mediated breakdown 
products to alpha-spectrin following controlled cortical impact injury in the rat", 
Journal of neurotrauma, vol. 14, no. 6, pp. 369-383.  
Nguyen, M.D., Lariviere, R.C. & Julien, J.P. 2001, "Deregulation of Cdk5 in a mouse model 
of ALS: toxicity alleviated by perikaryal neurofilament inclusions", Neuron, vol. 30, 
no. 1, pp. 135-147.  
179 
 
Niess, C., Grauel, U., Toennes, S.W. & Bratzke, H. 2002, "Incidence of axonal injury in 
human brain tissue", Acta Neuropathologica, vol. 104, no. 1, pp. 79-84.  
Nixon, R.A. 1998, "The slow axonal transport of cytoskeletal proteins", Current opinion in 
cell biology, vol. 10, no. 1, pp. 87-92.  
Nixon, R.A. 1993, "The regulation of neurofilament protein dynamics by phosphorylation: 
clues to neurofibrillary pathobiology", Brain pathology (Zurich, Switzerland), vol. 3, 
no. 1, pp. 29-38.  
Nixon, R.A., Paskevich, P.A., Sihag, R.K. & Thayer, C.Y. 1994, "Phosphorylation on 
carboxyl terminus domains of neurofilament proteins in retinal ganglion cell neurons in 
vivo: influences on regional neurofilament accumulation, interneurofilament spacing, 
and axon caliber", The Journal of cell biology, vol. 126, no. 4, pp. 1031-1046.  
Nixon, R.A. & Sihag, R.K. 1991, "Neurofilament phosphorylation: a new look at regulation 
and function", Trends in neurosciences, vol. 14, no. 11, pp. 501-506.  
Norton, A.J., Jordan, S. & Yeomans, P. 1994, "Brief, high-temperature heat denaturation 
(pressure cooking): a simple and effective method of antigen retrieval for routinely 
processed tissues", The Journal of pathology, vol. 173, no. 4, pp. 371-379.  
Nukina, N., Kanazawa, I., Mannen, T. & Uchida, Y. 1992, "Accumulation of amyloid 
precursor protein and beta-protein immunoreactivities in axons injured by cerebral 
infarct", Gerontology, vol. 38 Suppl 1, pp. 10-14.  
Nunez, G., Benedict, M.A., Hu, Y. & Inohara, N. 1998, "Caspases: the proteases of the 
apoptotic pathway", Oncogene, vol. 17, no. 25, pp. 3237-3245.  
Oehmichen, M. & Meissner, C. 2006, "Cerebral hypoxia and ischemia: the forensic point of 
view: a review", Journal of forensic sciences, vol. 51, no. 4, pp. 880-887.  
Oehmichen, M., Meissner, C., Schmidt, V., Pedal, I. & Konig, H.G. 1999, "Pontine axonal 
injury after brain trauma and nontraumatic hypoxic-ischemic brain damage", 
International journal of legal medicine, vol. 112, no. 4, pp. 261-267.  
Oehmichen, M., Meissner, C., Schmidt, V., Pedal, I., Konig, H.G. & Saternus, K.S. 1998, 
"Axonal injury--a diagnostic tool in forensic neuropathology? A review", Forensic 
science international, vol. 95, no. 1, pp. 67-83.  
Oehmichen, M., Meissner, C., von Wurmb-Schwark, N. & Schwark, T. 2003, "Methodical 
approach to brain hypoxia/ischemia as a fundamental problem in forensic 
neuropathology", Legal medicine (Tokyo, Japan), vol. 5, no. 4, pp. 190-201.  
Ogata, M. & Tsuganezawa, O. 1999, "Neuron-specific enolase as an effective 
immunohistochemical marker for injured axons after fatal brain injury", International 
journal of legal medicine, vol. 113, no. 1, pp. 19-25.  
Ohgami, T., Kitamoto, T. & Tateishi, J. 1992, "Alzheimer's amyloid precursor protein 
accumulates within axonal swellings in human brain lesions", Neuroscience letters, vol. 
136, no. 1, pp. 75-78.  
180 
 
Okonkwo, D.O., Buki, A., Siman, R. & Povlishock, J.T. 1999, "Cyclosporin A limits 
calcium-induced axonal damage following traumatic brain injury", Neuroreport, vol. 
10, no. 2, pp. 353-358.  
Okonkwo, D.O., Pettus, E.H., Moroi, J. & Povlishock, J.T. 1998, "Alteration of the 
neurofilament sidearm and its relation to neurofilament compaction occurring with 
traumatic axonal injury", Brain research, vol. 784, no. 1-2, pp. 1-6.  
Okonkwo, D.O. & Povlishock, J.T. 1999, "An intrathecal bolus of cyclosporin A before 
injury preserves mitochondrial integrity and attenuates axonal disruption in traumatic 
brain injury", Journal of cerebral blood flow and metabolism : official journal of the 
International Society of Cerebral Blood Flow and Metabolism, vol. 19, no. 4, pp. 443-
451.  
Olson, J.D., Kaufman, H.H., Moake, J., O'Gorman, T.W., Hoots, K., Wagner, K., Brown, 
C.K. & Gildenberg, P.L. 1989, "The incidence and significance of hemostatic 
abnormalities in patients with head injuries", Neurosurgery, vol. 24, no. 6, pp. 825-832.  
Ommaya, A.K., Yarnall, P., Hirsch, A.E. & Harris, E.H. 1967, "Scaling of Experimental 
Data on Cerebral Concussion in Sub-Human Primates to Concussion Threshold for 
Man", 11th Stapp Car Crash Conference, pp. 73.  
Ordonez, N.G., Manning, J.T.,Jr & Brooks, T.E. 1988, "Effect of trypsinization on the 
immunostaining of formalin-fixed, paraffin-embedded tissues", The American Journal 
of Surgical Pathology, vol. 12, no. 2, pp. 121-129.  
Osborn, A.G., Blaser, S.I. & Salzman, K.L. 2002, Pocket radiologist-brain top 100 
diagnosis, Saunders Co, Salt Lake City: Amirsys Inc./W.B.  
Otsuka, N., Tomonaga, M. & Ikeda, K. 1991, "Rapid appearance of beta-amyloid precursor 
protein immunoreactivity in damaged axons and reactive glial cells in rat brain 
following needle stab injury", Brain research, vol. 568, no. 1-2, pp. 335-338.  
Park, E., Bell, J.D. & Baker, A.J. 2008, "Traumatic brain injury: can the consequences be 
stopped?", CMAJ : Canadian Medical Association journal = journal de l'Association 
medicale canadienne, vol. 178, no. 9, pp. 1163-1170.  
Paschal, B.M., Shpetner, H.S. & Vallee, R.B. 1987, "MAP 1C is a microtubule-activated 
ATPase which translocates microtubules in vitro and has dynein-like properties", The 
Journal of cell biology, vol. 105, no. 3, pp. 1273-1282.  
Pasqualin, A. 1998, "Epidemiology and pathophysiology of cerebral vasospasm following 
subarachnoid hemorrhage", Journal of neurosurgical sciences, vol. 42, no. 1 Suppl 1, 
pp. 15-21.  
Peek-Asa, C., McArthur, D., Hovda, D. & Kraus, J. 2001, "Early predictors of mortality in 
penetrating compared with closed brain injury", Brain injury : [BI], vol. 15, no. 9, pp. 
801-810.  
Pentland, B., Hutton, L.S. & Jones, P.A. 2004, "Late mortality after head injury", J Neurol 
Neurosurg Psychiatry, vol. 76, pp. 395-400.  
181 
 
Pettus, E.H., Christman, C.W., Giebel, M.L. & Povlishock, J.T. 1994, "Traumatically 
induced altered membrane permeability: its relationship to traumatically induced 
reactive axonal change", Journal of neurotrauma, vol. 11, no. 5, pp. 507-522.  
Pettus, E.H. & Povlishock, J.T. 1996, "Characterization of a distinct set of intra-axonal 
ultrastructural changes associated with traumatically induced alteration in axolemmal 
permeability", Brain research, vol. 722, no. 1-2, pp. 1-11.  
Petzold, A. 2005, "Neurofilament phosphoforms: surrogate markers for axonal injury, 
degeneration and loss", Journal of the neurological sciences, vol. 233, no. 1-2, pp. 183-
198.  
Pickard, J.D. & Czosnyka, M. 1993, "Management of raised intracranial pressure", Journal 
of neurology, neurosurgery, and psychiatry, vol. 56, no. 8, pp. 845-858.  
Pierce, J.E., Trojanowski, J.Q., Graham, D.I., Smith, D.H. & McIntosh, T.K. 1996, 
"Immunohistochemical characterization of alterations in the distribution of amyloid 
precursor proteins and beta-amyloid peptide after experimental brain injury in the rat", 
The Journal of neuroscience : the official journal of the Society for Neuroscience, vol. 
16, no. 3, pp. 1083-1090.  
Pike, B.R., Zhao, X., Newcomb, J.K., Posmantur, R.M., Wang, K.K. & Hayes, R.L. 1998, 
"Regional calpain and caspase-3 proteolysis of alpha-spectrin after traumatic brain 
injury", Neuroreport, vol. 9, no. 11, pp. 2437-2442.  
Pileri, S.A., Roncador, G., Ceccarelli, C., Piccioli, M., Briskomatis, A., Sabattini, E., Ascani, 
S., Santini, D., Piccaluga, P.P., Leone, O., Damiani, S., Ercolessi, C., Sandri, F., Pieri, 
F., Leoncini, L. & Falini, B. 1997, "Antigen retrieval techniques in 
immunohistochemistry: comparison of different methods", The Journal of pathology, 
vol. 183, no. 1, pp. 116-123.  
Pineda, J.A., Wang, K.K. & Hayes, R.L. 2004, "Biomarkers of proteolytic damage following 
traumatic brain injury", Brain pathology (Zurich, Switzerland), vol. 14, no. 2, pp. 202-
209.  
Pinkus, G.S., O'Connor, E.M., Etheridge, C.L. & Corson, J.M. 1985, "Optimal 
immunoreactivity of keratin proteins in formalin-fixed, paraffin-embedded tissue 
requires preliminary trypsinization. An immunoperoxidase study of various tumours 
using polyclonal and monoclonal antibodies", The journal of histochemistry and 
cytochemistry : official journal of the Histochemistry Society, vol. 33, no. 5, pp. 465-
473.  
Polak, J.M. & Van Noorden, S. 2003, Introduction to Immunohistochemistry, 3rd edn, 
Scientific Publisher Ltd, Oxford, UK.  
Pondaag, W. 1979, "Disseminated intravascular coagulation related to outcome in head 
injury", Acta neurochirurgica.Supplementum, vol. 28, no. 1, pp. 98-102.  
Popovic, E.A., Lyons, M.K., Scheithauer, B.W. & Marsh, W.R. 1994, "Mast cell-rich 
convexity meningioma presenting as chronic subdural hematoma: case report and 
review of the literature", Surgical neurology, vol. 42, no. 1, pp. 8-13.  
182 
 
Posmantur, R., Hayes, R.L., Dixon, C.E. & Taft, W.C. 1994, "Neurofilament 68 and 
neurofilament 200 protein levels decrease after traumatic brain injury", Journal of 
neurotrauma, vol. 11, no. 5, pp. 533-545.  
Povlishock, J.T., Hayes, R.L., Michel, M.E. & McIntosh, T.K. 1994, "Workshop on animal 
models of traumatic brain injury", Journal of neurotrauma, vol. 11, no. 6, pp. 723-732.  
Povlishock, J.T. & Jenkins, L.W. 1995, "Are the pathobiological changes evoked by 
traumatic brain injury immediate and irreversible?", Brain pathology (Zurich, 
Switzerland), vol. 5, no. 4, pp. 415-426.  
Povlishock, J.T., Marmarou, A., McIntosh, T., Trojanowski, J.Q. & Moroi, J. 1997, "Impact 
acceleration injury in the rat: evidence for focal axolemmal change and related 
neurofilament sidearm alteration", Journal of neuropathology and experimental 
neurology, vol. 56, no. 4, pp. 347-359.  
Qiu, W.Q., Ferreira, A., Miller, C., Koo, E.H. & Selkoe, D.J. 1995, "Cell-surface beta-
amyloid precursor protein stimulates neurite outgrowth of hippocampal neurons in an 
isoform-dependent manner", The Journal of neuroscience : the official journal of the 
Society for Neuroscience, vol. 15, no. 3 Pt 2, pp. 2157-2167.  
Raghupathi, R. & Huh, J.W. 2007, "Diffuse brain injury in the immature rat: evidence for an 
age-at-injury effect on cognitive function and histopathologic damage", Journal of 
neurotrauma, vol. 24, no. 10, pp. 1596-1608.  
Raghupathi, R. & Margulies, S.S. 2002, "Traumatic axonal injury after closed head injury in 
the neonatal pig", Journal of neurotrauma, vol. 19, no. 7, pp. 843-853.  
Raghupathi, R., Mehr, M.F., Helfaer, M.A. & Margulies, S.S. 2004, "Traumatic axonal 
injury is exacerbated following repetitive closed head injury in the neonatal pig", 
Journal of neurotrauma, vol. 21, no. 3, pp. 307-316.  
Ramos-Vara, J.A. 2005, "Technical aspects of immunohistochemistry", Veterinary 
pathology, vol. 42, no. 4, pp. 405-426.  
Reale, F., Delfini, R. & Mencattini, G. 1984, "Epidural hematomas", Journal of 
neurosurgical sciences, vol. 28, no. 1, pp. 9-16.  
Redfern, M. 2001, The Royal Liverpool Children's Inquiry Report.  
Reichard, R.R., Smith, C. & Graham, D.I. 2005, "The significance of beta-APP 
immunoreactivity in forensic practice", Neuropathology and applied neurobiology, vol. 
31, no. 3, pp. 304-313.  
Reichard, R.R., White, C.L.,3rd, Hladik, C.L. & Dolinak, D. 2003a, "Beta-amyloid precursor 
protein staining in nonhomicidal pediatric medicolegal autopsies", Journal of 
neuropathology and experimental neurology, vol. 62, no. 3, pp. 237-247.  
Reichard, R.R., White, C.L.,3rd, Hladik, C.L. & Dolinak, D. 2003b, "Beta-amyloid precursor       
protein staining of nonaccidental central nervous system injury in pediatric autopsies",   
Journal of neurotrauma, vol. 20, no. 4, pp. 347-355.  
183 
 
Rie, M.A. & Bernad, P.G. 1980, "Prolonged hypoxia in man without circulatory compromise 
fails to demonstrate cerebral pathology", vol. 30, pp. 443.  
Rish, B.L., Dillon, J.D. & Weiss, G.H. 1983, "Mortality following penetrating craniocerebral 
injuries. An analysis of the deaths in the Vietnam Head Injury Registry population", 
Journal of neurosurgery, vol. 59, no. 5, pp. 775-780.  
Ritter, M.A. 1986, Immunohistochemistry. Modern Methods and applications, Wright 
Bristol, England.  
Roberts-Lewis, J.M., Savage, M.J., Marcy, V.R., Pinsker, L.R. & Siman, R. 1994, 
"Immunolocalization of calpain I-mediated spectrin degradation to vulnerable neurons 
in the ischemic gerbil brain", The Journal of neuroscience : the official journal of the 
Society for Neuroscience, vol. 14, no. 6, pp. 3934-3944.  
Roder, H.M., Hoffman, F.J. & Schroder, W. 1995, "Phosphatase resistance of ERK2 brain 
kinase PK40erk2", Journal of neurochemistry, vol. 64, no. 5, pp. 2203-2212.  
Roder, H.M. & Ingram, V.M. 1991, "Two novel kinases phosphorylate tau and the KSP site 
of heavy neurofilament subunits in high stoichiometric ratios", The Journal of 
neuroscience : the official journal of the Society for Neuroscience, vol. 11, no. 11, pp. 
3325-3343.  
Ropper, A.H. & Brown, R.H. 2005, Adams and Victor's principles of neurology, McGraw-
Hill, New York.  
Rosenorn, J. & Gjerris, F. 1978, "Long-term follow-up review of patients with acute and 
subacute subdural hematomas", Journal of neurosurgery, vol. 48, no. 3, pp. 345-349.  
Roy, S., Zhang, B., Lee, V.M. & Trojanowski, J.Q. 2005, "Axonal transport defects: a 
common theme in neurodegenerative diseases", Acta Neuropathologica, vol. 109, no. 1, 
pp. 5-13.  
Saatman, K.E., Abai, B., Grosvenor, A., Vorwerk, C.K., Smith, D.H. & Meaney, D.F. 2003, 
"Traumatic axonal injury results in biphasic calpain activation and retrograde transport 
impairment in mice", Journal of cerebral blood flow and metabolism : official journal 
of the International Society of Cerebral Blood Flow and Metabolism, vol. 23, no. 1, pp. 
34-42.  
Saatman, K.E., Bozyczko-Coyne, D., Marcy, V., Siman, R. & McIntosh, T.K. 1996, 
"Prolonged calpain-mediated spectrin breakdown occurs regionally following 
experimental brain injury in the rat", Journal of neuropathology and experimental 
neurology, vol. 55, no. 7, pp. 850-860.  
Saatman, K.E., Creed, J. & Raghupathi, R. 2010, "Calpain as a therapeutic target in 
traumatic brain injury", Neurotherapeutics : the journal of the American Society for 
Experimental NeuroTherapeutics, vol. 7, no. 1, pp. 31-42.  
Saatman, K.E., Duhaime, A.C., Bullock, R., Maas, A.I., Valadka, A., Manley, G.T. & 
Workshop Scientific Team and Advisory Panel Members 2008, "Classification of 
184 
 
traumatic brain injury for targeted therapies", Journal of neurotrauma, vol. 25, no. 7, 
pp. 719-738.  
Saatman, K.E., Graham, D.I. & McIntosh, T.K. 1998, "The neuronal cytoskeleton is at risk 
after mild and moderate brain injury", Journal of neurotrauma, vol. 15, no. 12, pp. 
1047-1058.  
Sabo, S.L., Ikin, A.F., Buxbaum, J.D. & Greengard, P. 2001, "The Alzheimer amyloid 
precursor protein (APP) and FE65, an APP-binding protein, regulate cell movement", 
The Journal of cell biology, vol. 153, no. 7, pp. 1403-1414.  
Saikumar, P., Dong, Z., Weinberg, J.M. & Venkatachalam, M.A. 1998, "Mechanisms of cell 
death in hypoxia/reoxygenation injury", Oncogene, vol. 17, no. 25, pp. 3341-3349.  
Salinas, S., Bilsland, L.G. & Schiavo, G. 2008, "Molecular landmarks along the axonal 
route: axonal transport in health and disease", Current opinion in cell biology, vol. 20, 
no. 4, pp. 445-453.  
Sarabia, R., Lobato, R.D., Rivas, J.J., Cordobes, F., Rubio, J., Cabrera, A., Gomez, P., 
Munoz, M.J. & Madera, A. 1988, "Cerebral hemisphere swelling in severe head injury 
patients", Acta neurochirurgica.Supplementum, vol. 42, pp. 40-46.  
Saxena, S. & Caroni, P. 2007, "Mechanisms of axon degeneration: from development to 
disease", Progress in neurobiology, vol. 83, no. 3, pp. 174-191.  
Schafer, D.A., Gill, S.R., Cooper, J.A., Heuser, J.E. & Schroer, T.A. 1994, "Ultrastructural 
analysis of the dynactin complex: an actin-related protein is a component of a filament 
that resembles F-actin", The Journal of cell biology, vol. 126, no. 2, pp. 403-412.  
Schmidt, M.L., Carden, M.J., Lee, V.M. & Trojanowski, J.Q. 1987, "Phosphate dependent 
and independent neurofilament epitopes in the axonal swellings of patients with motor 
neuron disease and controls", Laboratory investigation; a journal of technical methods 
and pathology, vol. 56, no. 3, pp. 282-294.  
Schreiber, M.A., Aoki, N., Scott, B.G. & Beck, J.R. 2002, "Determinants of mortality in 
patients with severe blunt head injury", Archives of surgery (Chicago, Ill.: 1960), vol. 
137, no. 3, pp. 285-290.  
Seelig, J.M., Marshall, L.F., Toutant, S.M., Toole, B.M., Klauber, M.R., Bowers, S.A. & 
Varnell, J.A. 1984, "Traumatic acute epidural hematoma: unrecognized high lethality in 
comatose patients", Neurosurgery, vol. 15, no. 5, pp. 617-620.  
Serbest, G., Burkhardt, M.F., Siman, R., Raghupathi, R. & Saatman, K.E. 2007, "Temporal 
profiles of cytoskeletal protein loss following traumatic axonal injury in mice", 
Neurochemical research, vol. 32, no. 12, pp. 2006-2014.  
Shah, J.V. & Cleveland, D.W. 2002, "Slow axonal transport: fast motors in the slow lane", 
Current opinion in cell biology, vol. 14, no. 1, pp. 58-62.  
185 
 
Shannon, P., Smith, C.R., Deck, J., Ang, L.C., Ho, M. & Becker, L. 1998, "Axonal injury 
and the neuropathology of shaken baby syndrome", Acta Neuropathologica, vol. 95, no. 
6, pp. 625-631.  
Shavelle, R.M., Strauss, D., Day, S. & Ojdana, K. 2007, "Life expectancy" in Brain injury 
medicine: principle and practice, eds. N.D. Zasler, D.I. Katz & R.D. Zafonte, Demos, 
New York, pp. 247-261.  
Shavelle, R.M., Strauss, D., Whyte, J., Day, S.M. & Yu, Y.L. 2001, "Long-term causes of 
death after traumatic brain injury", American Journal of Physical Medicine & 
Rehabilitation / Association of Academic Physiatrists, vol. 80, no. 7, pp. 510-6; quiz 
517-9.  
Shaw, G., Osborn, M. & Weber, K. 1986, "Reactivity of a panel of neurofilament antibodies 
on phosphorylated and dephosphorylated neurofilaments", European journal of cell 
biology, vol. 42, no. 1, pp. 1-9.  
Shea, T.B. & Chan, W.K. 2008, "Regulation of neurofilament dynamics by 
phosphorylation", The European journal of neuroscience, vol. 27, no. 8, pp. 1893-1901.  
Sherriff, F.E., Bridges, L.R., Gentleman, S.M., Sivaloganathan, S. & Wilson, S. 1994a, 
"Markers of axonal injury in post mortem human brain", Acta Neuropathologica, vol. 
88, no. 5, pp. 433-439.  
Sherriff, F.E., Bridges, L.R. & Sivaloganathan, S. 1994b, "Early detection of axonal injury 
after human head trauma using immunocytochemistry for beta-amyloid precursor 
protein", Acta Neuropathologica, vol. 87, no. 1, pp. 55-62.  
Shetty, K.T., Link, W.T. & Pant, H.C. 1993, "cdc2-like kinase from rat spinal cord 
specifically phosphorylates KSPXK motifs in neurofilament proteins: isolation and 
characterization", Proceedings of the National Academy of Sciences of the United States 
of America, vol. 90, no. 14, pp. 6844-6848.  
Shi, S.R., Cote, R.J. & Taylor, C.R. 2001, "Antigen retrieval techniques: current 
perspectives", The journal of histochemistry and cytochemistry : official journal of the 
Histochemistry Society, vol. 49, no. 8, pp. 931-937.  
Shi, S.R., Cote, R.J. & Taylor, C.R. 1997, "Antigen retrieval immunohistochemistry: past, 
present, and future", The journal of histochemistry and cytochemistry : official journal 
of the Histochemistry Society, vol. 45, no. 3, pp. 327-343.  
Shi, S.R., Gu, J., Turrens, J., Cote, R.J. & Taylor, C.R. 2000, "Development of the antigen 
retrieval technique: philosophical and theortical bases" in Antigen Retrieval 
Techniques: Immunohistochemistry and Molecular Morphology, eds. S.R. Shi, J. Gu & 
C.R. Taylor, Eaton Publishing, Natick, MA.  
Shi, S.R., Imam, S.A., Young, L., Cote, R.J. & Taylor, C.R. 1995, "Antigen retrieval 
immunohistochemistry under the influence of pH using monoclonal antibodies", The 
journal of histochemistry and cytochemistry : official journal of the Histochemistry 
Society, vol. 43, no. 2, pp. 193-201.  
186 
 
Shi, S.R., Key, M.E. & Kalra, K.L. 1991, "Antigen retrieval in formalin-fixed, paraffin-
embedded tissues: an enhancement method for immunohistochemical staining based on 
microwave oven heating of tissue sections", The journal of histochemistry and 
cytochemistry : official journal of the Histochemistry Society, vol. 39, no. 6, pp. 741-
748.  
Shi, Y. 2004, "Caspase activation, inhibition, and reactivation: a mechanistic view", Protein 
science : a publication of the Protein Society, vol. 13, no. 8, pp. 1979-1987.  
Siesjo, B.K., Hu, B. & Kristian, T. 1999, "Is the cell death pathway triggered by the 
mitochondrion or the endoplasmic reticulum?", Journal of cerebral blood flow and 
metabolism : official journal of the International Society of Cerebral Blood Flow and 
Metabolism, vol. 19, no. 1, pp. 19-26.  
Signorini, D.F., Andrews, P.J., Jones, P.A., Wardlaw, J.M. & Miller, J.D. 1999, "Predicting 
survival using simple clinical variables: a case study in traumatic brain injury", Journal 
of neurology, neurosurgery, and psychiatry, vol. 66, no. 1, pp. 20-25.  
Sihag, R.K. & Nixon, R.A. 1991, "Identification of Ser-55 as a major protein kinase A 
phosphorylation site on the 70-kDa subunit of neurofilaments. Early turnover during 
axonal transport", The Journal of biological chemistry, vol. 266, no. 28, pp. 18861-
18867.  
Sihag, R.K. & Nixon, R.A. 1990, "Phosphorylation of the amino-terminal head domain of 
the middle molecular mass 145-kDa subunit of neurofilaments. Evidence for regulation 
by second messenger-dependent protein kinases", The Journal of biological chemistry, 
vol. 265, no. 7, pp. 4166-4171.  
Sihag, R.K. & Nixon, R.A. 1989, "In vivo phosphorylation of distinct domains of the 70-
kilodalton neurofilament subunit involves different protein kinases", The Journal of 
biological chemistry, vol. 264, no. 1, pp. 457-464.  
Siman, R., Baudry, M. & Lynch, G. 1984, "Brain fodrin: substrate for calpain I, an 
endogenous calcium-activated protease", Proceedings of the National Academy of 
Sciences of the United States of America, vol. 81, no. 11, pp. 3572-3576.  
Singleton, R.H., Stone, J.R., Okonkwo, D.O., Pellicane, A.J. & Povlishock, J.T. 2001, "The 
immunophilin ligand FK506 attenuates axonal injury in an impact-acceleration model 
of traumatic brain injury", Journal of neurotrauma, vol. 18, no. 6, pp. 607-614.  
Singleton, R.H., Zhu, J., Stone, J.R. & Povlishock, J.T. 2002, "Traumatically induced 
axotomy adjacent to the soma does not result in acute neuronal death", The Journal of 
neuroscience : the official journal of the Society for Neuroscience, vol. 22, no. 3, pp. 
791-802.  
Sisodia, S.S., Koo, E.H., Hoffman, P.N., Perry, G. & Price, D.L. 1993, "Identification and 
transport of full-length amyloid precursor proteins in rat peripheral nervous system", 
The Journal of neuroscience : the official journal of the Society for Neuroscience, vol. 
13, no. 7, pp. 3136-3142.  
187 
 
Smith, C. 2005, "The Neuropathology of Head Injury". Advances in Clinical Neuroscience 
& Rehabilitation, vol. 5, no. 1.  
Smith, C. 2001, The response of the brain to traumatic injury and genetic influences, 
University of Glasgow.  
Smith, C. & Graham, D.I. 2005, "Subdural and extradural hemorrhages" in Pathology and 
Genetics Cerebrovascular disease, ed. Y. Olsson, ISN Neuropath Press, Basel.  
Smith, C. & Graham, D.I. 2001, "The pathology of head injury", Advances in Clinical 
Neuroscience & Rehabilitation, vol. 3, pp. 148-151.  
Smith, C., Graham, D.I., Geddes, J.F. & Whitwell, H.L. 2003, "The interpretation of beta-
APP immunoreactivity: a response to C. Neiss et al., Acta Neuropathol (2002) 104:79", 
Acta Neuropathologica, vol. 106, no. 1, pp. 97-98.  
Smith, C., Graham, D.I., Murray, L.S., Stewart, J. & Nicoll, J.A. 2006, "Association of 
APOE e4 and cerebrovascular pathology in traumatic brain injury", Journal of 
neurology, neurosurgery, and psychiatry, vol. 77, no. 3, pp. 363-366.  
Smith, C., Graham, D.I., Whitwell, H.L., Geddes, J.F., Gentleman, S.M. & Leclercq, P.D. 
2002, "Letter referring to the publication Lambri et al", Clinical neuropathology, vol. 
21, no. 5, pp. 241-2; author reply 242.  
Smith, C. & Whitwell, H. 2004, "Non-traumatic neurological conditions in medico-legal 
work", vol. 10, pp. 116-127.  
Smith, D.H., Chen, X.H., Nonaka, M., Trojanowski, J.Q., Lee, V.M., Saatman, K.E., Leoni, 
M.J., Xu, B.N., Wolf, J.A. & Meaney, D.F. 1999, "Accumulation of amyloid beta and 
tau and the formation of neurofilament inclusions following diffuse brain injury in the 
pig", Journal of neuropathology and experimental neurology, vol. 58, no. 9, pp. 982-
992.  
Smith, D.H., Chen, X.H., Xu, B.N., McIntosh, T.K., Gennarelli, T.A. & Meaney, D.F. 1997, 
"Characterization of diffuse axonal pathology and selective hippocampal damage 
following inertial brain trauma in the pig", Journal of neuropathology and experimental 
neurology, vol. 56, no. 7, pp. 822-834.  
Smith, D.H., Meaney, D.F. & Shull, W.H. 2003, "Diffuse axonal injury in head trauma", The 
Journal of head trauma rehabilitation, vol. 18, no. 4, pp. 307-316.  
Smith, D.H., Nonaka, M., Miller, R., Leoni, M., Chen, X.H., Alsop, D. & Meaney, D.F. 
2000, "Immediate coma following inertial brain injury dependent on axonal damage in 
the brainstem", Journal of neurosurgery, vol. 93, no. 2, pp. 315-322.  
Soba, P., Eggert, S., Wagner, K., Zentgraf, H., Siehl, K., Kreger, S., Lower, A., Langer, A., 
Merdes, G., Paro, R., Masters, C.L., Muller, U., Kins, S. & Beyreuther, K. 2005, 
"Homo- and heterodimerization of APP family members promotes intercellular 
adhesion", The EMBO journal, vol. 24, no. 20, pp. 3624-3634.  
188 
 
Sompuram, S.R., Vani, K., Messana, E. & Bogen, S.A. 2004, "A molecular mechanism of 
formalin fixation and antigen retrieval", American Journal of Clinical Pathology, vol. 
121, no. 2, pp. 190-199.  
Sosin, D.M., Sniezek, J.E. & Waxweiler, R.J. 1995, "Trends in death associated with 
traumatic brain injury, 1979 through 1992. Success and failure", JAMA : the journal of 
the American Medical Association, vol. 273, no. 22, pp. 1778-1780.  
Stein, S.C., Graham, D.I., Chen, X.H., Dunn, L. & Smith, D.H. 2005, "Apo E genotype not 
associated with intravascular coagulation in traumatic brain injury", Neuroscience 
letters, vol. 387, no. 1, pp. 28-31.  
Stein, S.C., Graham, D.I., Chen, X.H. & Smith, D.H. 2004, "Association between 
intravascular microthrombosis and cerebral ischemia in traumatic brain injury", 
Neurosurgery, vol. 54, no. 3, pp. 687-91; discussion 691.  
Steiner, L.A. & Andrews, P.J. 2006, "Monitoring the injured brain: ICP and CBF", British 
journal of anaesthesia, vol. 97, no. 1, pp. 26-38.  
Sternberger, L.A. & Sternberger, N.H. 1983, "Monoclonal antibodies distinguish 
phosphorylated and nonphosphorylated forms of neurofilaments in situ", Proceedings 
of the National Academy of Sciences of the United States of America, vol. 80, no. 19, 
pp. 6126-6130.  
Stewart, W., Black, M., Kalimo, H. & Graham, D.I. 2004, "Non-traumatic forensic 
neuropathology", Forensic science international, vol. 146, no. 2-3, pp. 125-147.  
Stock, M.F., Guerrero, J., Cobb, B., Eggers, C.T., Huang, T.G., Li, X. & Hackney, D.D. 
1999, "Formation of the compact confomer of kinesin requires a COOH-terminal heavy 
chain domain and inhibits microtubule-stimulated ATPase activity", The Journal of 
biological chemistry, vol. 274, no. 21, pp. 14617-14623.  
Stone, J.R., Okonkwo, D.O., Dialo, A.O., Rubin, D.G., Mutlu, L.K., Povlishock, J.T. & 
Helm, G.A. 2004, "Impaired axonal transport and altered axolemmal permeability occur 
in distinct populations of damaged axons following traumatic brain injury", 
Experimental neurology, vol. 190, no. 1, pp. 59-69.  
Stone, J.R., Okonkwo, D.O., Singleton, R.H., Mutlu, L.K., Helm, G.A. & Povlishock, J.T. 
2002, "Caspase-3-mediated cleavage of amyloid precursor protein and formation of 
amyloid Beta peptide in traumatic axonal injury", Journal of neurotrauma, vol. 19, no. 
5, pp. 601-614.  
Stone, J.R., Singleton, R.H. & Povlishock, J.T. 2001, "Intra-axonal neurofilament 
compaction does not evoke local axonal swelling in all traumatically injured axons", 
Experimental neurology, vol. 172, no. 2, pp. 320-331.  
Strauss, D.J., Shavelle, R.M. & Anderson, T.W. 1998, "Long-term survival of children and 
adolescents after traumatic brain injury", Archives of Physical Medicine and 
Rehabilitation, vol. 79, no. 9, pp. 1095-1100.  
189 
 
Strich, S.J. 1961, "Shearing of nerve fibres as a cause of brain damage due to head injury. 
Apathological study of twenty cases", , pp. 443-8.  
Strich, S.J. 1956, "Diffuse degeneration of the cerebral white matter in severe dementia 
following head injury", Journal of neurology, neurosurgery, and psychiatry, vol. 19, 
no. 3, pp. 163-185.  
Strong, M.J., Strong, W.L., Jaffe, H., Traggert, B., Sopper, M.M. & Pant, H.C. 2001, 
"Phosphorylation state of the native high-molecular-weight neurofilament subunit 
protein from cervical spinal cord in sporadic amyotrophic lateral sclerosis", Journal of 
neurochemistry, vol. 76, no. 5, pp. 1315-1325.  
Stroobandt, G., Fransen, P., Thauvoy, C. & Menard, E. 1995, "Pathogenetic factors in 
chronic subdural haematoma and causes of recurrence after drainage", Acta 
Neurochirurgica, vol. 137, no. 1-2, pp. 6-14.  
Summers, C.R., Ivins, B. & Schwab, K.A. 2009, "Traumatic brain injury in the United 
States: an epidemiologic overview", The Mount Sinai journal of medicine, New York, 
vol. 76, no. 2, pp. 105-110.  
Sun, X.M., MacFarlane, M., Zhuang, J., Wolf, B.B., Green, D.R. & Cohen, G.M. 1999, 
"Distinct caspase cascades are initiated in receptor-mediated and chemical-induced 
apoptosis", The Journal of biological chemistry, vol. 274, no. 8, pp. 5053-5060.  
Susin, S.A., Lorenzo, H.K., Zamzami, N., Marzo, I., Brenner, C., Larochette, N., Prevost, 
M.C., Alzari, P.M. & Kroemer, G. 1999b, "Mitochondrial release of caspase-2 and -9 
during the apoptotic process", The Journal of experimental medicine, vol. 189, no. 2, 
pp. 381-394.  
Susin, S.A., Lorenzo, H.K., Zamzami, N., Marzo, I., Snow, B.E., Brothers, G.M., Mangion, 
J., Jacotot, E., Costantini, P., Loeffler, M., Larochette, N., Goodlett, D.R., Aebersold, 
R., Siderovski, D.P., Penninger, J.M. & Kroemer, G. 1999a, "Molecular 
characterization of mitochondrial apoptosis-inducing factor", Nature, vol. 397, no. 
6718, pp. 441-446.  
Susin, S.A., Zamzami, N. & Kroemer, G. 1998, "Mitochondria as regulators of apoptosis: 
doubt no more", Biochimica et biophysica acta, vol. 1366, no. 1-2, pp. 151-165.  
Svien, H.J. & Gelety, J.E. 1964, "On the Surgical Management of Encapsulated Subdural 
Hematoma. a Comparison of the Results of Membranectomy and Simple Evacuation", 
Journal of neurosurgery, vol. 21, pp. 172-177.  
Tagliaferri, F., Compagnone, C., Korsic, M., Servadei, F. & Kraus, J. 2006, "A systematic 
review of brain injury epidemiology in Europe", Acta Neurochirurgica, vol. 148, no. 3, 
pp. 255-68; discussion 268.  
Talalla, A. & Morin, M.A. 1971, "Acute traumatic subdural hematoma: a review of one 
hundred consecutive cases", The Journal of trauma, vol. 11, no. 9, pp. 771-777.  
Tandon, P.N. 1964, "Brain Stem Hemorrhage in Cranio-Cerebral Trauma", Acta 
Neurologica Scandinavica, vol. 40, pp. 375-385.  
190 
 
Tate, R.L., McDonald, S. & Lulham, J.M. 1998, "Incidence of hospital-treated traumatic 
brain injury in an Australian community", Australian and New Zealand Journal of 
Public Health, vol. 22, no. 4, pp. 419-423.  
Tatsuno, Y. & Lindenberg, R. 1974, "Basal subarachnoid hematomas as sole intracranial 
traumatic lesions", Archives of Pathology, vol. 97, no. 4, pp. 211-215.  
Taylor, C.R., Shi, S.R., Barr, N.J. & Wu, N. 2002, "Techniques of immunohistochemistry: 
principles, pitfalls, and standardization" in Diagnostic Immunohistochemistry, ed. D.J. 
Dabbs, Churchill Livingstone, New York.  
Taylor, C.R., Shi, S.R., Chen, C., Young, L., Yang, C. & Cote, R.J. 1996, "Comparative 
study of antigen retrieval heating methods: microwave, microwave and pressure cooker, 
autoclave, and steamer", Biotechnic & histochemistry : official publication of the 
Biological Stain Commission, vol. 71, no. 5, pp. 263-270.  
Teasdale, G. & Jennett, B. 1974, "Assessment of coma and impaired consciousness. A 
practical scale", Lancet, vol. 2, no. 7872, pp. 81-84.  
Thinakaran, G. & Koo, E.H. 2008, "Amyloid precursor protein trafficking, processing, and 
function", The Journal of biological chemistry, vol. 283, no. 44, pp. 29615-29619.  
Thompson, H.J., Lifshitz, J., Marklund, N., Grady, M.S., Graham, D.I., Hovda, D.A. & 
McIntosh, T.K. 2005, "Lateral fluid percussion brain injury: a 15-year review and 
evaluation", Journal of neurotrauma, vol. 22, no. 1, pp. 42-75.  
Thompson, H.J., McCormick, W.C. & Kagan, S.H. 2006, "Traumatic brain injury in older 
adults: epidemiology, outcomes, and future implications", Journal of the American 
Geriatrics Society, vol. 54, no. 10, pp. 1590-1595.  
Thornhill, S., Teasdale, G.M., Murray, G.D., McEwen, J., Roy, C.W. & Penny, K.I. 2000, 
"Disability in young people and adults one year after head injury: prospective cohort 
study", BMJ (Clinical research ed.), vol. 320, no. 7250, pp. 1631-1635.  
Thurman, D.J., Alverson, C., Dunn, K.A., Guerrero, J. & Sniezek, J.E. 1999, "Traumatic 
brain injury in the United States: A public health perspective", vol. 13, pp. 1-8.  
Tiret, L., Hausherr, E., Thicoipe, M., Garros, B., Maurette, P., Castel, J.P. & Hatton, F. 1990, 
"The epidemiology of head trauma in Aquitaine (France), 1986: a community-based 
study of hospital admissions and deaths", International journal of epidemiology, vol. 
19, no. 1, pp. 133-140.  
Tomlinson, B.E. 1970, "Brain-stem lesions after head injury", Journal of clinical 
pathology.Supplement (Royal College of Pathologists), vol. 4, pp. 154-165.  
Trapp, B.D. & Hauer, P.E. 1994, "Amyloid precursor protein is enriched in radial glia: 
implications for neuronal development", Journal of neuroscience research, vol. 37, no. 
4, pp. 538-550.  
Trost, L.C. & Lemasters, J.J. 1996, "The mitochondrial permeability transition: a new 
pathophysiological mechanism for Reye's syndrome and toxic liver injury", The 
191 
 
Journal of pharmacology and experimental therapeutics, vol. 278, no. 3, pp. 1000-
1005.  
Unterberg, A.W., Stover, J., Kress, B. & Kiening, K.L. 2004, "Edema and brain trauma", 
Neuroscience, vol. 129, no. 4, pp. 1021-1029.  
Vale, R.D., Funatsu, T., Pierce, D.W., Romberg, L., Harada, Y. & Yanagida, T. 1996, 
"Direct observation of single kinesin molecules moving along microtubules", Nature, 
vol. 380, no. 6573, pp. 451-453.  
Vale, R.D., Reese, T.S. & Sheetz, M.P. 1985, "Identification of a novel force-generating 
protein, kinesin, involved in microtubule-based motility", Cell, vol. 42, no. 1, pp. 39-50.  
Valiron, O., Caudron, N. & Job, D. 2001, "Microtubule dynamics", Cellular and molecular 
life sciences : CMLS, vol. 58, no. 14, pp. 2069-2084.  
Van Hecke, D. 2002, "Routine immunohistochemical staining today: Choices to make, 
challenges to take", , no. 25, pp. 45-54.  
Vaughan, K.T. & Vallee, R.B. 1995, "Cytoplasmic dynein binds dynactin through a direct 
interaction between the intermediate chains and p150Glued", The Journal of cell 
biology, vol. 131, no. 6 Pt 1, pp. 1507-1516.  
Vazquez-Barquero, A., Vazquez-Barquero, J.L., Austin, O., Pascual, J., Gaite, L. & Herrera, 
S. 1992, "The epidemiology of head injury in Cantabria", European journal of 
epidemiology, vol. 8, no. 6, pp. 832-837.  
Verhey, K.J., Lizotte, D.L., Abramson, T., Barenboim, L., Schnapp, B.J. & Rapoport, T.A. 
1998, "Light chain-dependent regulation of Kinesin's interaction with microtubules", 
The Journal of cell biology, vol. 143, no. 4, pp. 1053-1066.  
Viancour, T.A. & Kreiter, N.A. 1993, "Vesicular fast axonal transport rates in young and old 
rat axons", Brain research, vol. 628, no. 1-2, pp. 209-217.  
Vosler, P.S., Brennan, C.S. & Chen, J. 2008, "Calpain-mediated signaling mechanisms in 
neuronal injury and neurodegeneration", Molecular neurobiology, vol. 38, no. 1, pp. 78-
100.  
Wang, C.C., Schoenberg, B.S., Li, S.C., Yang, Y.C., Cheng, X.M. & Bolis, C.L. 1986, 
"Brain injury due to head trauma. Epidemiology in urban areas of the People's Republic 
of China", Archives of Neurology, vol. 43, no. 6, pp. 570-572.  
Wang, H.C. & Ma, Y.B. 2010, "Experimental models of traumatic axonal injury", Journal of 
clinical neuroscience : official journal of the Neurosurgical Society of Australasia, vol. 
17, no. 2, pp. 157-162.  
Wang, K.K. 2000, "Calpain and caspase: can you tell the difference?", Trends in 
neurosciences, vol. 23, no. 1, pp. 20-26.  
Wang, K.K., Posmantur, R., Nath, R., McGinnis, K., Whitton, M., Talanian, R.V., Glantz, 
S.B. & Morrow, J.S. 1998, "Simultaneous degradation of alphaII- and betaII-spectrin by 
192 
 
caspase 3 (CPP32) in apoptotic cells", The Journal of biological chemistry, vol. 273, 
no. 35, pp. 22490-22497.  
Wang, S., Hamberger, A., Yang, Q. & Haglid, K.G. 1994, "Changes in neurofilament protein 
NF-L and NF-H immunoreactivity following kainic acid-induced seizures", Journal of 
neurochemistry, vol. 62, no. 2, pp. 739-748.  
Waterman-Storer, C.M., Karki, S. & Holzbaur, E.L. 1995, "The p150Glued component of 
the dynactin complex binds to both microtubules and the actin-related protein centractin 
(Arp-1)", Proceedings of the National Academy of Sciences of the United States of 
America, vol. 92, no. 5, pp. 1634-1638.  
Watson, D.F., Fittro, K.P., Hoffman, P.N. & Griffin, J.W. 1991, "Phosphorylation-related 
immunoreactivity and the rate of transport of neurofilaments in chronic 2,5-
hexanedione intoxication", Brain research, vol. 539, no. 1, pp. 103-109.  
Watson, D.F., Griffin, J.W., Fittro, K.P. & Hoffman, P.N. 1989, "Phosphorylation-dependent 
immunoreactivity of neurofilaments increases during axonal maturation and beta,beta'-
iminodipropionitrile intoxication", Journal of neurochemistry, vol. 53, no. 6, pp. 1818-
1829.  
Weber, M., Grolimund, P. & Seiler, R.W. 1990, "Evaluation of posttraumatic cerebral blood 
flow velocities by transcranial Doppler ultrasonography", Neurosurgery, vol. 27, no. 1, 
pp. 106-112.  
Weinman, D. & Muttucumaru, B. 1969, "Extradural haematoma", The Ceylon medical 
journal, vol. 14, no. 2, pp. 60-71.  
Wijdicks, E.F., Bamlet, W.R., Maramattom, B.V., Manno, E.M. & McClelland, R.L. 2005, 
"Validation of a new coma scale: The FOUR score", Annals of Neurology, vol. 58, no. 
4, pp. 585-593.  
Wolf, C.M. & Eastman, A. 1999, "The temporal relationship between protein phosphatase, 
mitochondrial cytochrome c release, and caspase activation in apoptosis", Experimental 
cell research, vol. 247, no. 2, pp. 505-513.  
Wolf, J.A., Stys, P.K., Lusardi, T., Meaney, D. & Smith, D.H. 2001, "Traumatic axonal 
injury induces calcium influx modulated by tetrodotoxin-sensitive sodium channels", 
The Journal of neuroscience : the official journal of the Society for Neuroscience, vol. 
21, no. 6, pp. 1923-1930.  
Wood, D.E. & Newcomb, E.W. 1999, "Caspase-dependent activation of calpain during drug-
induced apoptosis", The Journal of biological chemistry, vol. 274, no. 12, pp. 8309-
8315.  
Wright, J. & Kariya, A. 1997, "Assault patients attending a Scottish accident and emergency 
department", Journal of the Royal Society of Medicine, vol. 90, no. 6, pp. 322-326.  
Wu, H.Y. & Lynch, D.R. 2006, "Calpain and synaptic function", Molecular neurobiology, 
vol. 33, no. 3, pp. 215-236.  
193 
 
Yabe, J.T., Pimenta, A. & Shea, T.B. 1999, "Kinesin-mediated transport of neurofilament 
protein oligomers in growing axons", Journal of cell science, vol. 112 ( Pt 21), no. Pt 
21, pp. 3799-3814.  
Yaghmai, A. & Povlishock, J. 1992, "Traumatically induced reactive change as visualized 
through the use of monoclonal antibodies targeted to neurofilament subunits", Journal 
of neuropathology and experimental neurology, vol. 51, no. 2, pp. 158-176.  
Yakovlev, A.G., Knoblach, S.M., Fan, L., Fox, G.B., Goodnight, R. & Faden, A.I. 1997, 
"Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological 
dysfunction after traumatic brain injury", The Journal of neuroscience : the official 
journal of the Society for Neuroscience, vol. 17, no. 19, pp. 7415-7424.  
Yam, P.S., Takasago, T., Dewar, D., Graham, D.I. & McCulloch, J. 1997, "Amyloid 
precursor protein accumulates in white matter at the margin of a focal ischaemic 
lesion", Brain research, vol. 760, no. 1-2, pp. 150-157.  
Yamashima, T. & Yamamoto, S. 1984, "How do vessels proliferate in the capsule of a 
chronic subdural hematoma?", Neurosurgery, vol. 15, no. 5, pp. 672-678.  
Yan, T., Feng, Y. & Zhai, Q. 2010, "Axon degeneration: Mechanisms and implications of a 
distinct program from cell death", Neurochemistry international, vol. 56, no. 4, pp. 529-
534.  
Yates, P.J., Williams, W.H., Harris, A., Round, A. & Jenkins, R. 2006, "An epidemiological 
study of head injuries in a UK population attending an emergency department", Journal 
of neurology, neurosurgery, and psychiatry, vol. 77, no. 5, pp. 699-701.  
Yildiz, A., Tomishige, M., Vale, R.D. & Selvin, P.R. 2004, "Kinesin walks hand-over-hand", 
Science (New York, N.Y.), vol. 303, no. 5658, pp. 676-678.  
Zaloshnja, E., Miller, T., Langlois, J.A. & Selassie, A.W. 2008, "Prevalence of long-term 
disability from traumatic brain injury in the civilian population of the United States, 
2005", The Journal of head trauma rehabilitation, vol. 23, no. 6, pp. 394-400.  
Zhao, X., Pike, B.R., Newcomb, J.K., Wang, K.K., Posmantur, R.M. & Hayes, R.L. 1999, 
"Maitotoxin induces calpain but not caspase-3 activation and necrotic cell death in 
primary septo-hippocampal cultures", Neurochemical research, vol. 24, no. 3, pp. 371-
382.  
Zoratti, M. & Szabo, I. 1995, "The mitochondrial permeability transition", Biochimica et 
biophysica acta, vol. 1241, no. 2, pp. 139-176.  
194 
 
8. Appendices  













































NEUROPATHOLOGIES AFTER TRAUMATIC BRAIN INJURY 











Division of Pathology (Forensic Medicine) 









1.PM Number  
      
 
2.Histological study   





3. Sex     


















5. Mechanism of Injury 
 








Male:         1  
Female:       2 
RTA:  1 
Fall:  2 
Assault: 3 
Not Known:  9 
<12 months:  1 
1-19 years:  2 
20-39 years:  3 
40-59 years:  4 
60-79 years:  5 
80+ years:  6 
 
 
No:               1  
Limited:   2 






 24 hours: 1           3 months: 7      
 48 hours: 2           6 months: 8 
 72 hours: 3 12 months: 9 
 7 days: 4           >12 months: 10 (specify          ) 
 14 days: 5            Not known: 99 




7.If survival <24 hours, specify hours           
 Instantaneous death:        00         
 Not known/not applicable: 99        
 
 
8.Fracture of skull 
 No:  1                 
 Yes:  2 
 Not known: 9 
 
 
9. Contusion Index 
 Absent:  1                
 Present:                2 




10.Diffuse ischaemic brain damage   (global ischaemia) 
 
           Absent:           1                 
Present:           2     







11.Intracranial Haematoma        
                                  L            R 
None:         1 Supratentorial-Extradural          
 2 cm diameter:       2   Subdural   
>2 cm diameter:       3   Subarachnoid   
           Present, size unknown:     4  Intracerebral- Frontal    
    Removed at operation:     5 
 Not known:        9  - Temporal    
       -Parietal    
       -Occipital    
      -Basal ganglia    
    Burst lobe -Frontal    
      -Temporal    
      -Parietal    
      -Occipital    
    Infratentorial- Extradural    
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      Subdural    
      Intracerebellar    
Burst lobe    
 
 
12.Raised Intracranial Pressure 
  
                                                                                                                       L  R 
Absent:          1      Supracallosal hernia                 
Macroscopic:          2               Tentorial hernia                
          Macro plus micro:    3   
                                                                                            Tonsillar hernia            
           Microscopic only:   4 
           Not known:        9 
     Secondary brainstem haemorrhage/infarction    
    
 
13.Diffuse traumatic axonal injury 
 
 
            Absent:  1                           
 DAI grade 1:  2 
 DAI grade 2:  3 











14.Diffuse vascular injury 
 
 Absent:              1               
 Present:            2 
 Not known:                       9 
 
 
15.Brain swelling  
        L R 
  Absent:                 1  Related to ischaemia:     4       
               brain damage 
 Related to contusions:  2           Related to combination: 5  
















































Number Sex Age Survival Time Type of trauma 
Fracture of 
skull Contusions ICH Swelling 
Ichaemia/ 
Hypoxia TAI 
NA127/82 M 54 Y NA NA - - - - - - 
NA042/82 M 66 Y 3 W NA + - LEDH - - - 
NA143/82 M 20 Y 1 Y and 4 Mo RTA - - - - - - 





Number Sex Age Survival Time Type of trauma 
Fracture of 
skull Contusions ICH Swelling 
Ichaemia/ 
Hypoxia TAI 
NA009/83 M 47 Y NA NA - - - + - - 
NA025/83 F 33 Y NA Fall - - - - - - 
NA128/83 M 25 Y 10 D Fall - - LEDH,RSAH + + - 
NA148/83 F 5 Y NA NA - - ICH + + - 
NA190/83 M 45 Y NA NA - - - - - - 
NA218/83 F 95 Y NA NA - - - - - - 
NA241/83 M 84 Y NA Fall + - RSDH + - - 
NA248/83 F 63 Y NA NA - - SDH   + - - 





Number Sex Age Survival Time Type of trauma 
Fracture of 
skull Contusions ICH Swelling 
Ichaemia/ 
Hypoxia TAI 
NA064/84 M 75 Y NA NA - - - - - - 
NA112/84 F 78 Y NA NA - - - - - - 








Number Sex Age Survival Time Type of trauma 
Fracture of 
skull Contusions ICH Swelling 
Ichaemia/ 
Hypoxia TAI 
NA019/85 F 67 Y NA NA + + EDH,SDH,SAH - - - 
NA147/85 M 73 Y NA NA - + SAH,SDH + - - 





Number Sex Age Survival Time Type of trauma 
Fracture of 
skull Contusions ICH Swelling 
Ichaemia/ 
Hypoxia TAI 
NA009/86 M 72 Y NA NA - - - - - - 
NA065/86 M NA NA NA - - ICH - - - 
NA124/86 M NA NA NA - - - - - - 
NA139/86 M 63 Y NA NA - - - - - - 
NA172/86 M 26 Y NA RTA - - - - - - 





Number Sex Age Survival Time Type of trauma 
Fracture of 
skull Contusions ICH Swelling 
Ichaemia/ 
Hypoxia TAI 
NA076/87 M 64 Y NA NA - - - - - - 
NA140/87 M 73 Y NA Fall - - - - - - 
NA177/87 M 67 Y NA NA - - SDH + - - 
NA328/87 M 28 Y NA NA - - SAH + - - 










Number Sex Age Survival Time Type of trauma 
Fracture of 
skull Contusions ICH Swelling 
Ichaemia/ 
Hypoxia TAI 
NA009/88 M 50 Y 6 D Fall + - EDH + - - 
NA011/88 F 27 Y NA NA - + - + - - 
NA012/88 F 75 Y NA Fall + + SAH,SDH - - - 
NA047/88 M 75 Y NA NA - - - - - - 
NA075/88 F 81 Y 4 H and 15 Min RTA - + SAH + - - 
NA076/88 M 79 Y 8 Y W.Accident - - - - - - 
NA093/88 F 59 Y 2 D Fall + + SDH,SAH,EDH + - - 
NA137/88 M 88 Y NA NA - - - - - - 
NA174/88 M 12 Y 1 D RTA - + SAH,REDH + - - 
NA213/88 F 59 Y 6 D Fall - + SAH - - - 
NA214/88 M 61 Y 7 H RTA + + SAH + - - 
NA215/88 M 64 Y 16 H Fall + + SDH,SAH - + - 
NA226/88 M 20 Y 4 H and 25 Min W.Accident + + SAH + - - 
NA259/88 M 74 Y NA NA - - SDH,EDH + + - 
NA261/88 M 4 M 50 Min RTA + - - - - - 
NA282/88 M 74 Y NA NA - - - - - - 
NA294/88 M 47 Y NA NA - - - - - - 
NA304/88 F 57 Y NA NA - + SDH + - - 
NA305/88 F 56 Y 9 H and 20 Min RTA - + - + - - 
NA306/88 M 62 Y NA RTA - + SAH + - - 
NA307/88 M 45 Y NA RTA - - - - - - 
NA359/88 M 54 Y 40 Min Fall + + - + - - 
NA406/88 M 52 Y 4 D Gunshot - - SAH,SDH + - - 
NA408/88 M 44 Y NA RTA - + SAH,EDH + - - 









Number Sex Age Survival Time Type of trauma 
Fracture of 
skull Contusions ICH Swelling 
Ichaemia/ 
Hypoxia TAI 
NA017/89 F 69 Y 2 Min Fall - - SAH - - - 
NA018/89 M 40 Y 18 D Fall - - SDH + + - 
NA021/89 F 29 Y 2 D RTA + + SAH,SDH + - - 
NA025/89 M 74 Y NA NA - - - - - - 
NA049/89 F 79 Y 12 D RTA - + SDH,SAH + + - 
NA051/89 M 64 Y NA Fall - + SAH,LSDH + - - 
NA070/89 M 67 Y 1 D and 6 H Fall - - SDH,EDH,SAH + - - 
NA088/89 M 74 Y NA NA - - - - - - 
NA091/89 F 88 Y 6 W Fall - + SDH + - - 
NA114/89 M 78 Y 6 D RTA + - SAH,ICH + - TAI 
NA118/89 M 53 Y NA Gunshot + - SAH - - - 
NA120/89 F 19 Y NA RTA - - - + - - 
NA137/89 M 8 Y 25 Min RTA - - - - - - 
NA138/89 F 78 Y NA Collapse + + - - - - 
NA140/89 F 34 Y NA NA - - - - - - 
NA182/89 F 65 Y NA Assault - + - + - - 
NA183/89 M 20 Y 2 H Fall + + - + - - 
NA185/89 F 57 Y 2 H Assault + - SAH,SDH + - - 
NA186/89 M 33 Y 2 D Assault - + EDH,SDH + - - 
NA212/89 M 21 Y 1 H and 30 Min RTA - + SAH + + - 
NA231/89 F 42 Y 50 Min Assault - - SAH + - - 
NA232/89 F 70 Y 4 H and 10 Min RTA + + - + - - 
NA251/89 F 40 Y NA Assault + - - + - - 
NA252/89 M 84 Y 1 D Fall - + SAH + - - 
NA260/89 M 77 Y NA Collapse - - - - - - 
NA262/89 M 21 Y 0 M RTA - - - + - - 
NA265/89 M 22 Y 0 M Fall - + - + - - 
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NA268/89 F 82 Y 5 D RTA - + SAH,SDH - - - 
NA278/89 M 78 Y 1 D RTA + - SAH + - - 
NA279/89 M 21 Y 0 M RTA - - SAH + - - 
NA280/89 F 25 Y 12 H RTA - + SAH,SDH + - TAI 
NA281/89 F 63 Y 3 D Fall - + SAH,SDH + - - 
NA282/89 M 23 Y 0 M RTA - + - + - - 
NA295/89 F 41 Y 0 M RTA + - - + - - 
NA296/89 M 42 Y 3 D RTA - - SAH,SDH + + TAI 
NA297/89 M 25 Y 0 M RTA + - SAH + - - 
NA309/89 M 35 Y 0 M Fall - + SAH,SDH + - - 
NA312/89 F 65 Y 20 M RTA - + SAH + - - 
NA318/89 M 18 Y 18 H RTA - + - + - - 
NA334/89 M 29 Y 55 Min Fall - + - + - - 
NA335/89 M 21 Y 18 H RTA - + SAH,SDH + - - 
NA339/89 M 27 Y 1 H RTA + + - + - - 
NA340/89 F 22 Y 0 M RTA - - - + + - 
NA362/89 M 18 Y 18 H RTA - + - + - - 
NA371/89 M 28 Y 0 M RTA - + SAH + + - 
NA372/89 F 62 Y 0 M RTA + - - + - - 
NA373/89 F 21 Y 0 M C.building - - - + + - 
NA374/89 M 35 Y 0 M C.building - - SAH,SDH + + - 
NA381/89 F 86 Y 4 D RTA + - ICH + - - 
NA382/89 M 25 Y 3 D RTA - - ICH,SDH + + - 
NA384/89 M 72 Y 24 H RTA - - SDH - + - 
NA407/89 F 54 Y 0 M F.Wall - + SDH + + - 
NA408/89 F 63 Y NA RTA - - - - + - 
NA409/89 F 26 Y 1 H Fall - + SAH + + - 












Number Sex Age Survival Time Type of trauma 
Fracture of 
skull Contusions ICH Swelling 
Ichaemia/ 
Hypoxia TAI 
NA015/90 M 73 Y NA Gunshot - - - - - - 
NA019/90 F 68 Y NA Fall - - SDH,SAH - - - 
NA020/90 M 69 Y 18 H RTA + - SAH,SDH,ICH + + - 
NA025/90 M 19 Y 8 H RTA - - SAH + - - 
NA050/90 F 16 Y 1 H RTA + - - + + - 
NA053/90 M 44 Y 18 H Fall - + SAH + - - 
NA055/90 M 57 Y 18 H RTA - + SAH + + - 
NA056/90 F 73 Y NA RTA + + SAH + - - 
NA065/90 F 74 Y 0 M Assault - - SAH + - - 
NA066/90 F 2 Y 0 M RTA - + SAH + + - 
NA067/90 M 30 Y 0 M RTA - + SAH + - - 
NA070/90 M 77 Y 40 H Fall - - SDH + - - 
NA071/90 M 36 Y 1 H RTA - + SAH + - - 
NA072/90 M 77 Y 11 D RTA - + SAH + - - 
NA077/90 M 34 Y NA NA - - SAH + - - 
NA078/90 M 21 Y 0 M RTA + + SAH,SDH + + - 
NA079/90 M 40 Y 0 M Fall + - SAH + - - 
NA080/90 M 68 Y 1 H RTA + - SAH,SDH + - - 
NA089/90 F 66 Y 1 D NA - + SAH,ICH + - - 
NA110/90 M 75 Y NA Dementia - + - - - - 
NA132/90 M 18 Y 5 D RTA - + RSDH,SAH,ICH + - TAI 
NA133/90 M 66 Y 1 D Fall + + RSDH,SAH + + - 
NA136/90 M 24 Y 0 M RTA - + SAH + + - 
NA155/90 M 39Y 20 H Assault - - RSDH + + - 
NA158/90 M 25 Y 0 M RTA - - - - - - 
NA160/90 F 83 Y 24 H RTA + + RSDH,SAH + - - 
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NA161/90 M 80 Y 13 Y RTA + - - - - - 
NA162/90 M 61 Y 9 H    Fall + + SAH,IVH + + - 
NA163/90 F 75 Y 0 M RTA + + SAH - + - 
AN164/90 M 20 Y 1 D and 2 H RTA - + ICH,SDH + + - 
NA171/90 F 78 Y Brief RTA + + SAH + - - 
NA172/90 M 20 Y Minimum Fall - - BSAH,BSAH - + - 
NA174/90 M 32 Y 19 H RTA + - BSDH,SAH + + - 
NA191/90 M 21 Y 30 H RTA + - BSDH,SAH + + - 
NA192/90 M 38 Y 2 H Fall + + SAH.SDH + + - 
NA197/90 M 82 Y 26 D RTA - - - - - - 
NA198/90 F 75 Y 24 H NA - - SAH + - - 
NA199/90 F 17 Y 0 M RTA + + - + + - 
NA200/90 F 51 Y 2 H RTA + - SAH + - - 
NA208/90 M 15 Y 0 M RTA - + SAH + - - 
NA209/90 F 35 Y NA Stabbing - - - + - - 
NA221/90 M 71 Y 24 H NA - + - - + - 
NA230/90 M 30 Y 8 Y RTA - - - - + - 
NA231/90 F 17 Y 0 M RTA - - SAH + - - 
NA239/90 M 30 Y 24 H RTA - + SAH,SDH + + - 
NA242/90 M 31 Y 45 M RTA + - - + - - 
NA243/90 M 43 Y 1 H RTA - - - - + - 
NA245/90 M 37 Y 1 H RTA + + SAH + + - 
NA260/90 M 18 Y 0 M RTA + + - + - - 
NA262/90 M 41 Y 3 H Assault - - - - + - 
NA280/90 M 77 Y 1 W Fall - + BSDH,LEDH,SAH + - - 
NA281/90 M 47 Y 31 Y RTA  + - - - - - 
NA288/90 F 69 Y 0 M Fall - - SAH - + - 
NA297/90 M 28 Y 20 Y RTA  + - - + - - 
NA303/90 F 66 Y NA NA - - - - - - 
NA307/90 M 30 Y 0 M Fall + + LSDH,SAH + + - 
NA308/90 M 51 Y 0 M RTA + + SAH - + - 
NA309/90 M 14 Y 0 M RTA + - SAH - + - 
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NA330/90 F 80 Y 10 H and 30 M Fall + + BSDH + + - 
NA336/90 M 59 Y 11 D NA + + RSDH + + - 
NA337/90 M 36 Y 0 M RTA - - SAH + + - 
NA338/90 M 53 Y 10 D NA - + REDH,SAH + + - 
NA339/90 M 33 Y 0 M RTA + - ICH + - - 
NA344/90 M 58 Y 0 M Fall  + + SAH + - - 
NA379/90 F 77 Y NA NA + + - - - - 
NA393/90 F 81 Y 0 M Fall - + SAH - - - 
NA423/90 M 36 Y 0 M RTA - - - - - - 
NA424/90 F 2 Y 1 H and 30 M Fall - + SAH + - - 
NA425/90 M 33 Y 12 Y RTA - - - + - - 
NA426/90 M 23 Y 35 M RTA - + SAH + - - 
NA449/90 M 42 Y 0 M RTA - - SAH + - - 
NA464/90 F 31 Y 6 H Fall - + RSDH + - - 
NA465/90 F 79 Y 20 D RTA - + ICH - + TAI 
NA497/90 M 59 Y 4 H RTA - + SDH,SAH,ICH + - TAI 
NA500/90 M 17 Y 0 M RTA + + SAH + + - 
NA520/90 M 6 Y 40 M  RTA - + - + - - 
NA522/90 M 19 Y 0 M RTA - - - + +   
NA523/90 M 54 Y 3 H and 30 M RTA + + SAH - + - 
NA524/90 M 50 Y 5 H and 10 M Fall + + SAH + - - 
NA525/90 M 13 Y 0 M RTA - + SAH + - - 
NA534/90   68 Y NA NA - - SDH - - - 
NA548/90 M 59 Y 0 M Fall - + IVH + - - 
NA549/90 M 82 Y 5 H   RTA - - SAH - - - 












Number Sex Age Survival Time Type of trauma 
Fracture of 
skull Contusions ICH Swelling 
Ichaemia/ 
Hypoxia TAI 
NA016/91 F 20 Y 55 M RTA - + H in brain stem + - - 
NA018/91 M 62 Y 31Y Fall + + - - + - 
NA032/91 M 75 Y 6 D Fall - + SAH,SDH + - - 
NA034/91 M 47 Y 12 H Fall - + SAH + - - 
NA035/91 M 20 y 30 M RTA - - SAH + - - 
NA036/91 M 32 Y 3 H Fall - + ICH + - - 
NA050/91 F 70 Y 2 H and 35 M RTA + + SDH,SAH,ICH + - - 
NA053/91 M 68 Y 34 Y Fall - + - - - - 
NA054/91 M 65 Y 8 H Fall + + ICH,SAH + + - 
NA076/91 M 35 Y NA RTA + + SAH + - - 
NA089/91 M 62 Y 3 D Fall + + LSDH + - - 
NA090/91 F 72 Y 13 H RTA - - LEDH,SAH + - - 
NA092/91 M 61 Y NA NA - - LSDH + - - 
NA112/91 M 26 Y 24 D Assault - + - + - TAI 
NA121/91 M 24 Y 1 H RTA - + - + - - 
NA143/91 M 8 Y 3 D RTA - + SDH + - TAI 
NA151/91 M 20 Y 5 H RTA - + SAH + - - 
NA154/91 M 76 Y 2 H RTA + + SAH + - - 
NA168/91 M 64 Y 2 D Fall - + SAH,SDH + - - 
NA177/91 M 7 Y 5 H and 15 M RTA - - SAH + + - 
NA189/91 M 38 Y 0 M By train - - SAH + + - 
NA207/91 M 49 Y NA NA - + SAH,PVH + + - 
NA221/91 M 19 M 2 H Fall - + - + - - 
NA222/91 M 76 Y 30 M RTA - - SAH,PVH,IVH - - - 
NA229/91 F 19 Y 1 H RTA - - SAH,H in BS + + - 
NA232/91 M 68 Y 35 Y RTA + + - - - - 
NA256/91 M 55 Y NA NA - + - - - - 
NA262/91 M 35 Y 20 H RTA - - - + + - 
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NA273/91 F 65 Y 45 M RTA + - SAH + + - 
NA288/91 M 58 Y 0 M RTA - + SAH + + - 
NA289/91 M 17 Y 45 M RTA + + - + + - 
NA291/91 M 27 Y 9 Y NA - - - + + - 
AN292/91 M 41 Y 10 D RTA + + ICH - + TAI 
NA301/91 M 77 Y NA NA - + - - + - 
NA319/91 M 16 Y 0 M RTA - + SAH + + - 
NA323/91 F 43 Y 0 M Fall - + SAH + - - 
NA324/91 M 54 Y NA NA - + - + - - 
NA337/91 M 20 Y 0 M RTA - + SAH + - - 
NA344/91 F 63 Y 2 D Fall + + SDH,SAH,H in brain stem + + - 
NA345/91 F 51 Y 0 M RTA + + SAH,Stem H + + - 
NA350/91 M 73 Y 0 M Fall - + - + - - 
NA352/91 M 52 Y NA NA - - SDH - - TAI 
NA357/91 M 38 Y 5 Y Fall + + ICH + - - 
NA358/91 F 75 Y 1 Y NA - - SAH - - - 
NA360/91 M 52 Y 4 H and 45 M RTA - + SAH,IVH + - - 
NA362/91 M 30 Y 2 D RTA - + SDH,SAH + - TAI 
NA377/91 M 18 Y 1 H RTA - - SAH.IVH + - - 
NA383/91 M 81 Y 1 M Fall + - RSDH,LEDH - - TAI 
NA384/91 M 21 Y 0 M RTA + + - + + - 
NA387/91 M 26 Y 0 M Fall + + SAH,IVH + + - 
NA398/91 F 67 Y 1 H and 40 M Assault - - SAH + - - 
NA401/91 M 20 Y 1 H and 15 M RTA + + SAH,IVH + - - 
NA413/91 F 23 Y 12 H RTA - + SDH + + - 
NA417/91 F 26 Y 0 M RTA + + SAH + + - 
NA418/91 F 13 Y 0 M RTA - - SAH + - - 
NA419/91 F 3 Y 1 H RTA - - - + + - 
NA446/91 F 46 Y NA NA - + SAH,ICH,IVH + + TAI 
NA447/91 F 5 Y 1 H RTA - + SAH + - - 
NA448/91 M 2 Y 1 H RTA - + - + - - 
NA449/91 M 6 Y 1H RTA - - - + - - 
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NA454/91 M 63 Y 0 M Fall - + SDH,SAH,ICH,EDH + + - 
NA456/91 M 20 Y 23 H Gunshot - + SAH,ICH + - - 
NA461/91 F 38 Y 40 M RTA - - SAH + + - 
NA470/91 F 21 Y 30 M RTA + + SAH + + - 
NA472/91 M 25 Y 0 M RTA + - - + - - 
NA484/91 M 39 Y 0 M RTA - + SAH,PVH + - - 
NA489/91 M 28 Y 0 M RTA - + SAH,SDH + - - 
NA490/91 F 15 y 0 M RTA - - - + + - 
NA491/91 F 44 Y 0 M RTA - - - + + - 
NA492/91 M 19 Y NA RTA - - SAH + - - 
NA494/91 F 28 Y NA RTA - + H in Pons + - - 





Number Sex Age Survival Time Type of trauma 
Fracture of 
skull Contusions ICH Swelling 
Ichaemia/ 
Hypoxia TAI 
NA060/92 M 16 Y 1 H and 45 M NA - + - + - - 
NA061/92 M 14 Y 40 M Fall - + SAH + - - 
NA062/92 F 39 Y NA Fall - + SAH + - - 
NA064/92 M 89 Y 9 D RTA - + ICH + - - 
NA066/92 M 19 Y 10 H Fall + + SAH + - TAI 
NA067/92 F 86 Y 5 H Fall - + SAH,IVH - - - 
NA068/92 M 64 Y 40 M RTA - - SAH + - - 
NA069/92 F 82 Y 1 H RTA - + SAH + - - 
NA070/92 F 19 Y 1 D RTA - + SAH + - - 
NA089/92 M 25 Y 18 M RTA - + SAH,IVH + - - 
NA091/92 F 76 Y 2 H RTA - - - - - - 
NA102/92 F 14 Y 17 H RTA - + ICH - + TAI 
NA105/92 M 47 Y 50 M RTA - - SAH + + - 
NA114/92 M 54 Y NA Fall + + SDH,H in BS + - - 
NA117/92 M 70 Y NA NA - - - + - - 
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NA120/92 F 15 Y NA RTA - + SAH,ICH + - - 
NA121/92 F 71 Y 3 H and 15M Fall - + SAH,H in Pons + - TAI 
NA122/92 M 20 Y NA RTA - + SAH - - - 
NA195/92 F 13 Y 45 M RTA + + SAH,SDH + + - 
NA126/92 F 75 Y 40 M RTA - - SAH + + - 
NA129/92 M 73 Y 30 M RTA + + SAH,IVH + + - 
NA132/92 M 42 Y 50 M Fall - + SAH - - - 
NA133/92 M 72 Y 45 M RTA + + SAH - - TAI 
NA134/92 M 35 Y NA NA - + SAH + - - 
NA145/92 M 3 M NA Fall - - BSDH,SAH - - - 
NA172/92 M 59 Y 14 Y Fall + + SDH,SAH + + - 
NA174/92 M 24 Y 35 M RTA + + SAH + + - 
NA176/92 M 64 Y 19 D RTA + + RSDH,ICH + - - 
NA178/92 M 65 Y 2 D RTA - - SAH - - - 
NA179/92 F 19 Y 1 Month Fall + + - + - - 
NA206/92 M 54 Y 25 M RTA - - SAH - + - 
NA210/92 M 47 Y 3 H and 30 M RTA - + SAH + + TAI 
NA211/92 M 28 Y 1 D RTA - + SAH,IVH + + - 
NA212/92 M 16 Y 2 D RTA + + SAH + + - 
NA213/92 M 44 Y 0 M RTA - + LSDH,SAH,IVH - + - 
NA238/92 M 23 M NA NA - - LSDH,SAH, H in BS + - - 
NA240/92 M 20 Y 1 H RTA - + H in Pons + - - 
NA242/92 M 54 Y NA NA - + - + - - 
NA245/92 M 67 Y 7 D Fall + - SDH,SAH,H in BS,ICH + + TAI 
NA246/92 M 25 y 0 M RTA + + SAH,H in BS + + - 
NA250/92 F 30 Y 30 M RTA - + SAH - - - 
NA251/92 F 65 Y 5 D Fall - - RSDH - - - 
NA286/92 F 90 Y 1 Month RTA - - LSDH,SAH - + TAI 
NA290/92 M 23 Y 0 M RTA - - SAH,H in BS + - - 
NA325/92 M 19 Y 1 H RTA - - - - + - 
NA331/92 F 86 Y 5 D RTA + + SAH,ICH + + TAI 
NA346/92 M 20 Y 45 M RTA - + SAH - - - 
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NA347/92 M 27 Y 2 H and 40 M RTA - - SAH,IVH + - - 
NA348/92 M 49 Y 1 D and 6 H Fall + + LSDH,SAH,ICH + - - 
NA350/92 M 27 Y 2 D Fall - + SAH,SDH + - - 
NA359/92 M 13 Y 2 D Fall - + SAH,IVH + - - 
NA366/92 M 18 Y 35 M RTA - - IVH + - - 
NA411/92 M 18 Y 2 H and 10 M RTA + - SAH,ICH + + - 
NA442/92 M 27 Y 0 M Gunshot - - SAH + - - 
NA449/92 M 88 Y 3 D Fall + + SDH,SAH,ICH - - - 
NA456/92 M 19 Y 1 H RTA - - SAH,H in Pons + - - 
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Fracture of 
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Ichaemia/ 
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NA003/93 M 43 Y 35 M RTA - + SAH + - - 
NA004/93 M 15 Y 1 D and 10 H RTA + + - + - - 
NA0047/93 F 84 Y 2 H RTA - - - - - - 
NA072/93 M 51 Y 40 M RTA - - SAH + + - 
NA130/93 M 38 Y 0 M RTA + + H in BS + - - 
NA131/93 M 54 Y NA RTA - - - - - - 
NA132/93 M 21 y 4 H Fall - - - + - - 
NA177/93 M 57 Y NA NA - + - - - - 
NA229/93 M 2 M NA NA - - SDH,SAH - - - 
NA235/93 F 18 M NA NA - + SAH,ICH + + - 
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Fracture of 
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Ichaemia/ 
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NA131/94 M 71 Y NA RTA - - - - - - 
NA156/94 M 21 M NA Fall - - SAH,RSDH + - TAI 
NA175/94 F 69 Y 2 D Fall - - - + - - 
NA189/94 F 57 Y 15 D Fall + + SAH,H in BS - - - 
NA211/94 M 52 Y 3 Y W.Accident - - - - + - 
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Fracture of 
skull Contusions ICH Swelling 
Ichaemia/ 
Hypoxia TAI 
NA026/95 M 87 Y NA NA - - LICH,SAH + - TAI 
NA038/95 M 70 Y 9 D Fall - - IVH + - TAI 
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Fracture of 
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NA006/96 F 9 Y 1 D and 7 H RTA + + ICH,LSDH,REDH + - TAI 
NA032/96 M 46 Y NA Fall + + SAH,BSDH + + - 
NA055/96 M 8 Y NA RTA - + ICH,SAH + - TAI 
NA149/96 F 3 Y 9 H    Fall + + EDH,SAH,IVH,ICH,H in BS + + - 
NA197/96 M 54 Y NA Fall + + SDH,SAH,IVH + + TAI 
NA202/96 F 3 Y 9 H    RTA - - - + + - 
NA382/96 M 26 Y 12 D Fall - + ICH + + TAI 
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Fracture of 
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NA102/97 M 50 Y NA RTA - + SDH,EDH,SAH + + - 
NA103/97 M 55 Y NA Fall - + SDH,SAH,H in BS + + TAI 
NA211/97 M 65 Y 26 Y RTA - - - - - - 
NA262/97 M 48 Y 10 D Fall - + LSDH,SAH,IVH + + - 
NA268/97 M 26 Y NA Assault - - SAH,SDH + - TAI 
NA269/97 F 3 M NA NA - - SAH + - - 
NA322/97 F 11 Y NA Fall + + EDH,SDH + + - 
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Fracture of 
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NA036/98 M 57 Y NA NA - + - - - - 
NA047/98 M 10 Y NA Fall + - EDH,SAH + + TAI 
NA197/98 F 11 Y 1 D RTA + + SAH,IVH + + - 
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Fracture of 
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Ichaemia/ 
Hypoxia TAI 
NA074/99 M 41 Y NA NA - - SDH - + - 
NA103/99 M 32 Y 1 D Assault - + - + + TAI 
NA280/99 M 26 Y 5 D Assault - - - + + - 
NA314/99 M 89 Y NA Fall - - SDH - - - 
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Fracture of 
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NA101/00 M 30 Y 14 D Assault - + - + + - 
NA143/00 M 12 Y NA RTA - - - - - - 
NA151/00 M 3 Y NA RTA + + SAH - - - 
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Fracture of 
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Ichaemia/ 
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NA116/01 F 9 Y 7 D RTA - + SDH,SAH + + TAI 
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Fracture of 
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NA043/02 F 3 Y 1 H and 30 M Assault - - SDH,SAH + + TAI 
NA056/02 M 67 Y 5 D Fall + + SAH,H in BS,IVH + - TAI 
NA057/02 F 37 Y 1 D Assault - - SAH + - - 
NA060/02 M 40 Y 2 D RTA - - - - - TAI 
NA129/02 M 4 Y 1 H RTA + + SAH + + TAI 
NA150/02 M 43 Y NA Assault - - LSDH - + - 
NA160/02 M 82 Y 2 D Assault - - LSDH,ICH - - - 
NA188/02 M 26 Y 1 D NA + + SDH,SAH + + - 
NA189/02 F 84 Y NA NA - - LSDH - + - 
NA198/02 F 48 Y NA NA - - SAH - + TAI 
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NA058/03 F 75 Y 3 H and 30 M RTA - + SAH - - - 
NA113/03 M 38 Y 15 H Assault - - SAH - - - 
NA176/03 M 69 Y 10 Y NA + + - - - - 
NA179/03 M 10 Y 2 H RTA + + PVH + - - 
NA182/03 M 64 Y 5 H and 45 M Fall - + RSDH,SAH,EDH + - TAI 
NA185/03 F 51 Y NA Fall - - RSDH - - - 
NA210/03 M 86 Y NA Assault - - SAH,LICH - - - 
NA211/03 M 36 Y 1 M and 24 D Assault - - LSDH,SAH,H in BS - + - 
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Fracture of 
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UA095/04 M 22 Y 2 H RTA - - SAH + + TAI 
UA149/04 M 9 Y 1 H and 15 M Fall + + LSDH,SAH + + TAI 
UA218/04 M 65 Y 1 Y Fall - + - - + - 
UA274/04 M 51 Y NA Assault - - SAH - + TAI 
UA275/04 M 56 Y 0 M Fall + + SAH + - - 
UA386/04 M 41 0 M Assault + + H in Pons - - TAI 
UA390/04 M 64 Y 3 W Fall - + SAH,LSDH - - - 
UA392/04 F 9 Y 45 M RTA - - - + - - 
UA400/04 F 49 y 26 D RTA - + - - + TAI 
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Ichaemia/ 
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UA103/05 F 10 Y 40 M RTA - + - + + - 









































8.3.1 Cutting of paraffin-embedded tissue sections 
 [1] Preparing the water bath- 
1/ Fill the water path and heat to 40ºC. 
2/ Remove trapped air bubbles with designated „wet‟ brush. 
3/ Skim a piece of paper across water surface to remove any dust particles. 
[2] Attaching the tissue sample- 
1/ Make sure that the wheel brake is applied. 
2/ Secure the tissue block into its clamp. 
[3] Positioning the blade- 
1/ Ensure that the microtome wheel is in locked position.  
2/ Remove the microtome blade from its cassette and place in the blade clamp. 
3/ Lock the blade into position and raise the blade guard.   
[4] Adjusting the tissue block- 
1/ Lower the blade guard and release the wheel brake and slowly line the block up 
with the blade, advancing the block with the wheel. 
2/ Use the horizontal and vertical adjustment levers on the block holder to ensure that 
the block face is exactly perpendicular to the blade. 
3/ Clamp the block into position, apply the wheel brake, and replace the blade guard.   
[5] Cutting sections- 
1/ Adjust the microtome to the desire thickness setting (5 µm thick sections) 
2/ Use the designated „dry‟ brush to flatten out any imperfections. 





[6] Floating sections onto slides- 
1/ Dip the „wet‟ brush into the water bath and use it to gently lift the cut sections 
from the microtome and float onto the water surface.  
2/ Lift each section from the water bath onto the surface of a Superfrost plus slide, 
label, and place into a slide rack. 
3/ Incubate slides to dry at 37ºC overnight in a fan assisted cabinet.  
8.3.2 Immunohistochemistry protocol (ABC method) 
[1] Deparaffinization and rehydration- 
1/ Put the slides in a slide rack and place in Xylene for 5 minutes [x2]. 
2/ Rehydrate the sections by placing in graded alcohol solutions, 74OP (99% 
alcohol) for 5 minutes [x2] followed by 70% alcohol for 5 minutes [x2].  
3/ Immerse the slides in picric acid for 20-30 minutes to ensure all residual formalin 
has been removed from the sections. 
4/ Rinse in running water until the sections are clear of picric acid. 
[2] Antigen retrieval and immunohistochemical staining- 
1/ Perform antigen retrieval pre-treatment if required. 
2/ Quench endogenous peroxidases by placing slides in hydrogen peroxide (3%) for 
10 minutes. 
3/ Rinse in water. 
4/ Attach slides to coverplates and insert into Sequenza rack. 
5/ Rinse sections with TBS. 
6/ Incubate sections in serum (1 in 5 dilution in TBS) for 10 minutes. 
7/ Incubate sections with primary antibody (diluted in serum/TBS) for 30 minutes. 
8/ Rinse with TBS. 
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9/ Incubate sections with biotinylated antibody (diluted in serum/TBS) for 30 
minutes. 
10/ Rinse with TBS. 
11/ Incubate with ABC for 30 minutes. 
12/ Rinse with TBS. 
13/ Remove slides from Sequenza and incubate with DAB (or other chromogen) 
until the desired intensity is achieved, usually 30-60 seconds. 
14/ Rinse slides in running water. 
15/ Counterstain sections by dipping briefly in haematoxylin. 
16/ Rinse in running water. 
17/ Dip in Lithium carbonate. 
18/ Dehydrate the sections by briefly immersing in graded alcohol (70%, 99%, and 
absolute alcohol). 
19/ Immerse in xylene [x3]. 
20/ Coverslip sections using Pertex mounting medium.      
8.3.3 Double immunofluorescent labelling protocol 
[1] Staining for first antigen- 
1/ Wash sections in buffer (PBS) for 2 minutes [x2]. 
2/ Perform Avidin/Biotin blocking if required. 
3/ Incubate sections for 5 minutes in working solution of M.O.M.™ diluent.  
4/ Incubate section in diluted primary antibody for 30 minutes (dilute primary 
antibody in M.O.M.™ diluent to the appropriate concentration).  
5/ Wash sections in buffer for 2 minutes [x2]. 
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6/ Apply working solution of M.O.M.™ Biotinylated Anti-Mouse IgG Reagent for 
10 minutes.   
7/ Wash sections in buffer for 2 minutes [x2]. 
8/ Incubate sections with Fluorescein Avidin DCS for 5 minutes. 
9/ Wash sections in buffer for 5 mintes [x2]. 
[2] Staining for second antigen- 
1/ Perform Avidin/Biotin blocking step to prevent the interaction of the second set of 
labelling reagents with the first set of labelling reagents. 
2/ Incubate sections for 5 minutes in working solution of M.O.M.™ diluent.  
3/ Incubate section in diluted primary antibody for 30 minutes (dilute primary 
antibody in M.O.M.™ diluent to the appropriate concentration).  
4/ Wash sections in buffer for 2 minutes [x2]. 
5/ Apply working solution of M.O.M.™ Biotinylated Anti-Mouse IgG Reagent for 
10 minutes.   
6/ Wash sections in buffer for 2 minutes [x2]. 
7/ Incubate sections with Texas Red
®
 Avidin DCS (at a concentration of 15-20 µg/ml 
in buffer) for 5-10 minutes. 
8/ Wash sections in buffer for 5 minutes [x2]. 
9/ Mount with appropriate VECTASHIELD
®
 mounting media. 







8.4 Appendix 4  
Manuscripts in preparation 
Al-Hasani OH, Smith C. Traumatic white matter injury and Toxic leukoencephalopathies. Expert 
Review in Neurotherapeutics  
Al-Hasani OH, Smith C. The evolution of TAI diagnosis in neuropathology practice over a 40 
year period. (Submission to Neuropathol Applied Neurobiol) 
Al-Hasani OH, Ibrahim NG, Eucker SA, Ralston J, Margulies SS, Smith C. Sub-populations of 
traumatically injured axons in a gyrencephalic animal model and human. (Submission to J 
Neurotrauma)  
 
